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ABSTRACT
The effect of photolysis of nitroprusside was 
investigated in both frog ventricular trabeculae and rabbit 
ear arterial strips. Unphotolysed nitroprusside failed to 
elicit any effect on frog ventricular twitch tension. However, 
upon photolysis it had a potent negative inotropic action. The 
extent of twitch depression was shown to depend on the degree 
of photolysis. It was postulated that these effects are due to 
a labile physiologically active photolytic product. This was 
positively identified as nitric oxide. Preliminary results of 
the negative inotropic action of thiols and synthesised 
nitrosothiols are also presented. In contrast to frog 
ventricle, intact nitroprusside does exert a relaxing effect 
on precontracted mammalian smooth muscle. This effect is 
markedly potentiated by photolysis. It is concluded that the 
mechanism of action of nitroprusside on both tissues involves 
the release of nitric oxide which is postulated to activate 
guanylate cyclase. This suggests that mammalian vascular 
smooth muscle has a mechanism for degrading nitroprusside 
which is absent in frog ventricle.
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CHAPTER 1.
Literature review
Chapter 1 
INTRODUCTION
Despite almost a century and a half of scientific 
investigation, nitroprusside (NP) is still a subject of much 
controversy today. Questions about its structure, electron 
distribution, chemical properties, photolysis and reaction 
sequences still remain. Its clinical use in the management of 
hypertension is still under dispute due to its potential 
toxicity. The cellular mechanism which underlies its 
antihypertensive effect has yet to be fully elucidated. Over 
the years it has been used as an agent in chemical and 
pharmaceutical analysis, a therapeutic agent for hypertension 
and cardiac failure, and more recently as a pharmacological 
tool to specifically raise the intracellular concentration of 
cyclic guanosine monophosphate(cGMP) in a wide variety of 
tissues. In this last context, NP was first employed in this 
laboratory to test a hypothesis concerning the role of cGMP in 
frog cardiac muscle. Aware of the photosensitivity of the 
drug, these experiments were conducted in complete darkness. 
Unexpectedly, a response to NP could only be elicited if the 
room lighting was switched back on. This result led to a more 
detailed investigation of the mechanism of action of NP on 
both frog cardiac and mammalian smooth muscles, the results of 
which are presented in this thesis.
As there have been several specific reviews on various 
facets of NP (Rucki, 1977; Van Loenen & Hofs Kemper, 1978; 
Kreye, 1980; Leeuwenkamp, van Bennekom, van der Mark & Bult, 
1984; Butler & Glidewell, 1987), this introduction will 
concentrate on those aspects which are relevant to its 
physiological action.
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History
Nitroprusside was first prepared by the St. Andrews 
chemist Playfair in 1849. He noted that it reacted with a wide 
variety of chemicals to produce vividly coloured solutions, 
and stated that it was "by far the best test for the presence 
of a sulphuret . Similar investigations led to its early use 
in pharmaceutical analysis for the detection of sulphite 
(Boedecker, 1861); ketone bodies in the urine of diabetics 
(Legal, 1883); and primary and secondary aliphatic amines 
(Simon, 1897; Rimini, 1898) (see refs, in Leeuwenkamp et al, 
1984 & Swinehart, 1967). By 1961, numerous colour reactions
with a wide variety of organic and inorganic substances had 
been reported (Swinehart, 1967), The characteristic colour 
produced by the addition of NP to thiol (-SH) containing 
compounds led to its widespread use in the determination of 
glutathione and cysteine in blood (Vesey & Batistoni, 1977). 
Ketone bodies in serum and urine are still being measured 
using NP (Vesey & Batistoni, 1977),
The hypotensive action of NP was described as early as 
1887 by Davidsohn in his PhD thesis. It is perhaps indicative 
of how little read PhD theses are that it was not until some 
40 years later that Johnson performed the first clinical 
trial. He reported that NP lowered the blood pressure of a 
hypertensive patient with no undesirable side effects. Tests 
on a variety of laboratory species showed that NP was 50-1000 
times more potent in reducing blood pressure than nitrite, 
although the vascular effects of the two anions were otherwise 
similar (Johnson, 1929).
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Modern medical interest was re-kindled by Page and his 
colleagues (1955) who described the cardiovascular effects of 
NP on both animals and hypertensive patients. In this study, 
NP was given orally to hypertensive patients for periods of up 
to two years. It was also the first study to administer NP 
intravenously, and showed that its hypotensive action was much 
greater than with oral administration (Page, Corcoran, Dustan, 
& Koppanyi, 1955). Symptoms of hypertensive encephalopathy 
were completely alleviated by constant infusion of NP for up 
to 14 days, with no deleterious effects. The ability to reduce 
arterial pressure to a constant level by alteration of the 
infusion rate, led to NP being introduced in the 1960's as an 
agent to induce hypotension during surgical procedures under 
anaesthesia (Jones & Cole, 1968). In 1976, the introduction of 
sodium nitroprusside under the brand names Nipride (Roche) or 
Nipruss (Pharma-Schwarz) established its widespread use in the 
treatment of hypertension. Recently however, its use has been 
severely restricted by reports that it releases cyanide upon 
intravenous infusion (Smith & Krusyna, 1974; Vesey & 
Batistoni, 1977; Smith, Aitken, West, Peterson & Posnanski, 
1977; Arnold, Longnecker & Epstein, 1984). Several deaths have 
occured through cyanide poisoning following NP administration 
(Merrifield & Blundell, 1974). To counter this, low infusion 
rates and/or concomitant infusion of cyanide antedotes have 
been recomended (Kreye, 1980). Despite this, its therapeutic 
advantages have led to NP being called the 'drug of choice' 
for inducing hypotension during surgery (Kreye, 1980).
Chemistry
-Page 1.3-
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i.Structure
Sodium nitroprusside, sodium nitroprussate and sodium 
nitroferricyanide are all common names for the inorganic salt 
disodium nitrosylpentacyanoferrate{2-)dihydrate. This has the 
formula Na2Fe(CN)^N0.2H20, a molecular weight of 297.9, and 
is normally formed as dark ruby red crystals. The structure of 
the nitroprusside anion as determined by X-ray diffraction , 
infrared and Raman analysis is shown in figure 1:1 (Rucki,
1977; Butler & Glidewell, 1987; Leeuwenkamp, Van Bennekom, Van 
der Mark & Bult, 1984). Although there is some controversy 
over the exact molecular orbital distribution of the electrons 
(Rucki,1977; Leeuwenkamp et al, 1984), it is generally agreed 
that the unpaired electron of the NO group shifts towards the 
central metal ion thus resulting in a nitrosyl group with a 
formal charge of -Hi and a ferrous ion (+2). The nitrosyl group 
is susceptible to attack from nucleophil ic agents (ie bases), 
which explains the high reactivity of NP with a wide variety 
of these agents. It is this bond which is also susceptible to ft
5photolytic cleavage. Î
ii. Photochemistry
The unpaired electron of NO predominantly resides in
the lower energy orbitals of the ferrous ion (61% Fe (d ,d )xy y z
: 25% N0( 71*)), but irradiation with relatively long
wavelength light (>390nm) imparts enough energy to transfer it 
to a higher energy orbital located on the NO group (23% Fe :
73% NO) (Wolfe & Swinehart, 1975; Leeuwenkamp et al, 1984).
This transition to an excited state causes a weakening of 
the metal-ligand bond strength, and can result in bond 
cleavage as the bond disposes of its excess energy. This is
-Page 1.4-
Figure 1:1
The structure of nitroprusside.
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Table 1:1
Electronic spectrum of nitroprusside.
Band €(M~^cm“^) Assignment
I 498 8 Zb^— 7e *^ xy — 7t*(N0)
II 396 25 6e — ► 7 e ‘^ xy,yz— 7T* ( NO )
III 330 40 Zb^— ► 3bj <^ xy - dx2_y2
IV 265 900 6e —  53]^ *^xz,yz " dz2
V 238 700 6e — ^ 3b^ ‘^ xz.yz dx2_y2
r Wolfe & Swinehart , 1975 and Leeuwenkamp et al. 1984)
-Fig. 1:1
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summarised in table 1:1 which shows the electronic spectrum of 
NP together with the character of the absorption bands. Notice 
that wavelengths shorter than 400nm are all involved with d~d 
electron transitions. This would result in nonspecific 
metal-ligand cleavage (ie loss of CN ) and may account for the 
various photolytic products reported (ie. prussian blue, 
cyanide, ferrous ions etc) (Wolfe & Swinehart, 1975). A more 
extensive review of the photochemistry of NP is discussed in 
the introduction to chapter 4.
iii. Chemical reactions
Nitroprusside has numerous reactions with a variety of 
inorganic and organic substances, its propensity for forming 
highly coloured addition products has led to its use as a test 
reagent for numerous organic functional groups (for full list 
see Swinehart, 1967). In pharmaceutical analyses, these 
include the detection of ketones in urine of diabetics and of 
glutathione and cysteine in blood (Vesey & Batistoni, 1977). 
As already mentioned, the nitrosyl group is responsible for 
this reactivity as its formal charge of +1 means that it is 
open to attack from basic ligands (eg. -0H~, -SH~, SO^) 
(Swinehart, 1967; Leewenkamp et al, 1984; Butler & Glidewell, 
1987). The addition reaction involved is shown in equation 1, 
where B= basic ligand.
(Fe(CN>5NO]2‘ + B*" [Fe (CN ) gNOI B) ] < ~ eqn.(l)
In this regard, the chemical reaction of greatest 
physiological interest is that which occurs with thiols. Thiol 
groups have been implicated in the activation of guanylate 
cyclase by NP and other nitrovasodilators (Needleman & 
Johnson, 1973). It has even been suggested that formation of
-Page 1.5-
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S-nitroso-thiols is a prerequisite intermediate step in the 
mechanism of action of these vasodilators (Ignarro, Lippton, 
Edwards, Baricos, Hymen, Kadowitz & Gruetter, 1981). The 
reaction sequence that leads to the formation of nitrosothiols 
is as shown in equation 2. Thiol ligands (R-SH: where R 
represents an organic group) must first undergo deprotonation 
(to R-S ) before they can react with nitroprusside to form the 
addition product, except when RSH represents an amino thiol 
(eg, cysteine) when the protonated form has a similar rate of 
reaction (Butler & Glidewell, 1987). In the physiological pH 
range 6.5-8.5 this addition product loses the nitrosothiol 
<R-SNO) to yield [FeCCN)^]^- which may undergo a ligand 
redistribution to form [Fe(CN)g]^~ and Fe^+(Ignarro etal, 
1981; Butler & Glidewell, 1987). The nitrosothiol in turn 
decays to nitric oxide (NO) and a disulphide (R-SS-R). The 
addition step in this reaction proceeds slowly but once 
formed, the addition product decomposes quickly (Leewenkamp et 
al, 1984; Craven & Derubertis, 1978). An alternative pathway 
for the decomposition of the adduct has been reported to form 
[Fe(CN)^NQ]^ and free cyanide (Butler & Glidewell, 1987). 
Which of these pathways is dominant in vivo has yet to be 
resolved. The latter scheme could account for the reported in 
vivo release of cyanide (Leewenkamp et al,1984?), and the 
former one for the reported nitrosothiol and disulphide 
formation after NP administration (Ignarro et al, 1981; 
Needleman & Johnson, 1973).
Clinical Uses
Ever since Page and collègues (1955) demonstrated the
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Table 1:2
Toxicity (LD^Q values) of nitroprusside compared tocyanide and thiocyanate.
LD,
Species
Route of 
injection
N»,Fc<CN)*NO •2 H/)
mg/kg mM/kg CN mEq/kg
Mouse i.p. 9.4 0.032 0.16
Mouse ip 8.9 0.030 0.15Mouse ip 12.0 0.040 0.20
Mouse i.v. 8.0 0.027 0.14
Rut ip 9.9 0.033 0.17Rmt i.v. 9.3 0.031 0.16
NmCN
Mouse i.p. 5.9 0.120 0.12
KCN
Mouse i.v. 2.6 0.040 0.04
NtSCN
Mouse Lv. 483.5 5.960 5.96
Rat Lp. 540.0 6.660 6.66
(taken from Kreye, 1980).
Equation (2).
[Fe(CN)^NO] 2 - RS
[Fe(CN)^(N=0)SR]
[Fe(CN)g(N=0)SR]
[Fe(CN)^]
3 -  
^ RSNO
2 RSNO — ^ 2 NO + RS—SR 
(after Butler & Glidewell, 1987 and Leeuwenkamp et al, 1984).
-Fig. 1:2
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efficacy of intravenous infusion of NP in the treatment of 
malignant hypertension, it has been used in a variety of 
hypertensive conditions. Oral administration, previously used 
to treat arterial hypertension, was shown to be not nearly as 
effective and induce the same effects as sodium thiocyanate 
(Page et al, 1955) . The major advantages of NP infusion are; 
(i) it has an immediate onset of action, (ii) the extent of 
the hypotensive response can be accurately controlled by the 
rate of infusion, (iii) there is a very rapid reversal of its 
effects when the infusion is stopped, (iv) There are no 
untoward interferences with any other drugs, (v) it does not 
develop primary resistance (tolerance)or tachyphylaxis(vi) it 
is still effective when other drugs fail to lower blood 
pressure, (vii) it has a selective action on the vasculature 
without any negative inotropic effect on the heart (Kreye, 
1980).
The major dissadvantages of NP are; (i) its potent 
hypotensive action requires careful and constant monitoring of 
the patient's blood pressure so that the infusion rate can be 
continuously altered to maintain the desired depressor effect, 
and (ii) its potential toxicity (this is discussed later). Too 
rapid infusions of NP are dangerous for two reasons. Firstly, 
because of its high potency, a rapid infusion or change in the 
patients position can result in an exaggerated hypotensive 
response,with all the associated symptoms of circulatory 
failure. Secondly, excessive doses of NP can lead to cyanide 
poisoning. There have been a number of reported fatalities 
following excessive infusions of NP, all of which showed the 
classical signs of cyanide poisoning (Kreye, 1980). To prevent
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this acute toxicity, it is generally agreed that a maximum 
rate of 800-900 ug/min. should not be exceeded. Concomitant 
infusion of cyanide antedotes has also been suggested. The 
potential toxicity of nitroprusside through release of its 
cyanide ligands is discussed later.
The conditions successfully treated by NP 
administration are;-
i. Hypertensive emergencies and malignant hypertension
There are numerous clinical conditions giving rise to 
a hypertensive crisis, most of which have been successfully 
treated by NP infusion. These range from hypertension 
associated with renal failure, pulmonary oedema, subdural or 
intracranial hemorrhage, pre- and intra-operative hypertensive 
attacks, and drug induced hypertensive crisis (Kreye, 1980). 
Some authors have recommended the use of NP as the primary 
agent in hypertensive emergencies with subsequent substitution 
by oral hypertensives, whereas others have kept NP 'in
reserve' until other potentially less harmful drugs have been 
tried (Kreye, 1980) .
NP has little role to play in the treatment of 
malignant hypertension in the ambulatory patient, but it has 
been successfully used to treat malignant hypertension by 
continuous infusion over periods up to 45 days (Page et al, 
1955). Constant monitoring of plasma thiocyanate levels is 
required throughout. Thiocyanate is the final in vivo 
breakdown product of NP which although of low toxicity, is 
excreted very slowly such that toxic levels can be reached 
(chronic toxicity).
ii. Cardiac Failure
IPage 1.8- '|
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Irrespective of the underlying cause, cardiac failure 
is associated with symptoms of low cardiac output and/or 
circulatory congestion. Arterial vasodilators decrease 
afterload (ie. aortic or pulmonary impedance) and so increase 
cardiac output, whereas venodilators produce venous pooling 
and hence a reduction in preload, such that cardiac filling 
pressure is reduced. Since NP is a nonselective vasodilator, 
it induces both of the above effects and so is very successful 
in improving cardiac performance. As NP has to be infused, its 
administration is limited to the acute therapy of cardiac 
failure. It is reported to reduce left ventricular filling 
pressure and increase stroke volume in patients with acute 
myocardial infarction (Chatterjee, Swan, Kaushik, Jobin, 
Magnusson & Forrester, 1976), Although NP improves cardiac 
performance in acute myocardial infarction in the short term, 
it increases the extent of ischemic myocardial damage as the 
associated coronary vasodilation reduces perfusion pressure 
and induces 'stealing' of blood to unaffected areas. This is 
shown by an increase in the long term mortality rate of acute 
myocardial infarct patients following NP therapy (Chatterjee 
et al, 1976).
iii. Controlled Hypotension in Surgery
The aforementioned properties of NP make it an ideal 
drug to induce hypotension during surgery under anaesthesia. 
This is applied to minimise blood loss during surgical 
procedures which prevents obscuring the field of operation, • 
reduces the number of blood transfusions required (and so cuts 
down operating time and expense), and it reduces the 
probability of haemorrhage in delicate cerebral and intraocular
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surgery (Kreye, 1980). These factors have been shown to 
decrease the mortality rate following surgery.
Toxicity
The potential toxicity of NP is the major criticism 
of its clinical use today. There are numerous reports that NP 
releases cyanide when intravenously infused into either man or 
animals (Kreye, 1980; Arnold, Longnecker & Epstein, 1984; 
Smith & Kruszyna, 1974; Vesey & Batistoni, 1977; Page et al, 
1955). There have been several fatalities following 
administration of higher than average doses of NP (Kreye, 
1980), all of which display the classical signs of cyanide 
poisoning. At least three humans have successfully commited 
suicide using NP with cyanide being found in the stomach 
contents of all three (see refs in Kreye, 1980). In toxicity 
trials in mice and rats, intraperitoneal injection of NP was 
shown to have fourfold greater toxicity than CN~ alone (Smith 
& Kruzyna, 1974). This was taken as evidence that NP liberated 
all of its five cyanide groups in vivo. If injected 
intravenously, cyanide had a very similar lethal dose. This is 
summarised in figure 1:2 which shows the lethal doses (LD^^) 
of NP given by either route to small rodents.
The better invasion and distribution properties of the 
i.v. route of administration would seem to refute the earlier 
suggestion that NP releases all its cyanide groups. Comparing 
the substances with regard to their cyanide content,it appears 
that NP is four fold less toxic than cyanide alone, with only 
one cyanide group being released per molecule of NP. The time
-Page 1.10-
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delay between application and death is very much longer for NP 
than cyanide. Intravenous administration of KCN caused death 
within 2 minutes but it took 15 min. after NP administration. 
Intraperitoneal applications took longer with death occuring 
after 5min with KCN but as long as 30min. with NP. The longer 
time for the toxic effect of NP must be involved with the 
reactions that release cyanide ligands. This is in contrast to 
its fast vasopressor action which occurs instantaneously with 
i.v. administration.
Detoxification of cyanide is performed through an 
enzymic reaction catalysed by rhodanase. This system converts 
cyanide to thiocyanide which is 150 times less toxic (see 
table 1:2). The high activity of this enzyme in the liver and 
other tissues ensures that the body can inactivate quite large 
concentrations of cyanide, the limiting factor being the 
availability of thiosulphate. Thiosulphate is therefore used 
as an antedote to cyanide poisoning and has been used to 
counteract signs of cyanide toxicity in patients recieving NP 
infusions. Although of low toxicity, thiocyanate is excreted 
very slowly  ^days) such that its blood level must be
constantly monitored to prevent toxic levels being reached 
during long terra NP infusions (Page et al, 1955).
Mechanism of cyanide release from NP
The mechanism of cyanide release has mainly been 
studied in vitro by incubating NP with different tissue 
horaogenates. Liver and kidney were found to be slightly active 
but heart, brain, small intestine, skeletal muscle and lung 
horaogenates were not (Smith & Kruszyna, 1974), Blood was by
-Page 1.11-
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far the most active tissue tested, with the order of cyanide 
release being red cell lysates > whole blood > washed red 
cells > plasma (Page et al, 1955; Smith & Kruszyna, 1974). The 
observation that protein free filtrates of blood can similarly 
liberate cyanide over wide ranges of pH and temperature 
suggested that the reaction was non-enzymatic (Page et al, 
1955). This is substantiated by the ineffectiveness of enzyme 
inhibitors to prevent liberation of cyanide from NP in the 
presence of whole blood (Speigel & Kucera, 1977). As NP is 
known to react with sulphydryl groups (see above) it seemed 
likely that sulphydryl containing free amino acids in the 
blood might be responsible for this action. Incubation of some 
of these compounds (namely cysteine and glutathione) with NP 
liberated cyanide (Page et al, 1955). The rich sulphydryl 
content of erythrocytes, along with the high glutathione 
content of liver and kidney, support this hypothesis.
Smith & Kruszyna (1974) went on to suggest that a 
secondary fast reaction with haemoglobin could explain the 
high rates of cyanide release seen with red cell lysates or 
whole blood. In this reaction, NP receives an electron from 
haemoglobin to form methaemoglobin (metHb). The reduced NP 
then decomposes quickly to yield five cyanide groups, one of 
which reacts with metHb to form cyanohaemoglobin. It is 
however unlikely that this reaction has any physiological 
significance to the in vivo degradation of NP because it is 
unable to penetrate the erythrocyte membrane at therapeutic 
concentrations (Rodkey & Collison, 1977). NP is similar in 
structure to ferricyanide which is known not to penetrate 
intact cell membrane (Gruetter, Gruetter, Lyon, kadowitz &
-Page 1.12-
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Ignarro, 1981). It has been proposed that species differences 
in the ability of whole blood to breakdown NP is related to 
differing permeabilities to NP (Smith & Kruszyna, 1974). 
Rodkey & Collison (1977) found however that 90% of NP was
present exclusively in the plasma. After a bolus injection of 
NP into dogs, the peak level of cyanide in the plasma precedes 
that in the erythrocyte (Kreye, 1980). Taken together, this is 
evidence that the decomposition of NP occurs outside the
erythrocyte without involving Hb. If any cyanide is liberated,
it would be rapidly 'mopped' up by the Hb, which accounts for
the observation that 90% of the released cyanide is present 
inside erythrocytes (Kreye, 1980). Incidently, trapped cyanide 
would have little toxicological significance because free 
cyanide in the plasma is the critical factor in determining 
the acute toxicity of NP (Kreye, 1980).
A major criticism of the above work is that none of 
the studies mention (and so presumably overlooked) the 
precautions taken to protect NP from light during both the 
incubation and analysis for cyanide. This has important 
implications as NP is extremely photolabile and its photolytic 
product, aguapentacyanoferrate (Aq), more readily releases 
cyanide, especially at low pH. Since the analytical procedure 
normally used to determine cyanide involves acidifying the 
sample, then it will serve to liberate cn" from any Aq 
present. The amount of HCNmeasured will be the total cyanide 
present both free and that bound to Aq. Bisset, Butler & 
Glidewell (1981) have reported no release of cyanide from NP 
incubated with whole blood, plasma or erythrocytes, if light 
is rigourously excluded at all stages of the experiment and
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analysis. Conversely, if the analysis is conducted in light,
then cyanide liberation can be demonstrated. Preformed Aq
subjected to the analysis also liberates cyanide whether
illuminated or not {Butler & Glidewell, 1987). Subsequent
studies using nuclear magnetic resonance (NMR) to follow the
13fate of NP labelled with C, showed no trace of cyanide 
liberation when NP was incubated in the dark with whole blood 
(Butler, Glidewell, 1987). The in vivo release of cyanide has 
also been questioned by these authors. If NP was illuminated 
before or during infusion, any Aq formed would liberate CN in 
vivo as the pH of blood is lower than the pK for HCN formation 
(Bisset, Butler & Glidewell, 1981). Also, any analysis for 
cyanide undertaken on a blood sample which contains NP in the 
light, will measure cyanide released through artefactual 
photolysis during the analysis (which takes 2-3 hours) and not 
that actually released in vivo, in view of this, all results 
reporting cyanide release either in vitro or in vivo must be 
interpreted cautiously.
Is in vitro degradation of NP similar to the in vivo 
situation ?
Only decomposition studies conducted in complete 
darkness give a realistic measure of cyanide release that is 
devoid of any artefactual photolysis. Arnold, Longnecker & 
Epstein (1984) still found in vivo release of cyanide even 
though NP was protected from light during infusion into 
patients and during blood sample analysis for cyanide. 
Leeuwenkamp et al (1984) used a sensitive polarographic 
technique to measure the in vitro degredation of NP in the 
presence of various blood components in the dark. Although
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degradation was observed with all blood components, the amount 
and rate of degradation were far too small to account for the 
in vivo situation. The rapid restoration of blood pressure 
after cessation of NP infusion indicates a fast in vivo 
conversion. Whereas incubation with whole blood results in 
destruction of NP with a half life of 20-60 minutes, the in 
vivo half life is 30-120 sec (Smith & Kruszyna, 1974; Kreye, 
1980; Leeuwenkamp, Chin, Van der Mark, Bennekom & Bult, 1986). 
Similarly, degredation by this mechanism could not be involved 
in the mechanism of action of NP. Page et al (1955) admitted 
that the rate of decomposition by blood components is too slow 
for it to be an essential step in its depressor activity. The 
long incubation times required for in vitro degradation may be 
a consequence of photolysis being primarily responsible, it is 
clear that degradation of NP by blood or any of its components 
is not associated with the in vivo situation.
A clue as to the nature of the in vivo degredation 
came from the observation that 30-35% of NP was destroyed 
during a single passage through the perfused hind limb of the 
rat (Kreye, 1980). Incubation with crude aortic soluble 
fraction in the dark resulted in rapid breakdown of NP, at a 
rate comparable to in vivo degredation rates (Leeuwenkamp et 
al, 1986). It would appear from this that vascular smooth 
muscle is responsible for the in vivo decomposition. As NP 
acts directly on the vasculature, its site of action and 
degradation are the same. Indeed, the destruction of NP is 
thought to be essential for its vasodilator action.
It should be noted that in the study by Leeuwenkamp et 
al (1986), the change in the polarographic signal generated by
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NP was used to determine its degradation. Consequently, the 
nature of the chemical change is not defined, but could result 
from a loss of the nitrosyl raoeity, as opposed to cyanide 
ligand. As most of the other studies are concerned with the 
latter reaction, they have attempted to measure cyanide 
release and not the amount of intact NP remaining. This may be 
another factor why the degradation rate is so much faster, as 
this technique records the primary reaction liberating NO, and 
not the subsequent ones releasing cyanide. This also has 
important implications as to the mechanism of degradation 
especially since it seems to be associated with the 
vasopressor action.
Cellular mechanism of action of NP
It is well documented that NP enhances the cyclic 
guanosine-3~5-monophosphate (cGMP) concentration in a wide
variety of tissues. Cyclic GMP has been implicated as an
intracellular regulator of cellular function in many tissues, 
because the rise in cGMP induced by NP is associated with the 
tissue response (eg. vascular smooth muscle relaxation). 
Nitroprusside is thought to elevate cGMP levels by directly 
stimulating the activity of guanylate cyclase (GC), the enzyme 
that catalyses the formation of cGMP from GTP (guanosine
triphosphate). This enzyme is present in virtually all cell 
types and phyla, although it is only recently that its 
important cellular function is becoming recognised. It exists 
in two different forms, soluble (cytosolic) and particulate 
(membrane bound), although isoenzymes of each type with
different subcellular locations have been reported (Waldmann &
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Murad, 1987). Although NP is reported to stimulate both types
of GC, there is now doubt as to whether it can activate the
particulate form. Purified particulate GC is usually
contaminated with soluble GC, and if this is removed by
successive hypo- and hypertonic washes, the activation by NP
is virtually abolished (reduced to 1% of its former
activation) (Waldman & Murad, 1987). Highly purified
particulate GC cannot be activated by NP, although the use of
detergents in the purification procedure confuse this issue as
they have also been shown to prevent NP stimulation of soluble
GC (Waldman & Murad, 1987). Soluble GC is the better
understood enzyme as it is easier to purify and is more
homogeneous than its particulate counterpart. Enzyme isolated
from a wide variety of tissues has been shown to be markedly
activated by NP (Arnold, Mittal, Katsuki & Murad, 1977;
Waldman & Murad, 1987). The activation of soluble GC to
increase cGMP levels is the fundamental step in the mechanism
of action of NP and so this section will concentrate on the
various steps involved. Attention will be focused only on
soluble GC, and especially that associated with vascular 
smooth muscle.
Nitric oxide release from *nitrovasodilators".
The nitrovasodilators are a group of hypotensive 
agents that possess, generate or release nitric oxide. This 
diverse group includes inorganic and organic nitroso compounds 
(eg. NP, NaNOg), organic nitrates (eg. glyceryltrinitrate 
(GTN), nitrosoguanidine) and nitrate esters. since all of 
these compounds can lead to the formation of nitric oxide, and 
since they all relax vascular smooth muscle and stimulate
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isolated GC, it was suggested that nitric oxide was a common 
intermediate in their meachanism of action (Ignarro & 
Kadowitz, 1985; Murad, Arnold, Mittal & Braughler, 1979;
Ignarro, Lippton, Edwards, Baricos, Hymen, Kadowitz & 
Gruetter, 1981; Gruetter, Barry, McNamara, Kadowitz & Ignarro, 
1980; Waldman & Murad, 1987). Evidence for this is that
dissolved nitric oxide evokes similar relaxation and cGMP 
accumulation in coronary smooth muscle as that produced by NP 
and other nitrovasodilators (Gruetter et al, 1980). The 
protein phosphorylation profile which is associated with
relaxation of vascular smooth muscle is the same after NP, 
8-bromo-cGMP or nitric oxide treatment suggesting an identical 
mechanism of action (Rapoport, Draznin & Murad, 1982). Studies 
with purified soluble GC have shown a direct stimulatory
effect of nitric oxide, the size of which is similar to that 
produced by nitrovasodilators (Arnold, Mittal, Katsuki & 
Murad, 1977). Activation of soluble GC with nitric oxide is 
not additive to that by other nitrovasodilators, which again 
tends to support the hypothesis that they act through 
formation of nitric oxide (Waldman & Murad, 1987).
As nitric oxide is the prerequisite intermediate, the 
efficacy of the nitrovasodilators is dependent on their 
ability to generate it (ignarro et al, 1981; Waldman & Murad, 
1987; Ignarro & Kadowitz, 1985; Schroeder, Noak & Muller,
1985). The activation of isolated liver GC by simple
nitrovasodilators, azide and hydroxylaraine, is lost upon
further purification because they depend on the presence of a 
cofactor (probably catalase) that catalyses their oxygen 
dependent conversion to nitric oxide (Waldman & Murad, 1987),
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Other studies suggest that isolated GC from tissue that is 
unresponsive to these agents (ie heart & lung), contains an 
inhibitor (probably haemoglobin or myoglobin.) that prevents 
activation, by binding nitric oxide or preventing its 
formation (Kimura, Mittal & Murad, 1975).
Larger nitric oxide containing nitrovasodilators must 
first liberate their nitric oxide moiety before they can relax 
vascular smooth muscle or stimulate GC (Brien, McLaughlin, 
Breedon, Bennet, Nakatsu & Marks, 1986; Brien, McLaughlin, 
Kobus, Kawamoto, Nakatsu & Marks, 1987; Schroeder, Noak & 
Muller, 1985). Measurements of the biotransformation of GTN to 
GDN correlate well with the increased cGMP level and induced 
relaxation of rabbit aortic strips (Brien et al, 1986). 
Evidence that this is a causal relationship comes from an 
elegant time course study following the degredation of tritium 
labelled GTN, which showed that denitration of GTN preceded 
both relaxation and the rise in tissue [cGMP] (Brien et ai, 
1987). Similarly, the activity of isolated GC stimulated by 
GTN and other organic nitrates parallels the amount of nitric 
oxide liberated (Schroeder et al, 1985). Interestingly, only 
one molecule of nitric oxide is released from each drug 
molecule even if it contains several nitrate residues (ie. 
GTN). Nitroprusside was previously thought to ‘spontaneously 
release nitric oxide in solution' (Ignarro et al, 1981; 
Ignarro & Kadowitz, 1985; Waldman & Murad, 1987) , but this 
would appear to be due to artefactual photolysis as solutions 
of NP are completely stable if light is rigourously excluded 
(Vesey & Batistoni, 1977; Arnold, Longnecker & Epstein, 1984; 
Butler & Glidewell, 1987). A recent study in which NP was
-Page 1.19-
chapter 1
completely protected from light throughout showed that it does 
release NO when incubated with bovine aortic soluble fraction 
in a similar manner to other nitrovasodilators (Leeuwenkamp et 
al, 1986).
The questions then arise, how is the nitric oxide 
intermediate liberated from the parent molecule, and how does 
it stimulate GC activity ? Although various agents have been 
postulated to mediate this cleavage, there are now two major 
schools of thought. The first is that free thiols in the cell 
membrane or cytosol (probably cysteine) combine with the 
nitrosyl group to form unstable nitrosothiol intermediates 
which then stimulate GC (Ignarro et al, 1981; Ignarro & 
Kadowitz, 1985; Schroeder et al, 1985). The second school 
postulates that the precursor drug interacts directly with a 
prosthetic haem group associated with the GC which binds the 
nitric oxide and results in increased activity of the enzyme 
(Craven & DeRubertis, 1983). The evidence supporting each 
hypothesis will now be reviewed seperately.
Role of thiols in GC activation
An early indication that sulphydryl(thiol) groups were 
involved came from the observation that high doses of organic 
nitrate (GTN) can induce cross-tolerance to subsequent 
applications of other organic nitrates but not to other types 
of vasodilator (Needleman & Johnson, 1973). This suggested 
that the organic nitrates themselves changed the availability 
of a common intermediate 'receptor'. These were identified as 
sulphydryl groups because; (i) treatment with the -SH 
alkylating agent ethacrynic acid, which reduced the 
measureable tissue sulphydryl content, caused a decrease in
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the magnitude of relaxation induced by GTN; (ii) pretreatment 
with large doses of GTN, sufficient to cause tolerance, also 
reduced the tissue -SH content; (iii) disulphide reducing 
agents (ie. dithiothreitol) could prevent or reverse
tolerance, regardless of whether it was induced in vivo or in 
vitro; (iv) other known -SH oxidizers are also potent
vasodilators (eg. NP, cystamine) and cross tolerance to these 
can be induced by pretreatment with GTN (Needleman, Jakschik & 
Johnson, 1973; Needleman & Johnson, 1973). The above results 
led to a reaction scheme in which organic nitrates and other 
vasodilators, could only react with reduced sulphydryl groups 
(R-SH) in vascular smooth muscle, resulting in their oxidation 
to form disulphides (R-S-S-R). This step was coupled to
release of inorganic nitrite which stimulated guanylate 
cyclase (GC) (Needleman et al, 1973). This scheme
incorporates some of the known sulphydryl oxidising properties 
of NP, described earlier (Butler & Glidewell, 1987). The 
release of 'nitrite' is now thought to result from an actual 
release of nitric oxide (NO) which then combines with 
molecular oxygen. Indeed, the liberation of NO has been shown 
to occur if GTN, NP or NaNOg are incubated with thiols under 
certain conditions (Ignarro & Kadowitz, 1985) . it is the 
liberation of nitric oxide (NO) that is thought to be 
responsible for GC activation (Ignarro et al, 1981; Waldman & 
Murad, 1987; Ignarro & Kadowitz, 1985)
Desensitisation can also be seen at the level of the 
partially purified guanylate cyclase enzyme (Waldman, 
Rapoport, Ginsberg & Murad, 1986) . Soluble guanylate cyclase 
prepared from vascular smooth muscle previously rendered
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tolerant to GTN, has a diminished response to NP, GTN, and NO 
as compared to normal control enzyme (Waldman et al, 1986). 
This phenomenon could involve sulphydryl groups on the enzyme 
itself which play a key role in regulating its activity (see 
later) (Waldman & Murad, 1987).
Direct evidence for a role of thiols has come from 
investigations into the activation of isolated GC by various 
nitrovasodilators. The activation of unpurified coronary 
arterial GC by NO, NP and other nitrovasodilators was
enhanced by the addition of thiols, the most potent being
cysteine (Gruetter, Barry, McNamara, Kadowitz & Ignarro,
1980). Indeed, GTN failed to activate GC except when the thiol 
cysteine was present (Ignarro & Gruetter, 1980). The 
degradation of GTN was measured during activation of GC in the 
presence of various thiols (Schroder, Noak & Muller, 1985). 
Only in the case of cysteine was there a quantitative
correlation between the amount of NO liberated and the extent 
of GC activation (Schroder et al, 1985). The lack of a
correlation between the (high) degradation rate and the (low) 
stimulatory potency of other thiols, has led to the suggestion 
that thiols may modulate GC activation in some other way
beside NO release (Schroder et al, 1985).
The observation that nitrovasodilators react with 
thiols to form unstable S-nitrosothiol compounds, has led to 
the view that these substances are intermediates in the
activation of GC (Ignarro, Lippton, Edwards, Baricos, Hyman, 
Kadowitz & Gruetter, 1981). The evidence for this is that; (i) 
although nitrovasodilators elevate tissue cGMP levels, they 
require the addition of cysteine to maximally activate
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partially purified GC; (ii) all nitrovasodilators, including 
NO, react with cysteine to form S-nitrosocysteine; (iii) 
preprepared S—nitrosothiols are approximately 100 times more 
potent at activating partially purified GC then 
nitrovasodilators (NP) alone (iv) prefomed nitrosocysteine 
markedly activates GC, raises tissue cGMP levels, relaxes 
coronary arterial strips and decreases systemic blood 
pressure, similar to those effects of nitrovasodilators; (v) 
methylene blue and ethacrynic acid, which are known to inhibit 
nitrovasbdilator induced coronary arterial relaxation and cGMP 
accumulation, also inhibit the effects of S-nitrosothiols; 
(vi) when infused into anaesthetised cats, preprepared 
S nitrosothiols mimic the dose related effects of NP and GTN 
(Ignarro et al, 1979-1981; Gruetter et al, 1980; Ignarro & 
Gruetter, 1980; Ignarro & Kadowitz, 1985). The clinical 
effects of nitroglycerin in reducing arterial pressure are 
potentiated by preinfusion of acetylcysteine, which also 
served to reduce tolerance to GTN (Horowitz, Antman, Lorell, 
Barry & Smith, 1983) . From this evidence, it was proposed that 
the nitrogen oxide containing vasodilators caused vascular 
smooth muscle relaxation by interaction with intracellular 
thiols (primarily cysteine) to form S—nitrosothiols which then 
activate GC, resulting in cGMP formation (Ignarro et al, 
1981). The above argument suggests that thiols are responsible 
for cleaving the NO moiety off the parent nitrovasodilator 
molecule. This could explain the dependency of drug action on 
thiol groups (Needleman & Johnson, 1973), as their 
l^ t)i 1 i ty might then determine the amount of active 
S-nitrosothiol formed.
-Page 1.23-
chapter 1
The involvement of nitrosothiols in directly
activating GC has been criticised by Craven & DeRubertis
(1983), who suggest that GC activation occurs instead through
the formation of a NO-haem complex without any involvement of
thiols. When GC is purified to apparent homogeneity, so that
the enzyme lost the associated haem group, it does not respond
to NO, NP or preformed nitrosocysteine. By contrast, preformed
NO-haem markedly (60-80 fold) increases purified enzyme
activity (Craven & DeRubertis, 1983). Addition of exogenous
hematin restores the ability of all the agents to activate the
enzyme. Also, at neutral pH, S-nitrosothiol formation cannot
be detected between NP and cysteine (Craven & DeRubertis,
1983). Preformed nitrosocysteine decomposes rapidly, but even
fully decomposed solutions retain their ability to activate GC
providing haem is present (Craven & DeRubertis, 1983). The
reported activation of haem-containing GC by thiols, is
suggested to be due to the reducing action of thiols
facilitating the formation of NO-haem by maintaining haem iron
11in its ferrous (Fe ) state (Craven & DeRubertis, 1983; 
Waldman & Murad, 1987). These observations suggest that while 
S-nitrosothiols may activate haem-containing GC, they are not 
obligatory intermediates in the activation process and that 
the nitrosyl-haem group acts in this capacity.
Role of the prosthetic haem group of guanylate cyclase
An early indication that haem groups could have a 
profound effect on the activity cf GC was that simple 
nitrovasodilators (ie. azide) required the presence of a 
haemoprotein before they could activate the enzyme (Kimura et
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al, 1975; Waldman & Murad, 1987). Greater importance came from 
the observation that activation of crude isolated GC by NO and 
by nitrovasodilators was lost upon further purification of 
the enzyme (Murad, Lewicki, Brandwein, Mittal & Waldman, 
1981). Activation by these agents could be restored by the 
addition of haemoglobin, methaemoglobin or catalase (Craven & 
DeRubertis, 1978), The activation was enhanced by including a 
reducing agent into the incubation medium which facilitates 
the formation of nitrosyl haem from haemoproteins and NP or NO 
(Craven & DeRubertis, 1978). Subsequent authors using improved 
purification techniques, managed to purify GC without loss of 
stimulation by NP, and showed that this was due to the 
presence of a detectable prosthetic haem group associated with 
the enzyme (Gerzer, Hofmann, Bohme, Ivanova, Spies & Schultz,
1981). Whether the haem group is a normal prosthetic group for 
the enzyme in vivo or whether their association is an artefact 
of preparation remains unknown and is still a matter of 
controversy (Waldman & Murad, 1987).
The importance of the prosthetic haem group in the 
activation of GC by nitrovasodilators is highlighted by 
studies with haem deficient enzyme. The purified enzyme is 
totally unresponsive to NO, NP or preformed nitrosothiols but 
can be maximally activated by preformed nitrosyl haemoglobin 
(Craven & DeRubertis, 1983). Preformed NO-haem is 10 fold more 
potent at activating GC than nitro compounds or their 
derivatives, even in the presence of haem. The observation 
that reducing agents could potentiate nitrovasodilator 
activation but not that due to preformed NO-haem, supported 
the suggestion that such agents serve only to enhance the
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formation of NO-haem from the nitrocompounds (Craven & 
DeRubertis, 1983). Agents which bind to haem groups (eg. 
cyanide) block activation of GC by azide, NP or NO (Kimura, 
Mittal & Murad, 1975; Rapoport & Murad, 1984). Cyanide also 
abolishes the NP and NO induced relaxation and cGMP 
accumulation in rat aortic strip, but not those induced by 
8-bromo-cGMP (Rapoport & Murad, 1984). The above evidence 
supports the hypothesis that activation of soluble GC by 
nitrocompounds involves the interaction of NO with a haem 
moiety associated with the enzyme (Waldman & Murad, 1987).
The observation that mixtures of NP and haemoglobin in 
the presence of a reducing agent at pH 7.6, readily form NO-Hb 
has led to the suggestion that nitrovasodilators interact 
directly with the haem group of GC to form nitrosyl-haem 
(Craven & DeRubertis, 1983). The activation of GC by preformed 
NO-Hb supports this hypothesis. Also, the release of nitric 
oxide from GTN in the presence of thiols is markedly enhanced 
(10-15%) by the addition of GC to the incubation medium 
(Schroder et al, 1985). This evidence suggests that GC is
directly involved in nitro-compound cleavage. Measurements of 
the degradation of NP by crude aortic soluble fraction, in the 
dark and in the presence of excess cyanide, contradict this 
hypothesis (Leeuwenkamp et al, 1986). As cyanide has a high 
affinity for haem, it should bind to the haem group and 
prevent it reacting with the NO moiety on NP (leeuwenkamp et 
al, 1986). Instead, excess cyanide did not affect the rate of
NP degredation suggesting that it decomposes due to
interaction with a redactor other than the haem group of GC
(Leewenkamp et al, 1986) .
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Direct interaction of NP with GC would imply an 
intracellular site of degradation and action. Evidence for 
this is that NO induced coronary arterial relaxation is 
inhibited by methylene blue, but not by the impermeant 
ferricyanide although both compounds inhibit isolated soluble 
GC (Gruetter et al, 1979,1980; Arnold et al, 1980). Impermeant 
hemoproteins (haemoglobin & methaemoglobin) can abolish
relaxations induced by NO but not by any of the 
nitrovasodilators (Gruetter at al, 1979). From this, Ignarro 
(1981) has suggested that the efficacy of the various
nitrovasodilators is related to their ability to cross 
membranes. While this may be true for the lipophillic
nitrovasodilators (ie.NO, amyl nitrate, GTN), it becomes a 
problem for the impermeant ones, especially NP. The high
potency of NP does not correlate well with its low 
permeability. Explanations that NP spontaneously releases NO, 
may be a consequence of artefactual photolysis (Ignarro et al, 
1981; Ignarro & Kadowitz, 1987). A possible alternative is 
that NP could interact with thiol groups in the cell membrane 
to liberate NO. The test for this, measuring the degredation 
of NP when incubated with sarcolemmal fraction from vascular 
smooth muscle does not appear to have been done.
Taking an overview of all the above evidence, the most 
likely sequence of events in nitrocompound activation of GC 
is; (i) the drug molecule interacts with thiols either in the 
sarcolemma or cytosol of the vascular smooth muscle cell, 
which cleave the NO group off the drug, (ii) The liberated NO 
and thiol groups form transient unstable nitrosothiols, (iii) 
the nitrosothiols degrade yielding the NO to the haem group
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associated with GC (iv) the nitrosyl-haem group activates GC
to increase production of cGMP.
Redox regulation of guanylate cyclase
From the above evidence, it is clear that the
activation of GC by nitric oxide and related nitrocompounds,
involves several factors that are vulnerable to
oxidation-reduction agents. These include; (i) the tissue
thiol groups must be in the reduced state before they can
promote the liberation of NO from nitrocompounds or form
nitrosothiols, (ii) the formation of nitrosyl-haem responsible
for activation of GC is enhanced if haem iron is present in 
11its reduced (Fe ) state, (iii) Oxidising agents promote the 
conversion of NO to higher oxides which do not stimulate GC. 
These are responsible for the observed decrease in the nitric 
oxide induced activation of GC in liver supernatants when 
incubated in a high oxygen enviroment (Arnold, Mittal, Katsuki 
& Murad, 1977). Similarly, the activation by NO can be 
inhibited by oxidising agents (HgOg, methylene blue, 
Ke2Fe(CN)g) whereas it is augmented by various reducing agents 
(ascorbate, cysteine, glutathione, dithiothreitol (DTT)) 
(Arnold et al, 1977). That some of these reducing agents are 
thiols suggests an additional role in their augmentation of 
activation by NO and the nitrovasodilators. Direct evidence 
for this is the lack of a correlation between the rate of GTN 
cleavage by various thiols, and their stimulatory potency on 
GC (Schroder, Noak & Muller, 1985). Cysteine had by far the 
greatest stimulatory effect on GC activity, despite liberating 
the same amount of nitric oxide as other thiols. This suggests 
that thiols act directly in modulating GC activation as well
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as being a cofactor in organic nitrate cleavage (Schroder et 
al, 1985). Their relative potencies is thought to be due to 
their differing redox potentials (Schroder et al, 1985).
The oxidation state of purified guanylate cyclase has 
a profound effect on its activity. Incubation of purified 
enzyme in air or oxygen solutions resulted in an increase in 
activity (Haddox, Stephenson, Moser & Goldberg, 1978; Murad, 
Lewicki, Brandwein, Mittal & Waldman, 1981). Preincubations in 
an oxygen atmosphere for up to 20min (37*C) resulted in 
progressively increased GC activity (White, Crawford, Patt & 
Lad, 1976). However, this activity is reduced upon longer 
preincubations (>20min at 37°C; >30min at 30°C), a process 
that can be prevented or reversed by adding thiols (White et 
al, 1976). Enzyme activation followed by inactivation is very 
similar to that produced by nitric oxide activation of 
purified GC (Murad et al, 1981). Activation of enzyme with NO 
spontaneously deactivates, even in the presence of NO 
(Braughler, Mittal & Murad, 1979). Addition of DTT or other 
reducing agents, reverses this process and restores maximal 
activity.
There is an optimum concentration of NO, such that 
higher or lower concentrations do not activate the enzyme as 
effectively, giving rise to a bell-shaped dose response curve 
(Braughler et al, 1979). This curve is shifted to the left 
with purification of the enzyme and is altered by the addition 
of various proteins, thiols and sugars (Murad et al, 1981). 
The oxidant dehydroascorbic acid increases the activity of 
both isolated and cellular GC, whereas DTT or cysteine 
decreases it (Haddox, Stephenson, Moser & Godberg, 1978) . DTT
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and other reducing agents prevent and reverse activation cf GC 
by either preincubation in an oxygen environment or activation 
by NO (Waldman & Murad, 1987). This contrasts with the well 
known effect of reducing agents in augmenting GC activation by 
NO and nitrocompounds (Waldman & Murad, 1987) , The
interpretation of these results is that oxidation of GC (by
air, oxygen, nitric oxide or oxidants) initially results in 
activation,, but the enzyme can be overoxidised (by longer
incubations, high [NO] or long preincubations in oxygen) which 
leads to a decrease in activity. Reducing agents can decrease 
activity by preventing or reversing the initial oxidation. 
However, they can also increase activity by preventing or 
reversing overoxidation of the enzyme and by maintaining the 
enzyme in the reduced state such that the initial oxidising 
effect is greater. It is clear that the regulation of GC
activity by redox agents depends on the previous oxidation 
state of the enzyme, and that there is an optimum 'oxidation 
state* for maximal activity, A complication is that most of 
these studies are performed on purified GC, which would be in 
totally different oxidation states depending on the
purification procedures used, previous oxidation state in the
tissue, and the incubation conditions of the enzyme assay. For 
these reasons it is hard to draw any conclusions about the in
vivo situation from in vitro studies.
The targets for the redox regulation of GC have been 
suggested to be critical sulphydryl groups on the enzyme 
(Waldman & Murad, 1987). Agents which modify free sulphydryl 
groups alter basal and activated GC activity. Alkylating 
agents, which covalently modify -SH groups, decrease basal and
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NO stimulated enzyme activity (Waldman & Murad, 1987). Mixed 
disulphide formation by incubating with cystamine or cystine,
also reduces GC activity (Brandwein, Lewicki, & Murad, 1981;
3 5Murad et al, 1981). Radiolabelled [ Slcystine showed that 
radioactivity was incorporated into GC with a similar time 
course as inhibition of activity (Brandwein et al, 1981). DTT 
which reduces disulphides back to free thiols, reversed the
inhibition of activity and this corresponded to a release of 
radioactivity from the enzyme (Brandwein et al, 1981). From 
this it was suggested that sulphydryl groups on the enzyme are 
critical for basal and stimulated GC activity, and that 
thiol-disulphide transitions through redox reactions are an 
important mechanism for regulating GC activity.
Nitrovasodilator induced increase in cGMP and relaxation
There is now a wealth of evidence that cGMP is 
directly involved in mediating relaxation of vascular smooth 
muscle.The initial observations that led to the above 
hypothesis were that nitrovasodilator compounds induced 
relaxation and increased the cGMP levels in a variety of 
smooth muscle preparations (Kimura, Mittal & Murad, 1975;see 
Rapoport & Murad, 1983; Ignarro & Kadowitz, 1985), The 
increase in [cGMP] was dose dependent and correlated with the 
degree of relaxation induced by these compounds (Gruetter et 
al, 1979,1980,1981; Napoli, Gruetter, Ignarro & Kadowitz, 
1979; Lincoln, 1983; Ignarro, Burke, Wood, Wolin & Kadowitz, 
1983; see Rapoport & Murad, 1983). Evidence for a cause and
effect relationship came from time course studies which
revealed that the increase in [cGMP] induced by these agents
precedes relaxation (Gruetter, Gruetter Lyon, Kadowitz &
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Ignarro, 1981; Ignarro, Lippton, Edwards, Baricos, Hyman, 
Kadowitz & Gruetter, 1981; Brien, McLaughlin, Kobus, Kawamoto, 
Nakatsu & Marks, 1987). Direct evidence that cGMP mediates 
relaxation is that lipid soluble analogues of cGMP
(8-bromo-cGMP & dibutryl-cGMP) induce relaxation of 
precontracted arterial strips (Napoli et al, 1979; Lincoln, 
1983; Rashatwar, Cornwell & Lincoln, 1987). Similarly, cGMP 
phosphodiesterase inhibitors raise intracellular [cGMP] and 
induce relaxation in coronary and aortic strips (Schoeffer,
Lugnier, Demesy-Waeldele & Stoclet, 1987). Where they have
been measured, cAMP levels or cAMP protein kinase activty 
appears to be unaltered by nitrovasodilators (Lincoln, 1983; 
Rapoport & Murad, 1983). In vascular preparations, 
nitrovasodilator effects were shown to be independent of 
endothelium, although in endothelial denuded preparations, 
they cause a greater increase in cGMP due to the lower basal 
control levels (Rapoport & Murad, 1983).
Various in vitro inhibitors of guanylate cyclase (GC) 
activity have proved useful in testing the hypothesis that 
nitrovasodilator induced relaxation is mediated through an 
increase in cGMP formation. Whereas lipophilic GC inhibitors
(ie. methylene blue, cyanide, cystamine) inhibit relaxation 
and cGMP accumulation of arterial strips by all 
nitrovasodilators, impermeant ones only abolished the effects 
of free nitric oxide (haemoproteins) or had no effect at all 
(ferricyanide) (Gruetter, Lyon, Kadowitz & Ignarro, 1981; 
Rapoport, Brandwein & Murad, 1981). This suggested an 
intracellular site for liberation of NO.
The induction of tolerance also provides a test that
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GC activation mediates relaxation in vivo. Nitroprusside 
induced relaxation and cGMP accumulation in rat aorta were 
inhibited by GTN pretreatment, either in vitro or in vivo 
(Waldman, Rapoport, Ginsberg & Murad, 1986; Rapoport & Murad, 
1983). Purified GC, isolated from rat aorta made tolerant by 
GTN pretreatment, exhibited a marked desensitisation to 
activation by GTN, NP or NO, although its activation by other 
agents was not affected (arachidonic acid) or was increased 
(protoporphyrin IX) (Waldman, Rapoport, Ginsberg & Murad, 
1986). ^his is strong evidence that nitrovasodilators all act 
through a final common pathway and that this involves 
activation of GC.
Endogenous nitrovasodilators
The above results indicate that cGMP mediates 
relaxation induced by exogenous agents (ie nitrovasodilators), 
but it has also been implicated in relaxation by endogenous 
agents (ie, acetylcholine, ATP, ADP, adenosine, autacoids, 
fatty acids, thrombin, substance P, vasopressin, histamine & 
bradykinin) (Rapoport & Murad, 1983). All of these agents can 
only relax vascular smooth muscle in the presence of an intact 
endothelium and so have been called 'endothelial dependent 
vasodilators' (Furchgott, 1983), In 1980, Furchgott & Zawadzki 
demonstrated that relaxation of a rabbit aortic strip by ACh 
was dependent on the release of a Endothelial Derived Relaxant 
Factor (EDRF). The release of EDRF has subsequently been shown 
to occur for all of the endothelial dependent vasodilators 
(Furchgott, 1983; 1987) Although its chemical identity was 
unknown, EDRF was shown to be the same substance by the use of
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specific inhibitors (Furchgott, 1983). As the Ca ionophore 
A23187 is also an endothelial dependent vasodilator, release 
of EDRF was thought to be associated with an increase in 
endothelial [Ca] (Furchgott, 1981; 1983).
Studies of the mechanism of action of EDRF showed that 
it is very similar to that of the nitrovasodilators, EDRF 
increased intracellular cGMP levels in a dose dependent manner 
that preceded relaxation (Rapoport & Murad, 1983; Rapoport, 
Draznin & Murad, 1983; Ignarro, Burke, Wood, Wolin & Kdowitz, 
1984; Furchgott 1987). Both EDRF-induced relaxations and 
increases in cGMP are inhibited by haemoglobin and methylene 
blue (Ignarro, Harbison, Wood & Kadowitz, 1985; Martin,
Villani, Jothianandan & Furchgott, 1985). A specific cGMP
phosphodiesterase inhibitor (M&B22948) enhanced EDRF-induced 
relaxation and increases in tissue cGMP (Martin et al, 1985). 
Basal release of EDRF was shown to occur, as haemoglobin and 
methylene blue increased smooth muscle tone whereas M&B 22948 
decreased it (Martin, Furchgott, Villani & Jothianandan,
1986) . From this it was suggested that EDRF induces vascular 
smooth muscle relaxation by directly stimulating GC to 
increase intracellular [cGMP] in an identical manner to the 
nitrovasodilators. This was substantiated by recent reports 
showing that pretreatment of rat aorta with GTN inhibits 
relaxation and cGMP accumulation by ACH (Rapoport, Waldman, 
Ginsberg, Molina & Murad, 1987). Cross-tolerance between 
endothelium dependent and independent vasodilators is strong 
evidence that they share a common mechanism of action.
The chemical identity of EDRF eluded investigators for 
several years and has only recently been discovered. Bioassays
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in which the endothelial release of EDRF (donor) was separated 
from an endothelial denuded smooth muscle strip (detector), 
revealed that EDRF is very labile, with a half life in Kreb's 
solution of between 6 and 50 seconds (Griffith, Edwards, 
Lewis, Newby & Henderson, 1984; Angus & Cocks, 1987; 
Furchgott, 1987; Moncada, 1987). These studies also showed 
that EDRF is sensitive to inactivation by oxygen or superoxide 
( )« Thus redox agents which increase superoxide levels 
shorten the half-life whereas superoxide dismutase prolongs it 
(Moncada 1987; Furchgott, 1987). Haemoglobin added between the 
donor and detector also abolished the response, and this was 
thought to be due to binding of EDRF (Furchgott, 1987). EDRF 
was shown to possess similar characteristics (ie. all of the 
above) to nitric oxide, generated through nitrite 
acidification or,injected as a gas (Furchgott, 1987). This led 
to the suggestion that EDRF and NO are one and the same 
(Furchgott, 1987). Comparative pharmacology, directly 
comparing NO with EDRF in tissue cascade systems supported 
this hypothesis, as the two were indistinguishable (Moncada, 
1987; Furchgott, 1987). Confirmation came from measuring the 
release of NO from cultured endothelial cells using a 
chemiluminescent method (Moncada, 1987; Palmer, Ferridge & 
Moncada, 1987). The quantity of NO released in the effluent 
was found to be sufficient to account for the relaxant effects 
on the isolated strips. The discovery that EDRF is nitric 
oxide explains all the similarities to the nitrovasodilators 
and ensures that its postulated role as the endogenous 
nitrovasodilator is truly apt.
-Page 1,35-
chapter 1
Vascular smooth muscle contraction
In order to appreciate the intracellular mechanism of 
action of cGMP in mediating relaxation, something of the 
underlying basis of contraction in smooth muscle must be
understood. In common with other types of muscle, contraction 
is initiated by an increase in the free cytosolic calcium
concentration ([Ca]^). The rise in [Calais produced by an
increase in Ca influx through the sarcolemma, together with 
release of Ca from intracellular stores. Calcium influx is
controlled through both voltage operated (VOC) and receptor 
operated (ROC) channels in the sarcolemma. Depolarization of
the membrane, through either an action potential, passive 
depolarisation or by drug induced increase in Na permeability, 
causes VOCs to open, thereby increasing Ca entry and causing 
contraction. On the other hand, hyperpolarisation, by a
drug-induced increase in permeability, closes VOCs and so
reduces Ca influx and causes relaxation. Receptor operated 
channels, opened when a ligand binds to the receptor, increase 
Ca influx to a wide range of hormones and drugs (eg. 
(^-agonists, histamine, prostaglandins) without depolarisation 
of the membrane. It has also been suggested that operation of
this type of channel is coupled to an increase in
phosphoinositide turnover which mediates release of 
intracellular calcium through inositol trisphosphate 
formation(Downes & Mitchell, 1985; Huggins & England, 1985; 
Walker, Somlyo, Goldman, Somlyo & Trentham, 1987),
Intracellular release of calcium from sarcoplasmic 
reticulum (SR), mitochondria and membrane bound sites have 
been postulated to occur either through Ca-induced-Ca release
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or through inositol trisphosphate metabolism (Huggins & 
England, 1985; Downes & Mitchell, 1985; Walker, Somlyo, 
Goldman, Somlyo & Trentham, 1987). The precise mechanism of 
excitation contraction coupling depends on the type of smooth 
muscle. In vascular smooth muscle, which does not show action 
potentials and has a sparse SR, contraction is thought to be 
regulated mainly by the interplay between calcium influx and 
efflux across the cell membrane.
A decrease in free [Ca]^ is produced by both Ca efflux 
and Ca sequestration into the SR. Calcium efflux is mediated 
through both a Ca-ATP'ase pump and a Na/Ca exchange mechanism 
in the sarcolemma, although the relative importance of each 
process is not known. Ca uptake into the SR is also mediated
through a Ca-ATP'ase 'pump', although the relative
contribution from the SR in decreasing [Ca]^ is unknown. The 
activity of both sarcolemmal and SR Ca-ATP'ases is stimulated 
by calmodulin (Wuytack, Schutter & Casteels, 1980; Rashatwar, 
Cornwell & Lincoln, 1987).
The regulatory action of [Ca]^ on the contractile
proteins is mediated through the calcium binding protein
calmodulin. This protein is very similar to troponin found in 
cardiac and skeletal muscle, and takes on a similar role. The 
Ca-calmodulin complex is an important regulator of many key 
enzymes, none more so than its activation of myosin light 
chain kinase (MLCK) which promotes contraction. The P-light 
chain of smooth muscle myosin must be phosphorylated before 
actin activation of myosin ATPase and contraction can occur. 
The extent of phosphorylation therefore determines how much 
acto-myosin interaction occurs and consequently how much
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tension is generated. Dephosphorylation of myosin P-light 
chains and hence inhibition of acto-myosin ATPase activity, is 
catalysed by phosphatases form I & II. The contractile state 
of the muscle depends on the relative activity of MLCK and the 
phosphatases. Increased [Ca]^ produces more Ca-calmodulin 
complex, which increases the activation of MLCK and so 
produces contraction. A decrease in [Ca]^ causes relaxation 
through a reduced activation of MLCK.
As has already been said, the actions of many hormones 
and drugs on smooth muscle contractility are mediated through 
alterations in the calcium influx. A different mechanism 
exists for the relaxant actions of j5-adrenergic agonists which 
increase the intracellular conentration of cyclic adenosine 
3-5-monophosphate (cAMP). The rise in cAMP activates 
cAMP-dependent protein kinase (cA-PK), an enzyme which 
catalyses the phosphorylation of a variety of proteins. One 
substrate for cA-PK is MLCK which is itself a phosphoprotein. 
Phosphorlyation of MLCK by cA-PK results in a decrease in 
Ca-calmodulin stimulation of activity (Hathaway, Konicki & 
Coolican,1985). Other substrates for cA-PK include membrane 
bound proteins, and these may be responsible for reducing Ca 
influx and increasing Ca extrusion and accumulation by the SR, 
although the exact molecular mechanisms have not yet been 
elucidated (Huggins & England, 1985), The major action in 
jS-adrenergic relaxation is a reduced light chain 
phosphorylation via an attenuation of the Ca-calmodulin 
stimulation of MLCK activity.
The mechanism of relaxation by agents which increase 
cGMP is not so well understood. Initial suggestions that NP
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mediated relaxation through hyperpolarisation were refuted
when relaxation of rat tail artery by NP and 8-bromo-cGMP were
shown not to affect the membrane potential (Cheung & MacKay,
1985). Identification of a cGMP dependent protein kinase
(cG-PK) in smooth muscle suggested that protein
phosphorylation was involved, similar to the mechanism of
action of cAMP. Measurements of cG-PK activity in rat aortic
strips showed that NP and ACH increased activity in a manner
that correlated closely with the increased cGMP and relaxation
(Fiscus, Rapoport & Murad, 1983). Further evidence came from a
study which chromatographically isolated a spectrum of
phosphoproteins from vascular smooth muscle preloaded with
32C P]ATP (Rapoport, Draznin & Murad, 1983). NP, ACH and 
8-bromo-cGMP all elicited a similar pattern of protein 
phosphorylation which was associated with relaxation. 
Isoproterenol and dibutyryl-cAMP induced relaxation gave a 
different pattern of phosphorylation (Rapoport et al, 1982), 
Unlike cA-PK, purified cG-PK was shown to have no influence on 
the activity of MLCK, which suggested a different mechanism 
of action (Hathaway, Konicki & Coolican, 1985). Studies with 
Ca channel blockers (verapamil) and various external [Ca], led 
to the hypothesis that NP and 8-bromocGMP antagonised Ca
influx and increased Ca sequestration and efflux (Lincoln,
1982). This was substantiated by recent measurements of ^^Ca 
influx and efflux with tension showed that EDRF, NP & 
8-bromo-cGMP caused relaxation by reducing both Ca influx and 
intracellular Ca release (Collins, Griffiths, Henderson & 
Lewis, 1986; Collins, Henderson, Lang & Lewis, 1988).In vitro 
studies have shown cG-PK activation of sarcolemmal Ca-ATPase
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in rat aortic cells (Rashatwar, Cornwell & Lincoln, 1987), A 
decrease in phosphatidylinositol hydrolysis has been shown to 
occur in rat aorta after application of NP, ACH, 8-bromo-cGNP 
and ANF (which activates particulate GC) (Rapoport, 1986). 
This process is linked to ROC opening and is postulated to be 
a mediator of intracellular Ca release.
Taken together, these reports suggest that 
phosphorylation by cG-PK reduces (i) Ca influx through ROC and 
VOC, (ii) attenuates intracellular Ca release, (iii) 
stimulates Ca accumulation by the SR, and (iv) increases 
extrusion of Ca via the sarcolemmal Ca-ATPase. These will all 
cause a marked reduction in [Ca]^ which will inactivate MLCK 
and so mediate relaxation. The exact molecular events 
underlying these observations have still to be elucidated.
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Cardiac Muscle 
The force of contraction of cardiac muscle, unlike
sketetal muscle, is regulated by alterations in the force 
developed by each muscle cell. This can vary over a tenfold 
range without any change in muscle length or action potential 
height. The process of coupling excitation at the cell
membrane to force generation at the contractile proteins is
responsible for variations in contractile force induced by 
inotropic agents (ie. hormones, drugs and the ionic
environment). As the current theories and controversies of 
excitation-contraction coupling in cardiac muscle have been 
reviewed by numerous authors,(Morad & Goldman, 1973; Ebashi, 
1976; Fozzard, 1977; Fabiato & Fabiato, 1979; Chapman, 1979,
1983) only a short resume' of the major points of the theories 
are included in this introduction. The mechanisms by which 
various hormones and drugs affect this process will then be 
reviewed with particular emphasis on the role that cGMP plays 
in regulating cardiac contractility.
Excitation contraction coupling
In all muscle cells, contractile force is generated 
through interaction of the cross bridge head of the myosin 
(thick) filament with binding sites on the actin (thin) 
filament. In cardiac and skeletal muscles, the number of cross 
bridges formed is controlled by the tropomyosin-troponin
regulatory protein complex associated with the actin filament. 
Troponin-I (Tn-I), in the relaxed state, masks the binding 
site on the actin molecule such that attachment of the myosin 
cross bridge head is prevented. This steric inhibition is
removed when calcium binds to Troponin-C (Tn-C) which induces
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a conformational change in the protein structure that moves 
Tn-I away from the active site. The number of cross bridges 
able to generate force is dependent on the amount of calcium 
bound to Tn-C.
The primary control of contraction is the free 
calcium concentration in the cytoplasm ([Ca]i) available to 
bind to Tn-C. This can be shown experimentally in 'skinned* 
muscle preparations where the sarcolemma is removed either 
chemically or by microdissection. The force produced by these 
preparations is directly related to the free calcium 
concentration ([Ca]o) of the bathing solution. Tension is 
developed at [Ca]o greater than O.luM and reaches a maximum of
approx. 100mN/mm= at around 20uM (Fabiato & Fabiato,
1975;1979;1982; Fabiato ,1981; McClellan & Winegrad, 1980; 
Morad & Goldman, 1973; Chapman 1983). Intracellular 
Ca-sensitive microelectrodes, have estimated the [Ca]i of 
resting muscle as being 0.2-0.3 uM (Chapman, 1983). Fabiato
(1981) compared the twitch tension of intact mammalian cells
to the contracture produced after skinning, and showed that 
under optimal stimulation conditions (paired pulses), twitches 
can only produce 50-60% of the maximum contracture tension. 
Using the pCa-tension curve of the skinned preparations, this 
translated into a peak free [Caji of 4uM compared to the 18uM 
[Ca]o required to fully activate the contractile proteins. 
Chapman (1983) after accounting for the Ca binding capacity 
of calmodulin, suggested that for Tn-C to be fully activated 
requires a rise in [Ca]^ of lOOuM. Comparing the tension 
generated by various preparations, he further suggested that 
the maximal rise in CCa]^ was only 25-50 uM in mammali an
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fibres, but could reach lOOuM in frog heart (Chapman, 1983).
These results indicate that mammalian cardiac calls normally
work well below their maximum force generating capacity so
that increases in force can be induced by further increases in
[Ca]i. Further evidence for this comes from experiments using
2+the light-emitting Ca sensitive protein aeguorin to directly 
measure the free [Ca]i in intact muscle cells. After the 
membrane is depolarised, the [Ca]i rises to a peak 
(130-220msec in frog or 20-25msec in mammalian muscles) which 
decays back to control levels at the peak of the tension 
response (Allen & Blinks, 1978). The reduction in free Ca is 
due to it rapidly binding to Tn-C (& calmodulin) to generate 
tension, increases in twitch tension induced by increasing the 
extracellular calcium ([Ca]o), stimulation rate or applying 
isoprenaline are associated with larger transient increases in 
[Ca]i (Allen & Kurihara, 1980; Allen & Orchard, 1984; Morgan & 
Blinks, 1981) .
The source of calcium responsible for the increase in 
[Cali is still a controversial issue, and shows considerable 
species differences. It is well established that the 
contractile strength of cardiac muscle, unlike skeletal 
muscle, is strongly dependent on the [Ca]o. The relatively 
large extracellular Ca concentration ([Ca]o= ImM) coupled 
with a normal resting potential of -80mV, produces a large 
electrochemical gradient for Ca across the membrane ( >10^)
(Huggins & England, 1985). This has led to the suggestion that 
an influx of Ca through the sarcolemma is the major source of 
activator calcium. Calculations based on the Hill (1948) 
diffusion equations, estimate that the time for an influx of
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extracellular Ca to reach the required [Cajiis 50msec for 
frog but >1.3 sec for mammalian ventricular cells (Chapman, 
1983; Fabiato & Fabiato,1979) These times are compatible with 
the rate of tension generation and the aeguorin signal for 
frog heart, but too slow for mammalian heart (Allen & Orchard,
1984). Influx of Ca from the extracellular fluid cannot
directly contribute to tension development in the larger
mammalian cells ( 10-15um dia.), but can do so in the smaller 
diameter cardiac cells of the frog (2.Sum)(Morad & Cleeman,
1987).
The major route of trans-sarcolemmal influx of Ca is 
the inward Ca current during the plateau of the action
potential (Morad & Goldman, 1973). The size of this current as 
measured by voltage clamp experiments is not adequate to raise 
the [Cali by the required amount. Estimates of the rise in
[Caji by this route during a normal twitch, vary from 0.3-25uM
in mammalian and 6-40uM in frog, significantly less in 
mammalian muscle than the 25-50uM required for a normal twitch 
(Chapman, 1983). Another route of Ca entry is through reversal 
of Na/ca exchange across the sarcolemma. In the resting
condition (membrane potential -SOmV) this system operates to 
remove Ca from the cytoplasm, by allowing 3 Na^ ions to flow 
down their electochemical gradient in exchange for 1 Ca^^ion 
moving against its electrochemical gradient (Chapman, 1983; 
Caroni & Carafoli, 1983). However, during the action 
potential, depolarization of the membrane causes the
electrogenic exchange to reverse direction and allow Ca to 
enter. Evidence for this comes from experiments in which the 
exchange is artificially reversed by depolarising
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the membrane for long periods {either by voltage clamp, 
raising or by lowering [Na]^, These procedures produce
contractures in both mammalian and frog cardiac muscle which 
are associated with a rise in [Ca]i and a measured outward 
current (Chapman, 1983; Chapman & Leoty, 1981; Morad & 
Cleeman, 1987). Long lasting depolarisations induce different 
kinds of contracture in amphibian and mammalian ventricular 
preparations. Frog ventricle maintains a steady high level of 
tension (tonic) which is related to the extent of
depolarisation (Morad & Cleeman, 1987), However, frog atrial 
and mammalian preparations show an initial phasic component 
which rapidly declines to a secondary tonic phase (Chapman & 
Tunstall, 1981; Chapman, Coray & McGuigan, 1983; Flitney & 
Kennovin, 1984). The phasic component is associated with Ca 
release from the SR whereas the tonic phase is due to reversal 
of the Na/Ca exchange.
Low [Na]o contractures in frog can increase the [Ca]i 
enough to fully saturate Tn-C and generate maximum tension 
(lOOmM/mm^) (Chapman, 1983). Mammalian preparations by
contrast produce small contractures in low [Na]o which vary in 
relative size and only produce negligible rises in [Ca]i 
(0.5uM) (Chapman, 1983; Chapman, Coray, & McGuigan, 1983). 
This is thought to be due to the higher amount of SR present 
in mammalian tissue which quickly sequestrates incoming Ca.
The reversal of Na/Ca exchange can directly add to the 
activator Ca pool in frog cardiac cells, but indirectly in 
mammalian. It should be noted that most of the work on Na/Ca 
exchange has been done under unphysiological 'contracture' 
conditions and so its role in generating tension in the normal
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twitch has yet to be fully elucidated.
The preceding arguments against an extracellular 
source of Ca for activation of tension in mammalian heart 
imply that an intracellular release site must be involved. In 
skeletal muscle, activator calcium comes entirely from the
extensive sarcoplasmic reticulum (SR) system which releases it 
upon depolarisation through electrical couplings (triads) to 
the t-tubule system, Ultrastructural studies have revealed 
that SR is present in both frog and mammalian myocardium, but 
it is much less extensive in the former (0.5% fibre volume 
compared to 3.5% in mammalian; Morad & Cleeman, 1987). The SR 
takes up Ca through ATP dependent Ca pumps and has been shown 
to be able to accumulate up to 400uM per cell in mammalian but 
only 200 uM per cell in frog. The mechanism of its release is 
still a controversial issue. Mammalian myocardium does not 
possess triads, but instead there are close couplings with 
both the t-tubules and sarcolemma. Frog ventricle lacks a 
T-system and its sparse SR does not make direct connections
with the sarcolemma.
Unlike skeletal muscle, depolarisation of the SR does 
not seem to be the mechanism that initiates Ca release. In
partially skinned mammalian cardiac muscle cells, release of Ca
from the SR can be induced by rapidly raising the bathing Ca 
concentration. This Ca-induced-Ca-release (CICR) can liberate 
enough Ca to generate 60% of maximum tension. Although this 
may be an underestimate, it is still more than enough to 
account for the release and uptake of Ca neccessary for a 
normal twitch (Fabiato,1981). From this evidence it has been 
suggested that in mammalian muscle, activator Ca is released
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from the SR. The trigger for this is the rise in [Ca]i due to 
influx of Ca during the action potential. The size of 
Ca-triggered contractions has been shown to correlate with the 
quantity of triggering Ca and the rapidity of its increase 
{Fabiato & Fabiato, 1975; Fabiato & Fabiato, 1979). 
Alterations in the size of the inward Ca current would 
therefore induce the SR to release varying amounts of
activator Ca. The close proximity of the SR to the sarcolemma 
lends further evidence in support of this hypothesis.
Relaxation is associated with a decrease in [Ca]i 
caused by uptake of Ca by the SR, or by extrusion of Ca across 
the membrane. Estimates of the rate and capacity of Ca 
accumulation by isolated SR show that it is more than adequate 
to relax a normal twitch in mammalian muscle. However, the 
mechanism whereby CICR is inactivated, to allow Ca
accumulation, has still to be elucidated. The extrusion of Ca
is thought to play little part in the relaxation mechanism of
mammalian cardiac muscle.
CICR and rapid Ca accumulation by the SR cannot be 
demonstrated in frog ventricle (Fabiato & Fabiato, 1979). This 
lends further credence to the hypothesis that both activation 
and relaxation are due to Ca movements across the sarcolemma. 
The sparse SR in this tissue with its slow rate of uptake and 
release may serve as an intracellular Ca buffer. Relaxation is 
thought to occur by extrusion of Ca through the sarcolemmal Ca 
pump or Na/Ca exchange. Using isolated sarcolemmal vesicles, 
the maximal Ca flux carried by the sarcolemmal Ca pump was 
estimated to be 1/30-1/100 that of the Na/Ca exchange (Caroni 
& Carafoli, 1983).
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Another intracellular organelle that has been 
implicated in Ca homeostasis is the mitochondria. Mitochondria 
can accumulate and release large amounts of Ca through a Na/Ca 
exchange carrier in its membrane. It is thought however that 
they serve normally as a Ca buffer and are only involved in 
the release or accumulation of activator Ca when the [Na]i is 
altered, for example, during Na withdrawal contractures or 
inhibition of the sodium pump (Chapman, 1983). An increase in 
[Ca]i is thought to act as a second messenger inside
mitochondria to stimulate oxidative metabolism and so promote 
the synthesis of ATP (McCormack & Denton, 1986). Increases in 
[Ca]i therefore not only increase the energy requiring
processes in cells (ie. contraction) but also stimulates 
production of the neccessary fuel (ie. ATP)(Denton, McCormack, 
Hidgley, Rutter & Thomas, 1988).
In summary, the source of activator calcium is 
different in frog and mammalian cardiac muscle. In frog,
extracellular calcium is utilised on a beat to beat basis via
Ca influx through the slow inward calcium channel and 
reversal of Na/Ca exchange. In mammalian myocardium, these 
processes are only used to replenish the SR with calcium and 
the release of intracellular calcium activates contraction. 
These differences were highlighted recently in a comparative 
study of frog and mammalian excitation contraction coupling 
(Morad & Cleeman, 1987). After photolytic removal of 
nifedipine blockade of Ca channels, frog twitch tension fully 
redeveloped in the next beat, whereas 5-7 beats were required 
in mammalian ventricle (Morad & cleeman, 1987). Sufficient Ca 
is transported from the extracellular space to fully activate
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tension in a single beat in frog whereas mammalian cells must 
first load up the SR before full recovery of tension is 
achieved.
As EC coupling in these tissues is fundamentally 
different, then inotropic agents or interventions would be 
expected to affect each one differently, A good example of 
this is post-extrasystolic potentiation which increases 
contractile strength in mammalian but not frog myocardium. 
Inotropic drugs or hormones will similarly affect each type of 
muscle differently depending on their intracellular mode of 
action'.
Role of cyclic 3* 5•adenosine monophosphate (cAMP)
Following the discovery of its role in the regulation 
of liver metabolism, a similar 'second messenger* role for 
CAMP in heart muscle was proposed when its formation was shown 
to be increased by adrenaline (Murad, Chi, Rail & Sutherland, 
1962). This was substantiated in the perfused working heart 
when adrenaline caused an increase in cAMP levels which 
proceeded the positive inotropic response (Robison, Butcher, 
Oye, Morgan & Sutherland, 1965). It is now well established 
that ^-adrenergic agents increase the force and rate of 
contraction and also the rate of relaxation in cardiac muscle 
through an increase in intracellular cAMP levels (CcAMPji). 
Cyclic AMP is formed from ATP by the enzyme adenylate cyclase 
(AC) which is found in both SR and sarcolemmal membranes. 
Adrenergic agonist bound to ^-receptors are now known to 
directly activate sarcolemmal AC through a membrane 
transducing protein (G-protein)(Neer & Clapham, 1988). The 
CAMP produced combines with the regulatory subunit of
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cAMP-dependent-protein-kinase (cA-PK) which liberates the 
active catalytic subunit. The latter is responsible for 
phosphorylating a variety of regulatory enzymes (Corbin, Cobb, 
Beebe, Granner, Koch, Gettys, Blackmore, Francis & Wells, 
1988) . This introduction will concentrate on the substrates 
for cA-PK and how these are thought to influence various 
stages in the process of myocardial EC coupling.
Calcium influx.
Aeguorin studies showed that the increased force of 
contraction induced by adrenergic agents correlated with an 
increase in the transient rise of [caji associated with 
contraction (Allen & Blinks, 1978; Morgan & Blinks, 1981; 
Allen & Orchard, 1984). The amplitude of the calcium transient 
is a measure of the amount of Ca liberated into the cytoplasm 
via the slow inward current of the action potential and
by release from the SR. Indications of an increase in l^^ was 
the prolongation of the action potential duration following 
adrenergic application that correlated well with the increase 
in twitch tension (Boyett, 1978; Reuter, 1979), Intracellular 
injection of cAMP also prolonged the duration, and raised the 
plateau of the action potential (Trautwein, Tangiguchi & Noma, 
1982). Similarly, intracellular injection of cAMP into 
depolarised Purkinje cells induces slow action potentials 
which are mediated via l^^ (Vogel & Sperelakis, 1981), 
Dibutryl cAMP was found to augment frog action potentials and 
measured in voltage clamp conditions (Morad, Saunders & 
Weiss, 1981). Similar responses could be obtained following 
injection of the catalytic subunit of cA-PK supporting the 
hypothesis that phosphorylation of sarcolemmal Ca channel, or
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an associated protein modifies its conductance (Bkaily & 
Sperelakis, 1984), Direct measurements of using whole cell
clamp techniques showed that j3-adrenergic neurotransmitters 
increased the conductance of the channel without altering any 
of its other parameters (Reuter, 1983; Hartzell & 
Fischmeister, 1986; Morad et al, 1981). Detailed kinetic 
analysis of patch clamped or whole cell clamped myocardial 
preparations showed that ^-agonists, cAMP and 8-bromo-cAMP 
increased the probability of Ca channel opening during 
depolarisation (Reuter, 1983).
Direct evidence that phosphorylation is involved in
the ^-adrenergic increase in comes from the observation
that CAMP dependent phosphorylation of a membrane protein in
isolated sarcolemmal vesicles increases the calcium uptake
induced by depolarisation (Rinaldi, Le Peuch & Démaillé, 1981;
Rinaldi, Capony & Démaillé, 1982). A linear correlation was
established between the cAMP dependent phosphorylation of a
23,000 dalton sarcolemmal protein and the voltage dependent Ca
uptake by vesicles (Rinaldi et al, 1982). It is now thought
that this protein is 'phospholamban’ (meaning phosphate
acceptor) which is known to regulate calcium transport in SR
membranes (Huggins & England, 1985). Phosphorylation of
phospholamban has been demonstrated in sarcolemmal vesicles
3 2rapidly isolated from P perfused intact hearts after 
isopreternol treatment (Huggins & England, 1983) . 
Phospholamban was the only phophorylated protein and its 
phosphorylation by isoproterenol was rapid and preceded the 
positive inotropic response (Huggins & England, 1983). This is 
strong evidence that adrenergic agonists enhance contractility
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through an increase in via cAMP dependent phosphorylation
of phospholamban.
SR release of calcium
The functional capacity of the SR has been 
investigated using mechanically skinned single myocardial 
cells which removes the sarcolemma but leaves the SR intact 
(Fabiato, 1981). Addition of cAMP increased the amplitude of 
the CICR contraction (by 78%), and decreased its duration (by 
18%) with both a faster rate of tension development and 
relaxation (Fabiato & Fabiato, 1975; 1981). The tonic tension 
in low [EGTA] was also reduced by cAMP (Fabiato, 1975). In 
another skinned muscle preparation, caffine induced tension 
transients were increased by cAMP, or the catalytic subunit of 
cA-PK, if present in the calcium loading solution (Su & 
Makencik, 1982). The increase in tension transient by cAMP was 
inhibited by the heat stable inhibitor of cA-PK (Su & 
Malencik, 1982). These studies support the hypothesis that 
CAMP stimulates accumulation of calcium by SR through 
phosphorylation of a membrane component. This can be 
recognised in intact myocardium by shortening of the augmented 
aeguorin transient, with a reduction of the time to peak 
tension and a greatly accelerated decline of light intensity, 
following application of either noradrenaline, IBMX (PDE 
inhibitor) or dibutryl cAMP (Morgan & Blinks, 1981).
Calcium uptake into preparations of isolated cardiac 
SR vesicles is stimulated by cAMP, and this has been shown to 
be due to cAMP dependent phosphorylation of a membrane protein 
in SR of 22,00 dalton, called 'phospholamban'(Huggins & 
England, 1985). Phosphorylated phospholamban enhances the
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activity of the Ca-transport ATPase, by increasing its 
affinity for calcium and the turnover rate of elementary steps 
in the ATPase reaction (Kranias & Solaro, 1982). The
phosphorylation of phospholamban has been demonstrated in
32intact rabbit hearts perfused with Pi , from which highly
purified SR vesicles were extracted at the peak of the
inotropic response to isoproterenol (Kranias & Solaro, 1982).
3 2The incorporation of Pi into phospholamban was much greater 
than in control hearts and it paralleled the increase in 
contraction (Kranias & Solaro, 1982; Huggins & England, 1985).
The above evidence indicates that cAMP dependent 
phosphorylation of phospholamban increases the rate of calcium 
accumulation into the SR, which partly explains the increased 
rate of relaxation induced by ^-agonists. A consequence of the 
increased calcium accumulation is that more is available for 
release in subsequent contractions thus mediating the increase 
in tension.
Phosphorylation of contractile proteins
Phosphorylation of cardiac TN-I was demonstrated in 
vivo in a number of species; the extent of phosphorylation 
increased after exposure to adrenaline and other j3-agonists 
(England, 1980; Kranios & Solaro, 1982). Time course studies 
suggested a causal role of TN-I phosphorylation in the 
contractile regulation when the extent and rate of 
phosphorylation directly paralleled the increase in force of 
contraction of perfused whole rat hearts stimulated by 
adrenaline (England, 1975). It was proposed that TN-I 
phosphorylation might cause an increase in the affinity of
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TN-C for Ca, leading to a greater Ca-sensitivity of the 
contractile apparatus (England, 1975) . Other positive 
inotropic agents (ie. cardiac glycosides or raised [Ca]o) 
failed to phosphorylate TN-I which supported the hypothesis 
that it was mediated through cA-PK (England, 1980). A study 
which measured TN-I phosphorylation in 'hyperpermeable* rat 
ventricular cells showed that cAMP did augment TN-I 
phosphorylation but that this was associated with a decrease 
in the Ca sensitivity of the contractile apparatus (Mope, 
McClellan & Winegrad, 1980). In intact myocardium, the 
relationship between the calculated [Caji (deduced from the 
aeguorin signal) and tension, is lower for increases in 
contractility produced by adrenaline then those produced by 
raising [Cajc or stimulation rate (Allen & Orchard, 1984). 
This was interpreted as a reduced Ca sensitivity of the 
contractile proteins. Phosphorylation of TN-I is now thought 
to be associated with the increased rate of relaxation induced 
by j5-agonists and not the increase in tension.
In vitro measurements of acto-myosin ATPase activity
showed that phosphorylation of TN-I caused a 5-fold increase
in Ca concentration required for half maximal stimulation
(Holrode, Howe & Solaro, 1979; England, 1980). The rate of
2 +dissociation of Ca from dephosphorylated TN-I is relatively
slow (t^y2= 50msec) and it is increased by phosphorylation
(ti/2=30msec)(Huggins & England, 1985). This ensures that the 
2+rate of Ca dissociation from the myofibrils is still faster 
than the increased rate of uptake by the SR such that the 
overall relaxation rate is increased (Huggins & England,
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1985). The increase in the maximal velocity of relaxation over 
that of contraction after ^-agonist or dibutryl cAMP 
treatment, was shown to correlate with the cA-PK activity and 
increased [cAMPji in whole rat hearts (Argel, vittone,
Chiappe,Cingolani & Grassi, 1980),
The myosin P-light chain is also phosphorylated in
heart muscle (Jeacocke & England, 1980; England, 1980; Opie, 
1982). The precise role of phosphorylation of this contractile 
protein has not been established. Adrenaline was shown not to 
alter the level of P-light chain phosphorylation in rat heart 
(Jeacocke & England, 1980). A small increase in P-light chain 
phosphorylation was reported for rabbit heart, but this
reached a maximum after the peak of the inotropic response
(Westwood & Perry, 1981). There are reports however that light
chain phosphorylation increases actomyosin ATPase activity 
(Resink, Gevers, Noakes & Opie, 1981). Opie (1982) reviewed 
the evidence for and against a role for P-light chains and 
suggested that the negative effects of TN-I phosphorylation 
would mask any positive effects from myosin LC 
phosphorylation, so that it is probably not an important 
regulator of contractility.
In summary, jB-agonist induced increase in force of
contraction is mediated through a cAMP-dependent increase in 
Ca^* influx, which is later taken up by the SR. Increased rate
of relaxation is mediated through a decrease in Ca affinity of
the contractile proteins and an increase in the rate of ca 
sequestration by the SR. This scheme would increase the 
contractile response in both mammalian and amphibian 
myocardium although the lack of an effective SR in the latter
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could present problems in accounting for the increased rate of 
relaxation (Morad, Saunders & Weiss, 1981). An increase in Ca 
efflux may however be involved in the adrenergic response, as 
sarcolemmal ATPase activity has been shown to be stimulated by 
cA-PK phosphorylation of phospholamban (Caroni & Carafoli, 
1981; Lamers, Stinis & Jonge, 1981). Although activation by 
cAMP can increase Ca efflux through the Ca-pump, its low 
activity as compared to Na/Ca exchange would suggest that even 
after phoshorylation its contribution would be small. In this 
last regard, phosphorylation of Na/Ca exchange has been 
demonstrated to increase its exchange activity in vitro 
(Caroni & Carafoli, 1983). This is mediated through a 
Ca-calmodulin dependent kinase present in the sarcolemma, and 
so would only be indirectly affected by ^i-adrenergic 
stimulation through increased [Caji.
Role of calmodulin
Calmodulin is a ubiquitous and multifunctional Ca 
dependent regulatory protein, capable of activating a wide 
variety of key enzymes (Cohen, 1982). Upon an increase in 
cytosolic [Caji from pCa8 to pCa5, calmodulin binds Ca and 
forms an active Ca-calmodulin-enzyme ternary complex, which 
results in increased activity of that enzyme (Walsh, Le Peuch, 
Vallet, Cavador & DEmaille, 1980). The functions of calmodulin 
therefore depend on the particular substrate enzymes present, 
and this differs in individual tissues. In cardiac 
muscle,Ca-calmodulin is thought to activate a membrane bound 
protein kinase(present in both SR and sarcolemma), myosin 
light chain kinase, sarcolemmal Ca-ATPase and a cyclic 
nucleotide phosphodiesterase (PDE I) which hydrolyses both
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CAMP and CGMP. (Walsh et al, 1980; Cohen, 1982). As 
phosphorylation of the myosin light chain does not play a 
major role in regulating contractility, the main actions of 
calmodulin are associated with Ca fluxes and the regulation of 
cyclic nucleotide levels.
Most of the calmodulin effects on regulating Ca 
movements are similar to those of cAMP, in fact they augment 
one another at two important sites. The regulation of is
one such site. A calmodulin-dependent protein kinase in the 
sarcolemma mediates this effect by phosphorylating 
phospholamban at a different site to that of cA-PK (Cohen, 
1982). The importance of calmodulin in regulating l^^was shown 
by the ability of the calmodulin inhibitor calmidazolium to 
completely abolish slow action potentials in cultured heart 
cells (Bkaily & Sperelakis, 1986). Full recovery of these 
action potentials required both calmodulin and the catalytic 
subunit of cA-PK (Bkaily & Sperelakis, 1986). Similarly, the 
activity of CaATPases is also dependent on the dual 
phosphorylation of phospholamban (Walsh et al, 1980; Wuytack, 
DeSchulter & Casteels, 1980;Lamers, Stinis & Dejonge, 1981; 
Caroni & Carafoli, 1981). The extraction of calmodulin from 
cardiac sarcolemmal vesicles or the addition of 
trifluoperizine (TFP) results in a reduction of the Ca 
affinity of CaATPase (Caroni & Carafoli, 1981). The 
stimulatory effects of cAMP or calmodulin on Ca-ATPase are 
independent of each other (Lamers et al, 1981). 
Phosphorylation of SR phospholamban by the Ca-calmodulin 
dependent protein kinase alone results in activation of the Ca 
pump, whereas that mediated by cA-PK alone does not. However,
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cA-PK amplifies the activation induced by calmodulin (Walsh et 
al, 1980). It is clear from such studies that cAMP-dependent 
regulation of Ca influx, Ca sequestration and Ca efflux are
all strongly affected by calmodulin. The action of calmodulin
in vivo has been assessed by studying the effects of 
calmodulin blockers on the jÔ-*adrenergic responses in rat 
papillary muscles (Aass, Skomedal & Osnes, 1983). Calmodulin 
inhibition attenuated the increase in relaxation but augmented 
the positive inotropic response (Aass et al, 1983). It was
postulated that these effects are due to reduced rates of Ca 
sequestration and Ca efflux.
Calmodulin also plays a role in the regulation of 
cyclic nucleotide metabolism as it stimulates the activity of 
a cyclic nucleotide phosphodiesterase (PDE). Of the three 
PDE's present in cardiac muscle, calmodulin stimulates PDE I. 
This enzyme hydrolyses both cAMP and cGMP, although the
substrate affinity varies with species (Weishaar, Burrows, 
Kobylarz, Quade & Evans, 1986), Guinea-pig ventricular PDE I 
hydrolyses both nucleotides to similar degrees, whereas rat 
ventricular PDE I preferentially hydrolyses cGMP (Weishaar et 
al, 1986; Terasaki & Appleman, 1975). This has important 
implications when considering the calmodulin stimulation of 
activity as it will cause an increase in [cAMP] over [cGMPj in 
the rat but not in the guinea-pig. Inhibition of calmodulin in 
the frog ventricle elevated cGMP levels by a greater extent 
than CAMP levels and produced a decrease in twitch tension 
(Flitney, Moshiri, Robertson & Singh, 1981). This suggests a 
similar form of PDE I in frog as in rat. In mammalian 
ventricle, Ca-calmodulin stimulation of PDE activity does not
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appear to have the same importance, as calmodulin inhibitors 
(TFP or chlorpromazine) did not increase cAMP levels in 
perfused rat heart, with or without stimulation by
isoprenaline (Werth, Hathaway & Watanabe, 1982),
In summary, the actions of calmodulin in mammalian 
muscle augment those of cAMP, namely: increasing Ca influx, Ca 
sequestration and Ca efflux. However, in amphibian ventricle, 
calmodulin may play a major role in controlling the levels of 
cyclic nucleotides.
Role of cGMP in cardiac muscle.
The first indication of a role for cGMP in regulating 
myocardial contractile activity was the finding that the 
decrease in twitch tension after perfusing rat hearts with 
acetylcholine (Ach) correlated with increased intracellular 
cGMP levels (George, Poison, O'toole & Goldberg, 1970). 
Further studies showed that this réponse was also 
characterised by a decrease in cAMP levels (George, Wilkerson 
& Kadowitz, 1972). Lipid soluble cGMP analogues (8-bromo-cGMP) 
mimic the decrease in tension produced by Ach, whereas cAMP 
analogues increase tension, similar to adrenergic stimulation 
(Nawrath, 1976). Similar studies led to the hypothesis that 
cGMP mediates the inhibitory actions of the parasympathetic 
neurotransmitters analagous to the proposed role of cAMP in 
mediating sympathetic responses. Goldberg (1975) proposed the 
•ying-yang’ hypothesis that suggests cAMP and cGMP have 
opposing actions in intracellular regulation (Goldberg, 
Haddox, Nicol, Glass, Sanford, Kochi & Estensen, 1975).
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Subsequent studies have however criticised this 
hypothesis as they have shown a lack of correlation between 
intracellular cGMP and contractility (Diamond, TenEick & 
Trapani, 1977; Linden & Brooker, 1979). Consequently, Drummond 
and Severson in a 1979 review have stated "no definite role of 
this cyclic nucleotide in cardiac function is yet apparent". 
In recent years, some progress has been made in identifying 
the intracellular actions of cGMP, but its precise role in 
the regulation of myocardial contractility remains obscure.
Results from the frog ventricle provide the best 
evidence for a 'ying-yang' hypothesis of cyclic nucleotide 
regulation of myocardial contractility. Since 1977, Flitney 
and Singh have provided an increasing body of evidence in 
support of the idea that both cAMP and cGMP are involved in 
regulating ventricular contractility. The major evidence for 
this is that all inotropic agents or procedures, both positive 
and negative, alter the ratio of endogenous (cAMP]:[cGMP] in a 
manner that correlates precisely with the change in twitch 
tension. Positive inotropic agents (adrenaline, isoprenaline, 
ATP, UTP) or procedures (stretch), increase the ratio whereas 
negative inotropic agents (Ach, adenosine, NP) or procedures ( 
hypodynamia), decrease the ratio (Flitney, Lamb & Singh, 
1977a,b;1979; Singh, Flitney & Lamb, 1978;Flitney & Singh, 
1978;1979; • 1980a,b,c,d,e; Flitney, Moshiri & Singh, 1980a,b; 
Singh & Flitney, 1980a,b;1981). The magnitude of the responses 
are all paralleled by quantitatively equivalent changes in the 
ratio. The time course of these effects also correlates 
precisely, even in the complicated triphasic tension responses 
to ATP, the change in tension is quantitatively equivalent to
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the change in the nucleotide ratio throughout (Flitney & 
Singh, 1980(c)). Evidence that this is a causal relationship 
is that predetermined changes in the ratio can be induced by 
applying lipid soluble analogues of either nucleotide. The 
magnitude of the decrease in tension produced by 8-bromo-cGMP, 
or the tension increase produced by dibutryl cAMP, are each 
paralleled by quantitatively similar changes in the ratio of 
the total nucleotides (ie. endogenous and exogenously applied 
nucleotides).The increase in cGMP produced by Ach or 
8-bromc-cGMP is accompanied by a marked decrease in the cAMP 
level, whereas elevated cAMP levels by isoprenaline or 
dibutryl cAMP slighly raised cGMP levels (Singh et al, 1978; 
Flitney & Singh, 1981). Treatment with the phosphodiesterase 
(PDE) inhibitor theophylline, attenuated the effects of 
8-bromo-cGMP and Ach on endogenous cAMP levels (Flitney & 
Singh, 1981). This was taken as evidence that cGMP reduces 
cAMP levels by stimulating cAMP PDE activity (Flitney & Singh, 
1981) . Identifiation of a cAMP PDE in rat heart and other 
tissues, whose activity could be stimulated 6-10 fold by cGMP 
supported this hypothesis (Terasaki & Appleman, 1975). If such 
an enzyme is present in frog ventricle, then it could account 
for the conformity of the cyclic nucleotide ratio. The 
possibility that endogenous cGMP regulates cAMP hydrolysis is 
suggested as one of the underlying mechanisms in the cyclic 
nucleotide control of contractility. Other direct functions of 
cGMP in regulating contractility must also exist however, or 
the contractile response would correlate more closely with 
changes in cAMP alone.
In mammalian cardiac muscle the role of cGMP is less
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clear. Early studies suggested a role for both nucleotides in 
the regulation of mammalian contractility, but few authors 
measured intracellular cAMP and cGMP . concentrations 
simultaneously (see Diamond & Severson, 1979). Recently, 
Rodger & Shahid (1984) measured both in rabbit papillary 
muscles and tried to correlate them to the changes in 
contractility produced by various inotropic agents. 
Isoprenaline induced dose dependent increases in tension and 
both [cAMP] and [cGMP] (Rodger & Shahid, 1981). Direct 
stimulation of adenylate cyclase with forskoliin increased 
CAMP, without affecting cGMP levels. In both cases tension
correlated closely with intracellular [cAMP] and was not
related to the ratio of [cAMP]:[cGMP]. Direct stimulation of 
guanylate cyclase with NP elevated cGMP levels and slightly 
decreased cAMP, but failed to produce any inotropic effect. In 
contrast to results with frog ventricle, these results would 
suggest that cGMP plays no part in regulating contractility in 
mammalian ventricle (Rodger & Shahid, 1984). The direct role 
of total [cAMPli in mediating contractility has also been 
questioned. Although there are good correlations between
[cAMPli and tension, a similar increase in force of\ 
contraction was produced by isoprenaline and forskolin, 
despite cAMP levels being 8 times higher with the latter agent 
(Rodger & Shahid, 1984). This indicates that intracellular 
CAMP may be a determinant of increased contractility, but the 
relationship between the two is not one of simple
proportionality.
There are numerous reports showing that in mammalian 
atrial muscle, intracellular cGMP is not associated with the
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decrease in tension produced by various agents. Diamond, 
TenEick & Trapani (1977), showed that low doses of Ach 
decreased the twitch in cat atria without affecting cGMP or 
CAMP, levels. In the same preparation, NP induced large 
increases in cGMP with no change in cAMP, and produced a
slight (11%) increase in twitch tension (Diamond et al, 1977). 
In isolated guinea-pig atria, carbachol (3uM) reduced twitch 
tension by over 80% without affecting cGMP levels (Linden & 
Brooker, 1979). Similarly, rat atrial twitch is almost 
abolished by high doses of methacholine which produce no
increase in cGMP levels (Linden & Brooker, 1979).
A comparative study on the action of muscarinic 
agonists (carbachol), NP and 8-bromo-cGMP on canine atria and 
ventricle showed that these agents increase cGMP in both 
tissues, but only decreased the twitch in atrial preparations 
(Endoh & Yamashita, 1981). The size of the twitch depression
did not correlate with the increase in cGMP, as carbachol
almost abolished the twitch (91% depression) but only elevated 
cGMP 1.5 times (30-50fmol/mg), whereas NP increased cGMP 40 
fold (43-1800fmol/mg) but only reduced tension by 22% (Endoh & 
yamashita, 1981). The positive inotropic action of various 
agents (PE, isoprenaline, glucagon, papverine & caffine) were 
antagonised by carbachol, but not by NP or 8-bromo-cGMP (Endoh 
& Yamashita, 1981). A similar study in guinea pig showed that 
adenosine and related analogues decreased the force of 
contraction and reduced the action potential duration in atria 
but not in ventricle, although the cAMP or cGMP did not change 
in either tissue (Bruckner, Fenner, Meyer, Nobis, Schmitz & 
Scholz, 1985). In rabbit, carbachol increased cGMP, without
-Page 1,63-
chapter 1
affecting cAMP, in both atria and ventricular preparations, 
but only reduced the twitch in atrial tissue (MacCleod & 
Diamond, 1986). After treatment with forskoliin, carbachol was 
able to induce negative inotropic responses in both 
preparations. This latter effect of carbachol was blocked in 
ventricular muscle by the cGMP reducing agent LY83583 but not 
in atrial muscle (MacCleod & Diamond, 1986).
All the above evidence would suggest that cGMP 
generated through muscarinic stimulation (or some direct 
action not involving cGMP) is involved in the regulation of 
normal contractility of atrial muscle, but not ventricular 
muscle. The *antiadrenergic' action of muscarinic agonists is 
mediated through cGMP in ventricular muscle but not in atrial. 
Other agents which induce increases in cGMP not associated 
with muscarinic stimulation (ie. NP or 8-bromo-cGMP) appear 
not to affect contractility in either type of cardiac muscle. 
It would seem therefore that there are different intracellular 
pools of cGMP in mammalian myocardium, and the one associated 
with muscarinic stimulation is more important in regulating 
contractility.
The large discrepancy in the effects of intracellular 
cGMP between amphibian and mammalian preparations could be the 
result of two circumstances:- (i) The processes involved in 
excitation contraction coupling in frog are more susceptible 
to modulation by cyclic nucleotides than in mammalian 
myocardium. The greater dependence on trans-sarcolemmal 
movement of ’activator’ calcium in frog would appear to be 
more sensitive to cGMP regulation (see later), (ii) The more 
highly ordered structure of mammalian myocardium, with greater
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amounts of intracellular membranes and organelles, together 
with the larger size of the cell (16-40 fold larger volume) 
would tend to compartmentalise the cell to a much greater 
extent than in frog. It has already been suggested that 
different pools of cGMP are responsible for the differences 
between mammalian atrial and ventricular muscle, it is logical 
to propose that a similar (or even greater) difference could 
exist between mammalian and amphibian preparations.
In order to compare these suggestions, an insight into 
the intracellular actions of cGMP would be useful.
Intracellular actions of cGMP
Cyclic GMP dependent protein kinase If cGMP regulates 
myocardial contractility in an analogous way to that of cAMP, 
then this requires the presence of a cGMP dependent protein 
kinase (cG-PK) in heart muscle. Such an enzyme was shown to 
exist in substantial amounts in mammalian heart (Lincoln, 
Hall, Park & Corbin, 1976). It was postulated that as cA-PK 
activity correlates well with positive ^-adrenergic actions, 
then cG-PK should correlate with negative inotropic actions of 
muscarinic agonists (Lincoln & Keely, 1980). It was reported 
that whereas both NP and Ach increased the CcGMP] of rat heart 
(8- and 3-fold respectively), only Ach raised the activity of 
cG-PK and decreased the force of contraction (Lincoln & Keely, 
1981). This suggests that only the cGMP pool produced by Ach 
is coupled to protein kinase activity and that this activity 
is related to the decrease in the twitch (Lincoln & Keely, 
1981). The lack of coupling of cGMP produced by NP to cG-PK 
activity is thought to be responsible for its lack of
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inotropic efficacy, which suggests that some pools of cGMP are 
not compartmentalised with the enzyme (Lincoln & Keely, 1981). 
It would appear that guanylate cyclase (GC) coupled to
muscarinic receptors is more available to cG-PK, and is 
functionally different, than the GC that is activated by NP. 
This might suggest that GC activated by muscarinic receptors 
is membrane bound (particulate GC) as it has been shown in 
vitro that particulate GC is unresponsive to NP stimulation 
(Waldman & Murad, 1987). The total cGMP level of a tissue is 
not as physiologically relevant as that intracellular pool 
which is accessable to cG-PK. Similarly, physiologically
relevant changes in pools of cyclic nucleotides can occur upon 
hormonal stimulation without significant changes in the total 
cyclic nucleotide levels. This effect is not unique to cGMP as 
different cAMP pools are now thought to be associated with
different agonist effects. Isoproterenol (lOnM) and PGE^
(30uM) increase [cAMP] to approximately the same concentration 
in perfused rabbit heart, but only isoproterenol increased 
force of contraction. Futhermore, both agonists produced
different 'spectra* of activities in a variety of cA-PK
substrates (Brunton, Hayes & Mayer, 1981). This was thought to
involve different pools of cAMP and differing discrete pools 
of CA-PK (not just particulate and soluble)(Brunton et al,
1981). The discrepancy in total [cAMP] compared to tension
discussed earlier also suggests compartmentation of different
CAMP pools (Rodger & Shahid, 1984). Brunton et al (1981) 
offered a plausible explanation for these results, namely that 
"the precise spatial and temporal orientation of hormone 
receptors, adenylate cyclase, cAMP, protein kinases, and
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protein kinase substrates into functional compartments 
contribute to the specifity of cardiac contractility and 
metabolism by cAMP (Brunton, Hayes & Mayer, 1981).
Another problem with the proposed role of cG-PK in 
cardiac muscle regulation is the lack of demonstrated 
substrates for the enzyme. In contrast, smooth muscle cG-PK 
has been shown to phosphorylate numerous proteins, some of 
which have been identified as key regulators of contractility 
(ie. MLCK). In cardiac muscle however only one endogenous 
substrate protein of molecular mass 70,000, has been found in 
the cytosol of rat heart (Wrenn & Kuo, 1981). Further 
purification of this protein is required before its function 
can be determined. Other cytosolic substrates are conspicuous 
by their absence, which may infer that most of the substrates 
for this enzyme are particulate, although there is no evidence 
for this at present.
cGMP dependent phosphodiesterase (PDE II)
There are three main types of PDE in cardiac muscle. 
PDE I is similar to that found in smooth muscle and platelets, 
and its activity is calmodulin dependent. PDE I isolated from 
guinea-pig ventricle hydrolyses cAMP and cGMP equally, unlike 
that isolated from rat ventricle which preferentially 
hydrolyses cGMP (Weishaar, Burrows, Kobylarz, Quade & Evans, 
1986; Terasaki & Appleman, 1975). Cardiac PDE II has high K^ 
and / it. is not stimulated by calmodulin and has no
substrate specificity (Weishaar et al, 1986). It is this 
enzyme which is thought to act as a cGMP activated cAMP PDE 
(Terasaki & Appleman, 1975). The enzyme shows positive 
cooperativity for its two substrates (cAMP & cGMP). However,
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because the substrate affinity for cGMP is 2-3 fold below its 
reported level in myocardium and due to the higher cAMP
concentration, increases in low concentrations of cGMP 
activate cAMP hydrolysis (Terasaki & Appleman, 1975). This
enzyme is suggested to be responsible for cGMP regulation of 
cAMP levels and the basis behind the 'ying-yang' hypothesis 
(Terasaki & Appleman, 1977). The third PDE III only hydrolyses 
CAMP and it is not stimulated by calmodulin. Recent reports 
suggest that there are different subclasses of this enzyme
which are associated with different domains of the cell
(Manganiello, 1987). The subclasses are differentiated by 
their susceptibility to inhibition by various 'cardiotonic' 
drugs. For example, imazodon and cilostamide inhibit one
particular subtype, whereas RO 20-1724 and rolipram inhibit 
another (Weishaar et al, 1987).
The imazodan-sensitive subtype of PDE III is also inhibited by 
cGMP (Weishaar et al, 1987). Imazodan produces a marked 
positive inotropic action in canine ventricular preparations, 
but only exerts a modest positive inotropic action in
guinea-pig. This is taken as evidence for functional 
compartmentalisation of the enzyme as this subtype is
particulate in dog, but present in the cytosol of the 
guinea-pig (Weishaar et al, 1987).
Cyclic GMP could therefore regulate cAMP hydrolysis 
through two completely different PDE's, as it would enhance 
hydrolysis by PDE II, but attenuate hydrolysis by imazodan 
sensitive PDE III. With the discovery of different 
intracellular locations of PDE associated with different 
functional pools of nucleotides, only the cGMP present in the
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same 'compartment' would affect CAMP hydrolysis and this would 
have a variable effect depending on the associated function of 
that compartment.The use of specific PDE inhibitors may be the 
key to unravelling the complex network of separate functional 
pools of nucleotides.
Effect of cGMP on slow inward calcium current
The reduction in action potential duration seen with 
muscarinic agonists led to the proposal that cGMP decreases 
the slow inward calcium current (I^^) (Ikemoto & Goto, 1977). 
This is supported by experiments showing that intracellular 
injection of cGMP, or extracellular application of dibutryl 
cGMP, both shortened the action potential duration (APD) in 
isolated ventricular (guinea pig and rabbit) cells (Trautwein, 
Taniguchi & Noma, 1982). The lack of any effect of cGMP on Ach 
induced hyperpolarisation supports the hypothesis that cGMP is 
involved in the regulation of voltage operated Ca channels and 
does not affect the classical muscarinic increase in potassium 
channel conductance (Trautwein et al, 1982). Intracellular 
injection of cGMP, or perfusion with 8-bromo-cGMP, abolished 
slow action potentials, which implicated direct inhibition of 
the voltage dependent Ca channel (Wahler & Sperelakis, 1985). 
This was in direct opposition to the augmentation of I_ and 
slow action potentials seen with intracellular injection of 
CAMP (Vogel & Sperelakis, 1980). Contradictory results were 
obtained by measuring l^^ in voltage clamped frog trabeculae, 
in which the [cAMP]i or [cGMP]i was rapidly increased by 
photolysis of a membrane permeable 'caged' derivative 
(Nargeot, Nerbonne, Engels & Lester, 1983). intracellular
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concentration jumps of cAMP rapidly (<150msec) increased the 
amplitude of but similar increases in cGMP failed to have
any effect (Nargeot et al, 1983). Measurements of in frog
ventricle, using the whole cell clamp technique agreed with 
this result, in that intracellular perfusion of cGMP had no 
effect on (Hartzell & Fischmeister, 1986). However, if
is previously elevated by ^-agonists or intracellular cAMP, 
then cGMP markedly reduces the amplitude of the current 
(Hartzell, 1986). Similarly, Ach also had no effect on basal 
but it greatly reduced previously elevated by
isoprenaline (Fischmeister & Hartzell, 1986). I^^was also 
increased if cAMP was introduced into the patch pipette, but 
this increase could not be reduced by Ach (Fischmeister et al,
1986). This was taken as evidence that muscarinic agonists 
antagonise the jS-adrenergic induced elevation of by
reducing intracellular cAMP levels. As cGMP could not reduce 
the elevated by the non-hydrolysable 8-bromo-cAMP, nor
can it reduce cAMP elevated in the presence of a
phoshodiesterase inhibitor (MIX), it was proposed that cGMP 
stimulation of cAMP-PDE, caused a reduction in cAMP, which 
consequently reduced l^^(Fischmeister & Hartzell, 1987). This 
hypothesis agrees with that discussed earlier for the opposing 
roles of CAMP and cGMP in regulating contractility in this 
tissue (Flitney & Singh, 1981). Since ca influx is the major 
source of activator calcium in frog heart, then this mechanism 
would be an important determinant of contractile tension. 
However, in mammalian myocardium with its functional 
compartmentalisation of both nucleotides and activator calcium 
(SR), this mechanism would be less important.
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Other postulated actions of cGMP
Ach has been shown to markedly inhibit the 
isoproterenol-induced phosphorylation of phospholamban in 
mixed SR and sarcolemmal vesicles from guinea pig ventricle 
(Watanabe, Lindeman & Fleming, 1984). The decreased 
phosphorylation was shown to be associated with a reduced 
Ca-ATPase activity of the vesicles and was thought to due to 
decreased cAMP levels (Watanabe et al, 1984). This was 
postulated to be due to a reduction in adenylate cyclase 
activity, but it could equally well result from a cGMP 
mediated increase in cAMP hydrolysis. This mechanism would 
explain some of the 'antiadrenergic' actions of muscarinic 
agents and cGMP.
In hyperpermeable rat ventricular preparations, cGMP 
is postulated to activate a phosphatase which decreases the 
phosphorylation of TN-I (Mope, McClellan & Winegrad, 1978). 
This serves to increase the Ca sensitivity of the contractile 
apparatus and opposes the action of cAMP which phosphorylates 
TN-I. The physiological significance of this is unclear as an 
inrease in Ca sensitivity would augment contractile tension. 
It may however be reponsible for antagonising the enhanced 
relaxation seen with ^-agonists and so could mediate part of 
the 'antiadrenergic' action.
Summary
In summary, the physiological significance of cGMP in 
regulating myocardial contractility is much less clear than 
for CAMP. However, in frog ventricle it would appear that cGMP 
is as important as cAMP in regulating contractility. Evidence
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is growing that this is mediated through a cGMP dependent cAMP 
PDE (PDE II) which suggests that cGMP only modifies the 
concentration of cANP and hence has an indirect effect. While 
this may account for the inverse relationship demonstrated 
between the two nucleotides, it cannot account for the close 
empirical relationship between the ratio of cAMPzcGMP and 
tension. This suggests that cGMP must have other more direct 
actions in regulating contractility, as tension would 
otherwise correlate more closely to cAMP alone. The reliance 
of frog EC coupling on extracellular influx of calcium, and 
the demonstration that this is closely regulated by both 
nucleotides, is further evidence for a regulatory role for 
cGMP. A single pool of both nucleotides (as NP and 
8-bromo-cGMP mediate effects) reponsible for regulating I^^ 
and tension suggests that the system is more rudimentary than 
mammalian heart.
The role of cGMP in mammalian myocardium is still 
obscure. The in vitro evidence would suggest that all the 
chemical regulatory systems are geared towards cGMP having an 
opposing role to cAMP, but demonstrations of these effects in 
situ has proven difficult. This may be because of two 
important issues:
1. Functional compartmentalisation of both nucleotides hinders 
investigation as any nucleotide measurement may not be related 
to function. The possibility that in each separate 'pool' 
there exists a complex sequence of reactions and interactions 
to elicite a particular response means that each system must 
be treated as an entity in itself. Progress can therefore only 
be made when specific systems can be identified with
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particular functions without contamination from other systems 
(ie. the GC stimulated by Ach and not NP, and vice versa).
2. Muscarinic agonists mediate effects that are independent of 
cGMP. Muscarinic receptors are known to directly interact with 
key effectors without involving production of cGMP. They are 
thought to do this through specific guanine nucleotide binding 
proteins (G-proteins) which are present in the sarcolerama and 
act as 'go-betweens* coupling receptors to appropriate 
membrane bound effectors (Houslay, 1987; Neers & Clapham, 
1988). Three types of G-proteins are thought to interact with 
the muscarinic receptor; G^- which inhibits adenylate cyclase 
activity in the membrane; G^- increases potassium conductance; 
G^- inhibits voltage dependent Ca channels (Houslay, 1987). 
Presumably there must be another muscarinic G-protein 
responsible for stimulating guanylate cyclase, but that has 
not been identified yet.
Adenylate cyclase inhibition by muscarinic interaction 
with G^ has been demonstrated in whole hearts and cardiac 
sarcolemmal vesicles (Watanabe, Lindeman & Fleming, 1984). The 
muscarinic antagonism of ^-agonists increase in adenylate 
cyclase activity in isolated vesicles was dependent on the 
presence of GTP, which is known to be an important cofactor in 
the coupling of G-proteins to receptors (Neers & Clapham,
1988). The direct regulation of potassium channels by 
muscarinic agonists may have important implications in their 
reported ability to decrease l^^and action potential duration 
without altering cGMP levels. G^ has been shown to inhibit
voltage sensitive Ca channels in nervous tissue, its presence
in heart muscle could explain the direct effects of Ach on
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cAMP mediated in whole cell clamp preparations
(Fischmeister & Hartzell, 1987). Taken together, the direct 
actions of muscarinic receptors via G-proteins obviously 
lessens the role of cGMP as the second messenger of the 
parasympathetic system", and could explain some 'dissociation' 
results of cGMP and response.
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Material and methods
chapter 2
1. Experiments on frog ventricular trabeculae
i. Animals & Dissection
Experiments were performed using isolated ventricular 
trabeculae from the common frog Rana Temporaria. Prior to use, 
animals were kept at four degrees cent-igrade in shallow tanks 
to avoid the need for feeding. Each frog was first stunned by 
a blow to the head before being killed by decapitation and 
pithing. The heart was rapidly excised and washed in Ringer's 
solution (composition; NaCl llSmM, KCl 2.5mM, NaH^PO^ 2.15mM, 
NSgHPO^ 0.85mM, CaCl^ ImM,NaPyruvate 5mM, pH 7.2) at room 
temperature (18-22*C). After the atria and ventricle were 
separated, the ventricle was sliced vertically into two to 
expose the inner sponge-like surface. Free-running trabeculae 
of between 20-100 microns in diameter and 2-3 mm in length 
were then dissected out, with clumps of tissue at either end 
tc facilitate mounting. Ventricular trabeculae differed from 
those in the atria in that they were smaller and generally not 
free along their length, so that it was harder tc obtain 
single preparations. Bundles of two or three trabeculae were 
therefore sometimes used but only if they all had the same 
rest length and contracted synchronously.
ii. Apparatus
The isolated trabeculum was mounted between two metal 
supports using a snaring technique modified from Chapman & 
Tunstall (1971). The supports were made from syringe needles 
(21 guage) down which was glued thin stainless steel tubing 
(29 guage) which held the tungsten wire snares (13 micron 
diam. wire; Goodfellow Metals){inset fig.2:1). One of the
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Figure 2.1
C - Perfusion chamber (inset showing cross section) 
E - Platinum wire stimulating electrodes 
S - Tungsten wire snares 
H - Syringe needle metal supports 
A - Force transducer (Akers)
V - Trabeculum
D- Drain
M - Microdrives
N - Micromanipulators
F - Force transducer (Pixie)
T - Six way tap 
B - Binocular microscope
& T^- Computer controlled motorised taps 
W - Waste
-Fig.2:1
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supports was attached to a force transducer while the other 
was fixed to a rigid support (see fig.2:l). Two types of 
transducer, based on either a Pixie or Akers strain guage, 
were used. The Akers was slightly more sensitive although more 
fragile than the Pixie but both used the same electronics and 
holder system and had similar characteristics. The overall 
compliance of either apparatus was 0.01 mm/mN, equivalent to a
0.25% change in length for a trabeculum 2mm long producing a 
force of O.SraN (SOmg). The output of the transducer was 
amplified (3dB point, 15Hz) and fed simultaneously to a Gould 
digital oscilliscope, a JJ pen recorder and a Unilab computer 
interface. The latter allowed the signal to be digitised, 
displayed and later analysed by a BBC microcomputer. The data 
collection program automatically measured and stored the peak 
twitch tension produced by the muscle and had an option for 
selecting and storing complete twitches.
The required perfusate was selected by means of a six 
way tap connected tc six reservoirs through individual 
constant flow devices. Since the chamber was gravity fed, 
these kept the flow constant by maintaining the same height of 
solution above the level of the chamber (see fig.2:2), This 
was important as it prevented 'offset' artefacts when changing 
solutions. The normal flow rate was lOml/min. which due to the 
small size of the bath completely changed the bathing solution 
every 0.5 sec.. 
ill- Protocol
The isolated trabeculum was transferred tc the 
perfusion chamber in a small bath, and then mounted by snaring 
the clumps of tissue at either end as shown in the inset of
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Figure 2.2
R - Reservoirs for each different solution. Note the 
different levels
L - Constant level of solution in each float chamber ensuring 
the same head of pressure.
T - To the six way tap
The close up of the float chamber in the right hand 
panel shows how the constant level of perfusate is maintained. 
Solution from the reservoir flows into the chamber through the 
0-ring (0), and passes over the float (F) through cut groves 
in it's surround (G). As the efflux of fluid from the chamber 
is slower than the influx from the reservoir, the chamber 
fills with solution. The chamber continues to fill, thus
raising the float, until the float needle is pushed into the
0-ring which impedes the inflow of solution. If the level of 
solution then falls, due to perfusing the bath, the descent of 
the float needle allows some more fluid in from the reservoir
until the original level is attained. The float therefore
oscillates, switching the inflow from the reservoir on and off 
and thus maintaining the level of solution constant.
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fig.2:1. Using the micr oir.ani pula tors the mounted muscle was 
manoeuvered quickly into the perfusion chamber, taking care to 
ensure that it was never stretched or allowed to dry out. 
Once in position, the muscle was stretched to its normal rest 
length (ie. stretched until all the kinks just straighten 
out). Isometric twitch contractions were elicited by field 
stimulation through platinum wire electrodes fixed to the 
inner walls of the chamber. The stimulus voltage was increased 
from zero until the muscle started to twitch. The final 
voltage was set at double this threshold value. The normal 
stimulation parameters were a 12-25 V pulse of 1-2 msec 
duration every 5 sec (C.2 Hz).
After an initial stabilization period of 15min, the 
length of the trabeculum was stretched by 0.1 mm at 1 minute 
intervals, until the optimal twitch tension was obtained. A 
typical chart recording cf this procedure is shown in fig.2:3 
(top panel), which also shows the same event as recorded by 
the computer (bottom two panels). As the computer only records 
the twitch height, it effectively removes the change in 
resting tension, leaving only the change in active tension. 
The shape of any individual twitch could be stored by the 
computer as illustrated in the bottom right panel of fig.2:3. 
The length-tension relationship for 27 preparations determined 
in this way is shown in figure 2:4. Each muscle was left for a 
further 30min to settle down before commencing the experiment. 
The addition of pyruvate to the ringer solution prevented the 
onset of hypodynamia (Clarke, 1913) so that the constant 
twitch height remained constant throughout an experiment 
(Ventura-Clapier & Vassort, 1980a,b).
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Figure 2:3
The top panel is an original chart recording showing 
the increase in isometric twitch tension when muscle length is 
increased stepwise, in increments of 0.1mm every minute. The 
increase in muscle length is illustrated in the middle panel, 
while the bottom panel shows the same trace as recorded by the 
computer. The change in resting tension shown in the chart 
recording is ignored by the computer such that a clearer 
measure of the active tension is obtained. The bottom right 
hand panel is superimposed computer recordings of the shape of 
twitch contractions selected at the end of every second length 
change.
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Figure 2:4
This graph shows the mean (+ s.E.) normalised length 
tension relationship for 27 trabeculae.
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CHAPTER 3.
Preliminary observations of the effects 
illumination has on the response of frog 
ventricle to nitroprusside.
chapter 3
Introduction
Previous studies from this laboratory have shown that 
changes in the relative concentrations of intracellular cyclic 
3'5*-nucleotides are associated with changes in the strength 
of the twitch contraction of isolated frog ventricular muscle 
(Flitney, Lamb & Singh, 1977a,b; 1978a,b; 1979). The ratio of 
the concentrations of adenosine 3’5’cyclic monophosphate 
(cAMP) to guanosine 3*5'cyclic monophosphate (cGMP) correlates 
closely with changes in the size of the twitch. This was shown 
to hold true for numerous inotropic agents, both positive and 
negative, and also for the gradual decline in twitch tension 
during the development of the hypodynamie state {Flitney, 
Lamb & Singh, 1977a,b; 1978; Flitney & Singh, 1978; 1979; 
1980a,b,c,d,e). Even the time course of the tension response 
to these agents was found to follow closely the time course of 
the change in the cAMP/cGMP ratio. These observations suggest 
that both nucleotides are involved in mediating the change in 
twitch tension and that they function antagonistically, cAMP 
augmenting twitch contractions and cGMP attenuating them. 
Evidence for a causal relationship, was obtained when the 
ratio was changed in a controlled manner by applying lipid 
soluble analogues of either cAMP or cGMP. Both of these 
induced the appropriate change in the twich tension (Flitney & 
Singh, 1980a; 1981). On the basis of these results, Flitney 
and his co-workers concluded that both cAMP and cGMP are 
involved in regulating the inotropic status of the frog 
ventricle.
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Flitney et al thought they would test their hypothesis 
with an agent that increased the cGMP concentration. Scdium 
Nitroprusside (NP) had been shown to directly stimulate 
guanylate cyclase activity both in vitro and in vivo (Murad, 
Arnold, Mittal & Braughler, 1979). They found that SNP reduced 
the size of the twitch and . increased the concentrations of 
both nucleotides, cGMP being raised more than cAMP such that 
the ratio was reduced (Flitney, Moshiri & Singh, 1980a).The 
rate and size of this effect was however much greater on 
exposing the preparation to the same solution of SNP for a 
second time. NP was known to be photosensitive, and so the 
experiments were conducted under darkened room lighting with 
much of the apparatus covered with aluminium foil. The results 
now to be described are from experiments which were undertaken 
to confirm these observations using a better preparation, with 
improved apparatus and under more carefully controlled 
lighting conditions. Flitney, Moshiri & Singh (1980) had shown 
that NP is an extremely potent negative inotropic agent, which 
can exert an effect at InM. The results now to be presented 
however, show that it is completely inotropically inert even
7at concentrations 10 fold greater than this, if sufficient 
care is taken to prevent its photolysis.
-Page 3.2
chapter 3 
Methods
NP was prepared by dissolving crystalline sodium 
nitroprusside in low scdium Ringer (112mM) so that a 10 
stock solution with a normal sodium, content (llSraM) was 
obtained. This was later diluted to the appropriate 
concentration with normal Ringer's solution. Both procedures 
were carried out in darkness with the only means of 
illumination being dull red light from a small hand torch. 
Solutions were then either protected from light or exposed to 
light using one of the following two methods;-
i. The NP solution was exposed to light before use. This 
was done in a controlled way, by constantly stirring a 1 litre 
conical flask of SNP solution (at the desired concentration) 
in front of two 60W desk lamps placed 20cm away for a period 
of 1 hour.
or
ii. The solution was prepared in darkness and exposed as 
it flowed through the muscle chamber. Initially this was done 
using the fibre optic light guide (see fig. 3.1) which was the 
normal source of illumination. When greater light intensities 
were required, a 150W xenon arc lamp was used which was 
focused onto the chamber through a slide mount (see fig. 3.1). 
This enabled the relative intensity and colour of the light to 
be altered by inserting neutral density and/or spectral 
filters (Ilford gelatin: Nos,600-608) in the path of the 
incident beam. Both types of experiment were carried out in a 
darkroom with a red photographic safelight as the only means 
of illumination.
-Page 3.3-
chapter 3
Figure 3:1
The perfusate, selected by means of the six-way tap 
(T), flows in the through the muscle chamber (C) and down to 
waste (W). It can be illuminated in the muscle chamber by 
light from either the fibre optic light guide (LG) or the 
xenon arc lamp (XL). Early experiments used light from the 
fibre optic which is normally only used for setting up the 
preparation. The source of light for this is a 150 W tungsten 
filament halogen bulb (not shown) which gives a poorer 
ilumination than the xenon lamp. Light from the xenon arc lamp 
was reflected off a mirror (R) and focused by two lenses 
before passing through a slide mount (S). The intensity and 
wavelength of the incident light can be altered by putting 
neutral density or spectral filters in the path of the beam. 
The whole apparatus was enclosed in a solid aluminium faraday 
cage that prevented any extraneous light entering or leaving 
the site of exposure.
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Results
i. Effects of unexposed nitroprusside.
Sodium nitroprusside solutions that had been carefully 
protected from exposure to light had no effect on the twitch. 
This is illustrated in figure 3:2, which shews computer 
recordings from two experiments. In both cases the peak twitch 
tension is unaffected when the bathing solution is changed 
from normal Ringer’s solution (R) to one containing 10~^M
sodium nitropusside solution (R+NP).
ii- Effects of nitroprusside pre-exposed to ’white* light.
Panel A in figure 3:2 show recordings from an experiment
in which a solution of 10 NP was pre-exposed to light
*before it was applied to the muscle (R+NP ). Perfusing a
preparation with this solution caused the strength of the
twitch to slowly decrease, reaching a new steady state level
of around 42% of the initial control twitch after 15 minutes.
Re-perfusing with protected NP, allowed the twitch to recover
to its pre-treated control level. This emphasizes the inert
nature of unexposed NP as it can washout the effects of the
physiologically-active pre-exposed NP.
This procedure was repeated for concentrations of NP 
-5 -2ranging from 10 to 10 M. The log dose response curve (see 
fig.3:5) obtained is sigmoidal in shape with an ED^^value of 5
-410 M NP. The maximum twitch depression was 57% + 2,0% (S.E.: 
n=12).
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figure 3:2
The two panels of this diagram show computerised 
recordings of the peak twitch height with time. Each vertical 
bar indicates the peak tension of every fifth twitch according 
to the scale bar on the left. The time interval between each 
bar is 25 seconds. The top trace in each case marks the 
perfusate changes, a downward deflection of the bar along with 
an arrow showing when a changeover occurs.
Panel A shows the effect of changing the perfusate 
from normal Ringer (R) to Ringer containing 10 NP that had 
been totally protected from light (R+NP). There is no change
in the strength of the twitch. Changing the perfusate to
-2Ringer containing 10 M NP that had been pre-exposed to light 
(R+NP*), the twitch tension gradually decreases to reach a new 
steady level after 15 minutes. Changing the perfusate back 
into protected NP solution (R+NP) recovers the twitch back to 
normal.
Panel B illustrates responses from an experiment in 
which the NP was exposed to light while it was flowing through 
the muscle chamber. Ringer containing 10 NP that had been 
totally protected from light does not affect the twitch as 
before. Illuminating the this solution in the muscle chamber 
with the light guide (thick black bar), caused the twitch 
tension to quickly decrease to a new steady level. Once the 
light is switched off, the twitch tension recovers back to 
control levels.
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iii. Effects of directly exposing nitroprusside to white light 
in the perfusion chamber.
Panel B in figure 3:2 shows the effect cf expcsing NP 
solutions to white light in situ, ie. while it is in the bath
and in close proximity to the muscle. The twitch was again
unaffected by changing the perfusate from normal Ringer (R) to
-  2Ringer containing 10 M protected NP (R+NP). Light from a 
tungsten halogen lamp was then directed cnto the preparation 
through a light guide. Twitch tension immediately started to 
decline at the onset of illumination and continued to do so 
throughout the duration of the exposure (black bar; fig.3:2)
until a new steady level was reached. The new twitch tension
was 52% of the original control twitch and was reached 5min. 
after the onset of illumination. On switching the light off 
(end of black bar), twitch tension immediately began to
recover, even though the muscle remained in unexposed
nitroprusside solution. Complete recovery normally took 
approximately 6 mins.
This experiment was repeated using a number of different 
intensities of light to illuminate the muscle chamber. Neutral 
density filters were placed in front of a 150W Xenon arc lamp
(see methods), so as to vary the amount of light reaching the
preparation. An example of this type of experiment is shown in 
figure 3:3. Four traces are shown here to illustrate the 
responses obtained by illuminating the same NP solution (lo”  ^
M) in the perfusion chamber, with different intensities of 
white light. The top left hand panel shows the changeover from 
normal Ringer’s solution to one containing protected NP (thick
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Figure 3:3
This computer record shows four sequential traces from
the same experiment, each illustrating the effect of
illuminating 10 protected NP to varying light intensities.
The large downward arrow indicates the changeover of perfusate
_2from normal ringer to ringer containing 10 M protected NP, 
after which the perfusate was not changed again throughout the 
remainder of the experiment. The small downward arrow 
indicates the start of illumination of the perfusate in the 
muscle chamber, the number immediately above giving the 
relative intensity. The upper left hand response was with the 
full intensity of the xenon lamp and so has a relative 
intensity of 1.0. Lower relative intensities of 0.5,0.2 & 0.1 
were produced by placing 2-,5- & 10- fold attenuating neutral 
density filters in front of the incident beam. Both the rate 
and extent of the depression of the twitch were reduced by 
reducing the intensity of illumination as is shown in the 
other three panels. The small upward arrow indicates the end 
of ilumination after which the twitch tension always recovers, 
even though the perfusate is still NP solution.
-Fig - 3:3-
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arrow). Again, protected NP does not alter the twitch tension, 
until such time as it is exposed to light, some four minutes 
later (downward arrow). In this panel there was no filter to 
attenuate the light (relative intensity = 1) which reduced the 
twitch tension to 47% of its control value. On switching the 
light off (upward arrow) the twitch fully recovered whilst the 
preparation was still being perfused with protected NP 
solution. The remaining panels show three, sequential 
exposures of the perfusate to decreasing levels of 
illumination. Reduction of the incident intensity, decreased 
both the rate and extent of the twitch depression. This is 
more clearly seen in the averaged responses shown in figure J 
3:4. This shows the time course of the decrease in twitch 
tension after the perfusate was exposed to light of varying 
intensities. At maximum illumination (relative intensity 1.0), 
the twitch tension rapidly decreases, with a half time of 1.1 
min, to 42(+ 8)% of its pre-illumination value. Lower
intensities (relative intensities of 0.5,0.2 & 0.1) reduce the 
twitch to an extent which is related to the amount of 
illumination (69%,75% & 81% of control respectively). The rate 
of depression of the twitch is also related to the intensity 
of illumination as the higher intensities produce the faster 
decrease in tension. The inset shows the plot of the log of 
the intensity against the time for half maximum response. The 
linear relationship indicates that there is an exponential 
increase in the rate of depression of the twitch when the 
intensity of illumination is increased, when the illumination 
ceases (right hand portion of fig 3:4), the twitch recovers 
back to control levels while still in unexpcsed NP solution.
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Figure 3;4
Plotted here is the average {+ S.E.) twitch tension of
6-12 preparations, sampled each minute up to 6 minutes during
—  2and after illumination of a 10 M NP perfusate. The response 
to four different intensities of illumination have been 
superimposed to show that the rate and extent of depression of 
the twitch is dependent on the intensity of illumination. The 
relative light intensity of each averaged response is 
indicated beside the respective trace.
The inset shows a plot of the log of the relative 
intensity against the time to half maximal response for both 
the depression (solid circles) and recovery (open circles). 
The linear relationship suggests that the rate of depression 
varies exponentially with the intensity of illumination. The 
rate of recovery however seems to be more independent of the 
intensity of illumination.
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These data show that the rate of recovery is approximately the 
same, except that for the maximal illumination intensity. This 
suggests that the recovery process may be a washout 
phenomenon, governed by the rate of diffusion of the
physiologically active agent out of the muscle. The reason for
the faster rate of recovery at the greater depression is not 
known.
Similar responses were obtained using various
concentrations of SNP in the solution. The resulting log dose
response curves from these are shown in figure 3:6. The top
curve is the log dose response curve for a relative intensity
of 1.0. It has the normal sigmoidal shape with an ED^g value
-4of approx. 5 10 M. This curve is comparable to that for the 
results obtained by pre-exposing NP solutions (white dots) 
described earlier. The log dose response curves for the lower 
intensities (0.5 & 0.2) show reduced responses at each NP 
concentration but the values are similar for all three
curves.
iv. Effect of directly exposing NP to light of different 
wavelengths.
The above results clearly indicate that NP must be
exposed to light before it can exert any effect on the twitch.
An experiment was therefore conducted to see whether this was
influenced by the wavelength of the illuminating light. A 
—  210 M NP solution was exposed to light of different spectral 
content by passing the beam through different coloured filters 
(see methods). A suitable combination of neutral density 
filters was used to ensure all the colours were of the same
Chapter 3
Figure 3:5
The log dose response curves to SNP that had been
pre-exposed (open circles) and directly exposed (closed
circles) to various light intensities are shown here.
Pre-exposure for Ihr or direct exposure to the full intensity
of the xenon lamp causes the same maximal depression of the
— 4twitch (58%) and has the same ED^q value of 5 10 M. Lower 
intensities have a lower maximal effect but the same 
value.
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intensity. Figure 3:6 shows the extent of twitch depression, 
superimposed on the absorption spectra of NP. The points are 
plotted against the wavelength at which transmission through 
the filter is maximal, but most filters had a fairly wide 
bandwidth such that they overlapped one another. Even sc, the 
size of the response clearly varies with wavelength, with the 
blue end of the spectrum being much mere effective at 
depressing the twitch. The absolute size of the maximal 
response measured here is very small due to the low intensity 
of light used in order to keep it constant at all wavelengths. 
The sharp increase in the size of the response seen at shorter 
wavelengths (<500nm) roughly parallels the increase in 
absorption of NP.
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Figure 3:6
The wavelength of the incident light was changed by 
using a combination of neutral density and coloured filters to 
keep the total intensity constant. The extent of the twitch 
depression caused by 10 NP, varied with the wavelength of 
illumination as shown in the right hand curve. The left hand 
curve shows the absorption spectrum of NP plotted along the 
same X-axis as the response curve. The increased depression of 
the twitch correlates with an increased absorbance of the 
drug. It should be noted that the filters are plotted at the 
wavelengths of their peak transmission but the spectral spread 
of each filter is large and overlapping.
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Discussion
The most important conclusion to be drawn from these 
results is that NP must first be exposed tc light before it 
can exert any effect on the twitch. This was an unexpected 
result in view of the previous report of a strong negative 
inotropic action of NP on frog ventricle (Flitney, Moshiri & 
Singh; 1980a,b). There are however a number cf important 
differences between these two studies. Flitney, Moshiri & 
Singh (1980) showed a greater rate and level of depression of 
the twitch for a given concentration of NP; eg. at 10 ^M, the 
twitch was reduced to 20% of its control within 2 rain. They 
were also able to elicit responses at NP concentrations 100 
fold less than the threshold concentration seen in these 
experiments. These differences can however be explained by the 
different experimental conditions.
The reason why NP has any effect at all is because 
although the authors were aware of the photosensitivity of NP, 
they did not realise how extremely sensitive it is. Their 
experimental set up had a constant reservoir of NP which was 
gravity fed to superfuse the half ventricle and then 
re-circulated back to the reservoir via a peristaltic pump. 
The flow rate was lOOml/min, and so the 1 litre reservoir 
solution was being completely circulated every 10 min. 
Although most of this tubing was covered with aluminium foil, 
the solution was nevertheless exposed to the ambient light 
just before and during the time when it was in contact with 
the preparation. This repeated exposure to light was 
presumably sufficient to elicit a response. Evidence for this
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comes from their observation that a second application of the 
same solution potentiated both the rate and extent of 
depression of the twitch. Presumably, some photolytic product 
accumulated in their solution, so that a second exposure
resulted in a more rapid and greater response.
The greater efficacy of NP seen in the previous
experiments may be due to two reasons,
1. The half ventricle preparation was allowed tc 
become hypodynamie before the effects of the drug was tested. 
In our experiments this was prevented from happening by adding 
pyruvate to the ringer. It is possible that the depressant 
effect of NP is exaggerated on an already weakened
preparation, although this hypothesis has not been tested.
2. Flitney, Moshiri & Singh (1980) may have
inadvertently exposed their solutions to a greater total
amount of light. The present results show that increasing the 
intensity of illumination enhances its ability of NP to 
decrease the twitch. If the total illumination of NP in the 
previous studies was greater than in these experiments, then 
this might explain the greater sensitivity to NP. This does 
not seem likely since solutions which were pre-exposed for Ihr 
to a high intensity of light, produced a smaller response. A 
possible explanation for this discrepancy may be that the 
active agent formed during exposure of the NP soln. may be 
unstable. If this were the case then much of the 
physiologically active agent may be lost. On the other hand, 
if the active agent were instead generated close to its site 
of action as is the case when exposing solutions in the muscle 
chamber, then it would have a greater effect. In other words,
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the total amount of exposure may be less important than where 
the exposure takes place in relation to the muscle.
The results from this series of experiments can be 
summarised as follows: Firstly, the nitroprusside anion per se 
has no effect on twitch contractures of frog ventricular 
muscle. Secondly, exposure of NP to light elicits a response 
that is directly related to the NP concentration and the 
intensity of illumination, but inversely related to the 
wavelength. Thirdly, the rate and extent of depression of the 
twitch are both influenced by the time interval between 
exposure of NP to light and its delivery tc the muscle.
Taken together, these results suggest that i. 
photolysis of NP generates a physiologically active species 
that can depress contractility, and ii. the photolytic product 
in question is relatively unstable in solution.
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CHAPTER 4.
An investigation into the nature of the 
photochemical transformation of nitroprusside
Chapter 4
Introduction
It is clear from the preceding chapter that
nitroprusside (NP) undergoes a photochemical reaction that
transforms it from being physiologically inert to active. The
nature of this change is investigated in this chapter.
Sodium nitroprusside in solution is extremely
photosensitive and undergoes a variety of reactions when
exposed to light. Even in the crystalline state, NP is
reported to be light-sensitive (Rucki 1977). This may however, 
be due to small amounts of moisture facilitating breakdown, as 
solid NP kept in closed amber vials, did not show any 
decompostition after a year. Moreover, solutions of NP in 
water are stable for at least two years both at room
temperature, and at 4°C provided they are kept in the dark 
(Vesey and Batistoni 1977).
Descriptions in the literature of the photolytic
reaction sequences and products of NP are as numerous as they
are contradictory. It appears that the final products of
photolysis depend on the solvent used, the wavelength of the
light, the oxygen content of the solution and the pH.
Unbuffered solutions of NP in water irradiated by either
sunlight, fluorescent light, tungsten light or wavelengths
greater than 300nm, resulted in the formation of Prussian blue 
TXT XT(Na Fe Fe (CN)^ ), nitric oxide (NO), hydrogen cyanide
(HCN) and free cyanide (CN ) (Arnold, Longnecker, & Epstein,
1984; Vesey and Batistoni, 1977; Rucki, 1977; Frank, Johnson &
Rubin, 1976; Wolfe and Swinehart, 1975). In buffered solutions 
(pH 6) nitric oxide and aquapentacyanoferrate
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) are the only decomposition products observed
over photolysis periods of up to 16 hr (Wolfe & Swinehart,
1975). This agrees with other studies that the observed
increase in the absorption spectra at 394nm during photolysis
of BNP is due to production of aquapentacyanoferrate(III) as
the primary photolytic product ( Espenson & Wolenuk, 1972;
Arnold et al, 1977; Rucki, 1977 ).
The other primary photolytic products of nitroprusside
and the photochemical pathways involved remain contentious
issues. Mitra, Jain, Banergee & Chari (1963) proposed the
following reaction sequence to explain their observations ;
Fe(CN)^NO^“ — ^ Fe^^(CN)^^“ + (eqn.l)
n o '*' + H^O — ^ HNOg 4 (eqn.2)
HNOg — ► + NO." (eqn.3)
Fe^^(CN)g^~ + H^O — Fe^^(CN)^H20^“ (eqn.4)
Fe(CN)g3- + NOg" — ^ Fe(CN)gN02^" (eqn.5)
They postulated that the primary photochemical
reaction (eqn.l) liberates the nitrosyl cation (NO^) from
nitroprusside. The formation and dissociation of nitrous acid
(eqns.2&3) has been suggested to be ' responsible for the
observed decrease in pH when NP is photolysed in unbuffered
solution. Detection of the nitrite ion has supported this
II 3“theory. The formation of Fe (CN)^H20 (eqn.4) is reported
to be responsible for the increased absorbance at 394nm. There 
is however disagreement on this point, as others have shown 
that the species with maximum absorbance at 394nm is 
Felll(CN)^H2Û  ^ (Espenson & Wolenuk, 1972). Further evidence 
for this pathway comes frorasthe observation that a photolysed 
solution of NP regains its original pH if left in the dark
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(Mitra et al, 1972). This is consistent with the equilibrium 
shown in equation 6 ;
Fe(CN)^N0 2 ^~+ 2H^ — Fe(CN)^NO^~ + H O  (eqn.6 )
Wolfe and Swinehart (1975) after further 
investigations of these phenomena have criticised this 
hypothesis. They found that the large pH decrease during 
photolysis was oxygen dependent, and that the phctolysed 
solution did net recover its original pH if left in the dark. 
The size of the pH drop in oxygenated solutions compared to 
that in deoxygenated solutions cannot be accounted for by 
Mitra's scheme. Dissociation of nitrous acid (eqn.2 & 3) could 
only increase the hydrogen ion content by a factor of 2 , not 
the tenfold increase observed. This has led these authors to 
propose another pathway, with liberation of nitric oxide (NO), 
rather than NO^, as the primary photochemical reaction.
FeII(CN)gN0 " 2 Fe^^^(CN)^"^ + NO (eqn.7)
Felll(CN)^ 4- HgO — ^ FeIII(CN)gH20"2 (eqn.8)
2 NO + NUO. (eqn.9)2 "2 4
N2O4 + H2O HNO2 + NO " + H^ (eqn.lO)
3 HNO2 — 2 NO + NO^ 4 H2O 4 H^ (eqn.ll)
On this scheme, the aquapentacyanoferrate(III) species 
(eqn. 8 ) is responsible for the increased absorbance at 3 9 4 nra 
(Espenson & Wolenuk, 1972). The production of NO gas was 
confirmed by mass spectrometry (Wolfe & Swinehart, 1975). The 
decrease in pH can be accounted for by the sequence of 
chemical reactions given in equations 9-11. These reactions 
not only increase the hydrogen ion concentration by the 
required amount, but also account for the oxygen consumption
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during photolysis (Wolfe & Swinehart, 1975). The 
disproportionation of dinitrogen tetroxide (eqn,10) could also 
be responsible for nitrite formation in air saturated 
solutions of photolyzed NP. Reports of nitrite production in 
deoxygenated NP solutions may be due to the use of air 
saturated reagents (Mitra et al, 1972).
Leeuwenkamp, (1984) in his review suggested that the 
two pathways might be integrated in view of the results 
reported by Jarzynowski et al (1977). They found that the
mechanism of photolysis of NP was dependent on the wavelength
of irradiation. Irradiation at 498nm wavelength (band I) did 
not cause any photodegradation, and whereas 396nm (band II) 
irradiation resulted in hydration (eqn, 1&4), 265nm or lower 
(band IV-VI) irradiation resulted in photo-oxidation and 
exchange of NO by H^O (eqn. 7&8). These wavelengths correspond 
to the absorption bands of NP and are interpreted as being due
to specific transitions in the electron distribution of the
molecule. Different irradiation wavelengths therefore change 
the molecular orbital distribution in different ways and so 
result in different breakdown products. The overlapping of 
photochemically active bands (band III overlaps with band II & 
IV) means that both pathways can occur simultaneously. 
However, this interpretation does not agree with the MO level 
diagram according to the self-consistent charge and 
configuration (SCCC) method (see table 1:1)(Swinehart, 1967; 
Wolfe & Swinehart, 1975; Leeuwenkamp et al, 1984). According 
to this diagram, longer wavelength irradiation (>390nm ; bands 
I & II) result specifically in nitric oxide cleavage (not 
nitrosyl cation), whereas shorter wavelengths cause relatively
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non-specific metal-1igand bond cleavage (Wolfe & Swinehart, 
1975). Any polychromatic (and even some monochromatic) 
irradiation would result in a mixture of breakdown products, 
depending on which photochemically active bands it covered and 
the relative intensity at each. This may account for some of 
the variation in the reported products of nitroprusside 
photolysis.
The preceding account is only concerned with the primary 
photochemical reactions in the photolysis of nitroprusside. 
Numerous secondary reactions have been described in the
literature. Aq (II or III) , undergoes rapid equilibrium with6- ITT 4-Fe ^^(CN)IO Fe^ (CN)^^ respectively ( Rucki, 1977).
 ^ 3 — 2 —Oxidation of Aq(II) to Aq(III) has been reported and is
thought to be responsible for the orange to blue colour change
of a photolysed solution of NP ( Rucki, 1977 ; Van Loenen &
Hofs-Kemper, 1978 ). Conversion of Aq(II or III) to
hexacyanoferrâtes (II or III) has also been reported, with the 
2 •4’ 34*release of Fe , Fe , CN and ultimately forming prussian 
blue ( Leeuwenkamp et al, 1984; Van Loenen & Hofs-Kemper, 
1978). In the presence of Fe ions and oxygen Aq degrades to 
form numerous dimetallic ionic species ( Hofs-Kemper, 1978). 
In solutions with pH > 7 Aq(3-) forms Aq(4-) which further 
photodegrades to release cyanide and produce
aquatetracyanoferrate(4-) (Van Loenen & Hofs-Kemper, 1978). 
The secondary reactions are therefore numerous and complex but 
can only occur after the Nitroprusside is exposed to light. 
This is because after photolysis, the change in the oxidation 
state of the central iron weakens the bond strength to the 
surrounding cyanide groups, such that they become susceptable
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to substitution reactions. The stable NP molecule is then 
transformed into the labile Aq molecule which is then able to
participate in numerous reactions. Note that it is only during 
these secondary reactions that cyanide is liberated. This is 
relevant in the clinical use of NP as it has been reported 
that photodegradation before infusion may be responsible for 
the in vivo release of cyanide ( Bisset, Butler, Glidewell, 
Reglinski, 1981).
The results from the previous chapter show that 
nitroprusside must first be exposed to light before it can 
exert any negative inotropic action on frog ventricle. These 
results were of a preliminary nature as neither the method of 
exposure nor the interval between exposure and application 
were carefully controlled. Illuminating the drug solution 
while it is bathing the muscle is not altogether satisfactory 
as the degree of exposure would vary. Most of the solution 
being exposed would be flowing past the trabeculum in the 
chamber and so would only be briefly irradiated before being 
washed away without exerting any effect. NP in the locality of 
the trabeculum, especially that 'trapped' within the 
intercellular clefts, would be exposed for longer and thus 
exert a greater effect. The effective concentration of 
photodegraded NP could not therefore be easily controlled. 
Since the muscle would also be illuminated then the light 
could be affecting it directly. Although control experiments 
showed no effect of illuminating the muscle in Ringer 
solution, the light could be affecting one or more steps in 
the chain of events leading to a response. Indeed there is 
evidence of a direct effect of long UV light (350-450nm) on
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crude soluble guanylate cyclase, the enzyme thought to
stimulated by NP (Karlsson, Axelsson & Anderson, 1985). In
order to study the effect of light on NP alone, solutions 
must be illuminated away from the muscle and then applied to
it. This was attempted in the ’pre-exposure' experiments 
described in the previous chapter, but it led to difficulties 
in the time between exposure and application. The remedy 
adopted here was to illuminate NP solutions en route to the 
muscle chamber, such that photolysis takes place just before 
the perfusate reaches the muscle. This was achieved using the 
apparatus described below and shown in figure 4:1.
A laser was used to illuminate the solution in this 
tube for two reasons (i) the small beam allowed light to be 
accurately directed down the tube; (ii) it allowed an exact 
quantitative measure of the intensity and wavelength of the 
incident light. This enabled a detailed study to be made of 
the effect of changing both the intensity and wavelength of 
light on the physiological responses.
The photolysis of NP was monitored in these 
experiments by measuring the increase in absorbance at 395nm 
before and after exposure to light. This is due to the 
formation of Aq(III) which has an extinction coefficient at 
395nm of 7 43 M ^cm  ^ as compared to only 20.4 M~^cm  ^ for NP. 
The increase in absorbance measured at this wavelength is 
therefore proportional to the concentration of Aq produced.
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Methods
This section deals only with the method used to 
illuminate the NP solution, as the procedure for recording 
twitch contractions was described previously.
The apparatus used is shown in figure 4:1. Exposure of 
solutions to laser light was achieved by passing them through 
a curved glass tube, fitted with a quartz glass window and 
outlet at one end, and which tapered away to an inlet at the 
other. The outer walls of the tube were silvered such that 
light entering through the window was totally internally
reflected along its length. The perfusate, selected by means 
of the six way tap, flowed directly into the glass tube where 
it was then exposed to laser light entering through the quartz 
window. The volume of the tube was 10ml and the flow rate was 
adjusted to around lOml/min. such that the total exposure 
time was 1 minute. On leaving the tube the exposed solution 
flowed directly into the muscle chamber through a small bore 
(1mm) connecting pipe. This kept the dead space to a minimum 
(0.5ml) and ensured that the time interval between exposure to 
light and reaching the muscle was as small as possible
(3sec.).The laser was a 5W argon-ion laser (Spectra-Physis; 
model 168-09) which allowed the choice of any one of 10 
discrete wavelengths. The orientation of the laser was
critical, in that the beam of light had to be directed into 
the middle of the window. This ensured that the fastest 
flowing solution in the centre of the tube was properly
illuminated and that reflection off the end window was minimal 
(<4%). The laser beam was scattered by the solution and
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reflected continuously off the mirrored surface of the tube,
such that it became diffused throughout the lumen of the tube.
All the experimental procedures were performed in
darkness, the only form of illumination being red light from
either a small hand torch or a darkroom safe lamp. The
apparatus was enclosed in an aluminium box to prevent stray
light entering and to ensure that the solution was only
exposed to laser light during its passage to the chamber.
The degree of photolysis was estimated by monitoring
the quantity of aquapentacyanoferrate (Aq) formed. This was
done by measuring the absorbance at 395nm of an exposed NP
solution against an unexposed NP solution. A sample of NP
solution was collected after it had flowed through both the
exposure tube and muscle chamber and this was read against an
aliquot of the same solution that had been kept in the dark.
The increase in absorbance at 395nm wavelength is directly
related to the concentration of Aq formed during photolysis.
An illustrative example is shown in figure 4:2. The
two superimposed traces show the absorption spectra of 5mM
nitroprusside, read against distilled water, before (bottom
trace) and after (top trace) exposure to 20mW 457nm laser
light in the exposure tube. In this example, the flow rate
-1through the exposure tube was 10.5 ml.min , the difference 
between the two spectra at 395nm (= 0.322 A), normally
obtained directly by reading exposed NP against an unexposed 
sample, is equivalent to an Aq concentration of 43.3uM.
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Figure 4:1
C - Muscle chamber 
E - Exposure tube 
Q - Quartz glass window 
T - six way tap 
L - Argon ion Laser 
X  - Laser beam 
W - to waste
The required perfusate selected by the six way tap 
(T), flowed in the direction of the arrows through the 
exposure tube (E) into the muscle chamber (C) and then to 
waste (W) . A beam of light ( A )  from the laser (L), was 
directed into the exposure tube through a quartz glass window 
(Q) where it was diffused by reflecting off the mirrored walls 
of the tube. This ensured that the perfusate was completely 
exposed to light during its passage through the exposure tube.
-Fig.4:1
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Figure 4;2
Shown here are two superimposed scanning absorption 
spectra of the same solution of 5 mM NP before and after
exposure to 20mW of 457.9 nm laser light. The bottom trace 
{NP> is the absorption spectra of protected NP solution, read 
against distilled water as a reference. The top trace (XNP) is 
the same solution after exposure to 20mW of 457.9nm laser 
light, again read against distilled water. The increased
absorbance of the exposed solution at 395nm is due to the
production of aquapentacyanoferrate (Aq). This anion has an
mm»'] “Iextinction coefficient at 395nm of 743 M cm compared to
- 1 - 120.4M cm for NP. The concentration of Aq can therefore be 
determined by dividing the difference in absorbance at 395nm 
by the molar extinction coefficient. In this example, the 
concentration of Aq is 44.2 uM.
Fig.4:2-
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Results
i. The effect of Nitroprusside that was totally protected from 
light on the twitch tension.
As in the earlier experiments. Ringer's solutions 
containing nitroprusside (NP) that had been protected from
exposure to light failed to have any effect on the twitch,
-2even at concentrations of 10 M . Examples of this are shown in
figures 4:3 & 4:4 where the perfusate was changed from normal
— 3Ringer's solution to one containing either 10 M NP (fig. 4:3) 
_2or 10 M NP (fig. 4:4), neither of which had any effect on 
peak twitch tension.
ii. Effects of changing the wavelength and intensity of 
illumination.
On exposing the solution to laser light, the 
contractile performance of the trabeculum further downstream 
was impaired. This result shows that the response is not due 
to any direct effect of light on the muscle, but is instead a 
consequence of the photolysis of NP. The decrease in twitch 
tension begins soon after the laser is switched on and reaches 
a steady level in a time which is comparable to that seen on 
exposing the perfusate in the muscle chamber (<10min). 
Presumably, this is because photolysis occurs close to the 
muscle.
The results of these experiments confirm that at any 
given wavelength, the effect on the twitch is proportional to 
the intensity of illumination. Figure 4:4 shows a response in 
which the light intensity is increased from 3mW to 20mW during
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Figure 4:3
A - Panel showing pattern of illumination of
exposure tube by laser. Upward defection of bar indicating
start and intensity of illumination, downward deflection of 
bar showing end of illumination. Intensity shown above bar in 
raw.
B - Panel showing sequence of changeover of
perfusates. NR = normal ringer; NP = ringer containing 10 
nitroprusside.
C - Computer recordings of twitch height against 
time. Each vertical bar shows the active tension generated by 
every fifth twitch (i.e. time interval between bars is 25 sec 
). The timescale and force produced are indicated by the scale 
bars on the right.
D - Steady state isometric twitches before (top
traces) and after exposure (bottom traces). The timescale and 
force values are indicated by the scale bars to the right.
Fig.4:3
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Figure 4:4
The panels in this figure are similar to those in 
figure 4:3, showing the negative inotropic action of 10 NP 
after exposure to various intensities and wavelengths of 
light.
-Fig.4:4
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a single exposure. Peak twitch tension is reduced to a 
constant level by 3mW and then is further reduced when the 
intensity is increased to 20mW,
The results from the previous chapter also showed that 
the degree of depression of the twitch is inversely related to 
wavelength. This was studied in more detail using three 
different wavelengths; 514.5nm (green light), 488nm 
(blue/green light) and 457.9nm (violet light). Some responses 
are shown in figure 4:3. At a constant intensity of 
illumination, either 3mW (1,2 &3) or 20mW (4&5), the
depression of the twitch increases with decreasing wavelength. 
The difference in sensitivity amounts to a factor of almost 7 
over the range studied: thus 20mW of light at 514.5nm is
required to produce an equivalent twitch depression to only 
3mW at 45 7.9nm.
iii. The effects of exposed NP on the shape of the twitch.
The decrease in peak tension induced by exposed NP, is 
accompanied by a decrease in both the time to peak (TTP) and 
maximum rate of rise (dp/dt) of tension. To illustrate this 
effect, representative steady state twitches produced by two 
different NP concentrations after each illumination condition, 
are shown superimposed on the control twitch (figure 4:5). 
The differentiated tension signals are shown below on the same 
time scale. These show more clearly the shortening in the TTP 
(where the signal crosses the zero line) and the decrease in 
the dP/dt (decrease in the peak of the differentiated signal). 
It can be seen that the moderate reductions in peak 
tension, produced at low light intensities, lower NP
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Figure 4;5
The change in the twitch shape for a preparation 
exposed to 10 (panel A) or 10 (panel B), NP before and 
during illumination at varying intensities and wavelengths of 
light. The top half of each panel shows the isometric twitch 
recorded before (C) and after exposing NP to 3mW (middle 
traces) or 20mW (lower traces) laser light. Each twitch is 
superimposed on its respective preceding control twitch (C), 
recorded before the onset of illumination. The wavelength of 
light used is shown above each column. Two separate columns 
are required for 457nm light as each intensity was tested on 
different experiments such that the controls varied.
The bottom half of each panel shows the differentiated 
form of the twitches on the same time scale. This helps to 
illustrate the changes in twitch shape that occur. The peak of 
the differentiated signal corresponds to the maximum rate of 
rise of tension, whereas the time to peak tension corresponds 
to the point where the signal crosses the baseline.
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concentrations and longer wavelengths, are associated with a 
reduction in dP/dt but with little or no change in TTP. Any 
further decrease in peak tension, caused by higher 
intensities, NP concentrations or shorter wavelengths is 
accompanied by reductions in both dp/dt and TTP.
iv. Time course of the decline in peak twitch tension.
Figure 4:6 shows the time course of the decline and 
recovery of the twitch after 10 NP was exposed to each of 
the three wavelengths at intensities of 3mW (top panel) and 
20mW (bottom panel). Each trace is the averaged peak twitch
tension from 5 experiments with the standard error of the mean
plotted for every fifth twitch. The results show that the rate
at which the twitch reaches its new steady state level is also
determined by the illumination conditions. For any given 
intensity, the rate of decline of tension is increased by 
reducing the wavelength. Similarly, for a given wavelength, 
the rate is also increased at greater intensities of 
illumination,
The time course for the recovery of the twitch after 
illumination ceases, but while the preparation is still in NP, 
is similar for all three wavelengths at any given light 
intensity. This is shown in the legend to fig.4:6, the small 
differences in the half time to recovery being well within the 
margin of experimental error. It would appear therefore that 
the recovery process, is not influenced by the choice of 
wavelength. There are differences, however, in recovery rates 
between the two light intensities. This does not seem to be 
related to the degree of depression of the twitch, as similar
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Figure 4:6
The averaged time course of the decline and recovery
— 3of the twitch after exposing 10 M NP to light of 3mW (top 
graph) or 20mW (bottom graph) at three different wavelengths. 
The three wavelengths used were 514nm (top traces), 488nm 
(middle traces) and 457nm (bottom traces). Each trace is the 
averaged time course of 5 computer recordings of the peak 
twitch tension, normalised to the value recorded at the onset 
of illumination. Standard error bars are shown for every fifth 
twitch.
The times to a half maximum response are tabulated
below;
ON (sec.) OFF (sec.)
nm 3mW 20mW 3mW 20mW
514.5 102 + 18 69 + 5 94 + 6 63 + 10
488 72 + 6 54 + 3 81 + 9 48 + 5
457.9 54 + 5 39 + 3 78 + 10 6 7 + 5
-Fig.4:6
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responses, for example those elicited by 3mW 488nm and 20mW 
514, recover at different rates. It is of interest to note 
that responses produced at the lower intensity show slower 
recovery rates. This is an indication that the overall 
duration of exposure may be important because the twitch took 
longer to reach a steady depressed state at the lower 
intensity.
V ,  Time course of the change in isometric twitch shape.
Figure 4:7 shows a series of twitches recorded during
— 4 —2exposure to either 10 M (top panel) or 10 M (bottom panel)
NP illuminated with 3mW of light at each of the three
wavelengths. The time elapsed from the onset of illumination
to each recording is listed in the legend. The corresponding
differentiated twitches are shown below. Under all
illumination conditions and [NP]'s, the initial decrease in
peak tension is accompanied by a decrease in dP/dt but there
is little or no change in TTP. However, as the duration of
exposure to NP increases, the depression of the twitch becomes
more pronounced, and this is associated with reductions in
both dP/dt and TTP. Under conditions that cause maximal
depression of the twitch (i.e. 10”^M NP illuminated with 20mW
457.9nm), dP/dt reaches its minimum value before peak tension.
Any further reduction of the twitch is then associated with a
shortening of the TTP. These results confirm that small
depressions of the twitch are associated only with a decrease
in the rate of tension generation, whereas larger depressions
also involve a shortening of the time to peak tension.
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Figure 4:7
Isometric twitches recorded at different times after
the onset of 3mw intensity illumination of either 10 (panel 
_2A) or 10 M (panel B) NP. The wavelength used is shown above 
each column. Each panel shows superimposed twitches and the 
corresponding differentiated traces. These show the changes in 
twitch parameters more clearly. The times (in minutes) of 
recording each twitch after the onset of illumination are 
tabulated below.
10 10
514 488 457 514 488 457
a 0 0 0 0 0 0
b 5.1 2.0 1.9 0.9 0.4 0 . 6
c 8.3 3.0 3.9 1.6 1.8 1.1
d 10.7 5.2 4.5 2.8 2.5 1.5
e 14.2 9.0 6.6 4.3 4.8 2.0
f 13.8 12.7 8.4 7.7 4,5
9 - 15.8 5,4
■Fig .4:7
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vi- Dose response curves to NP under various conditions of 
illumination.
All the data on the effect of exposed NP on the peak 
twitch tension is summarised in figure 4:8. Each log dose 
response curve shows the average depression of the twitch for 
one exposure condition over a range of [NPl's. The curves are 
grouped according to intensity of illumination, 3mW on the 
left and 20mW on the right, while the different wavelengths 
are indicated by the key (see fig.4:8).
Each curve approximates to a normal sigmoidal dose 
response curve,reaching a plateau at [NP] of 10 The level
of the maximum response is found to depend upon the 
illumination conditions. It is elevated by either decreasing 
the wavelength or increasing the intensity of the 
illumination. As well as an increase in the maximal level of 
depression, the whole curve is shifted upward and to the left. 
Thus for each [NP], increasing the intensity at constant 
wavelength enhances the response whereas increasing the 
wavelength at constant intensity depresses it.
To demonstrate that this is indeed due to a shift of 
the dose response curve and not merely a consequence of the 
altered maximum response, all the data were normalised to 
their respective maximal responses and plotted together in 
figure 4:9. At any one intensity, either 3mW (C-E-F) or 20mW 
(A-B-D), the log dose response curve is shifted to the right 
with increasing wavelength. Conversely at any one wavelength 
the dose-response curve is shifted to the left by an increase 
in intensity (ie, C-A, E-B or F-D). It is clear from this that 
the most effective illumination condition is 20mW at 457nm and
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Figure 4:8
A. Log dose response curves to NP exposed to 3inW of 
light at three different wavelengths.
B. Log dose response curves to the same wavelengths 
but at the higher intensity of 20mW. The wavelengths used were 
514 nm (bottom curves), 488 nm (middle curves) and 457 nm (top 
curves).
-Fig.4:8-
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Figure 4:9
The log dose response curves shown in figure 4:8 were 
normalised to their respective maximum responses. This shows 
more clearly the shift in the position of the curve under the 
various lighting conditions. The measured E.D.g^ values for 
each illumination condition are shown in the inserted table.
-Fig.4:9-
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the least effective is 3mW at 514nm,
vii. Log dose response curves for the change in twitch shape
parameters
An analysis was made of the effect of changing the 
illumination conditions and [NPl on twitch shape. The 
resultant log dose response curves for the effects on dP/dt 
and on TTP are shown in figures 4:10 and 4:11 respectively.
The decrease in dP/dt is dependent on both the NP
concentration and illumination condition. All of the curves 
are sigmoidal, with a maximum depression of 55%, Note that 
this maximum is independent of the illumination condition; the 
more efficient illumination conditions (i.e. 20mW 457/488nm) 
reach this level at lower [NP]'s than less efficient ones 
(i.e. 3mW 514nm), so that the relative position of the curve 
moves to the left. Hence, increasing the intensity of 
illumination produces a leftward shift of the curve whereas
increasing the wavelength moves it to the right. It is of
interest to note that both the 20mW 457nm and 20mW 488nm 
relationships are nearly superimposible. Presumably both 
conditions are sufficient to produce a maximal reduction in 
dp/dt.
In comparison, the shortening of TTP (fig. 4:11) is 
only appreciable at higher [NP]'s. The dose response curves 
show that both the slope and maximum degree of reduction in
TTP are determined by the illumination conditions. More
effective illumination conditions do not shift the position of 
the curve but instead steepen the relationship and increase 
the size of the maximum response. This explains why although
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Figure 4:10
The percentage decrease in the maximum rate of rise of
tension (dP/dt) is plotted against log [NP] for each
illumination condition. Each point represents the mean (+ SE.) 
from 5 experiments with both 3mW (open symbols) and 20mW
(closed symbols) being plotted on the same graph for each
wavelength.
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Figure 4;11
The percentage decrease in the time to peak tension 
(TTP) is shown plotted against [NP] for each illumination 
condition. Each point represents the mean value {+ SE.) of 5 
experiments. Both 3mW (open symbols) and 20mW (closed symbols) 
are plotted on the same graph for each wavelength.
-Fig.4:11-
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two illumination conditions may have the same effect on dp/dt 
(i.e. 20mW 457nm & 20mW 488nm), the overall reduction in peak 
twitch tension can still be greater at the shorter wavelength 
due to a greater effect on the TTP.
The reduction in peak tension seen at lower [NP]’s, 
especially under less effective illuminations, is mainly due 
to a decrease in the rate of tension generation as the TTP is 
virtually unchanged. However, at higher (NP]*s and more 
effective illuminations, the effects on dP/dt are maximal and 
any further decrease in peak tension is due to a shortening of 
the TTPJ. Examples of these effects on the twitch shape can be 
seen in figure 4:5, Similar changes can be seen during the 
tiraecourse of a single response, in that initially, only the 
rate of tension generation is reduced, but as the 
concentration of active agent increases so the time to peak 
tension becomes shortened (see fig.4:7).
viii. Measurement of Aquapentacyanoferrate production 
following exposure of Nitroprusside to laser light.
The preceding results suggest that in order for NP to 
have any inotropic effect, it must first be exposed to light. 
The magnitude of the resulting effect is then dependent upon 
the quantity and wavelength of light used. Evidence in the 
literature suggests that NP is extremely photosensitive and 
readily undergoes photolysis to yield a number of 
photochemical products. It therefore seems likely that one or 
more of these is reponsible for altering the twitch. We can 
therefore anticipate that the magnitude of the physiological
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response is correlated with the efficacy of the photolytic 
process. This was investigated directly by monitoring the
production of aquapentacyanoferrate by measuring its
concentration in the chamber effluent. Measurements were made 
for the various illumination conditions over a range of NP 
concentrations. The results are shown in figure 4:12, As each 
individual measurement is plotted the scatter is large. There
is however a high correlation (r^=0.651; p > 0.001 for 124
degrees of freedom) between the depresson of the twitch and 
the breakdown of NP. The calculated best fit line shows that a 
50% depression of the twitch is associated with the photolysis 
of 3.7 uM of NP.
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Figure 4:12
The concentration of aquapentacyanoferrate was
measured spectrophotometrically in the effluent of 130
experiments and plotted against the twitch depression in each
case. The experiments involved a variety of different
intensities, wavelengths and concentrations of NP. Linear
regression analysis on the data revealed a high degree of
2correlation ( r = 0.651 for 124 degrees of freedom: p > 0.001)
with a best fit line as plotted.
•Fig.4:12“
100
80 •••co
CO
COCD
•  • • • • • •
60
Q.CDQ
ü 40
H- ••
20
6 5
b g  A q u a p .  c o n c . C M ]
chapter 4
Discussion
The major conclusion to be drawn from these results is 
that the nitroprusside anion per se does not affect the 
twitch. The negative inotropic effect previously attributed to 
NP (Flitney, Moshiri & Singh, 1980) comes instead from one of 
its photolytic products. The extent of the inotropic action 
therefore depends on the amount of product. Although this is 
related to the initial [NP], it will also depend upon the 
efficiency of photolysis. The higher the intensity of 
illumination, then the more photons of light are available to 
react with the NP molecules such that more product is formed. 
In terms of the physiological responses, this manifests itself 
as a leftward and upward shift of the NP-dose response 
curve.The wavelength chosen also influences the photolytic 
process. As already mentioned in the introduction, particular 
wavelengths induce specific transitions in the electronic 
distribution of the molecule and therefore create different 
products. These wavelengths correspond with the peaks in the 
absorption spectrum. In the experiments described here, the 
relatively long wavelengths that are used (>457nm) are all 
associated with the photoreaction that liberates the nitrosyl 
moiety from the parent molecule (Wolfe & Swinehart, 1975). The 
absorption band most effective at cleaving this bond occurs at 
ca 400nm, and so wavelengths closer to this are more efficient 
at splitting NP (Wolfe & Swinehart, 1975). The order of 
efficacy in these experiments is therefore 457.9 > 488 > 514.5 
nm. Illumination at 457nm would generate more of the 
physiologically active component than 488 or 514nm. This is
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supported by the finding that it requires 20mW at 514nm to 
elicit the same response as only 3mW at 457nm. The leftward 
shift in the NP-dose response curves at constant intensity is 
also indicative of the greater efficacy of the shorter 
wavelengths.
The effects on the shape of the twitch presumably also 
depend on the concentration of the active agent formed during 
photolysis. This product seems to affect the mechanism of 
tension generation only at low concentrations, without 
changing the time to peak tension. Under conditions that 
favour its formation however, the effects on the TTP become 
more marked, indeed, the TTP can still be reduced when dP/dt 
is maximally depressed. It is interesting that the NP-dose 
response curves for the effects on these two parameters 
differ. The maximum rate of rise of tension varies sigmoidally 
with [NP], which has always the same maximal value of 55%, and 
is shifted to the left under more efficient illumination 
conditions. The relationship between [NP] and TTP is 
curvilinear with both the maximal value and slope being 
dependent on the illumination condition. This may mean that 
the physiologically active species depresses the twitch via 
two distinct mechanisms.
As discussed in the general introduction, NP is 
thought to act by increasing the intracellular concentration 
of cGMP (Flitney, Moshiri & Singh, 1980). In frog ventricular 
cells, most of the Ca required to activate the contractile 
machinery enters through the sarcolemma (Chapman, 1983). 
Cyclic GMP is reported to reduce the calcium influx during the 
action potential (Wahler & Sperelakis, 1985). A decrease in
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the availability of Ca for the contractile apparatus would 
therefore reduce its tension generating ability. It is 
interesting to note that the NP-dose response curve for peak 
tension is influenced by the illumination conditions in a way 
that appears to result from a combination of the effects on 
both dP/dt and TTP.
Clearly, the results presented here pose an important 
question; what is the chemical identity of the physiologically 
active species formed during photolysis ? According to Wolfe & 
Swinehart (1975), the conditions used in these experiments, 
namely air saturated buffered Ringer at pH 7.0 and relatively 
long wavelength irradiation, would favour production of 
aquapentacyanoferrate(III) (Aq) and nitric oxide (NO). NO is 
well known for its ability to stimulate guanylate cyclase 
directly and so must be the obvious candidate. Evidence in 
support of this hypothesis is presented in later chapters.
Meantime, we can note that the concentration of the 
active substance generated by photolysis would be related to 
the [Aq] formed, NO, for example, is produced with a 1:1 
stoichiometry to [Aq]. Measurement of the [Aq] formed 
therefore gives an upper estimate of the concentration of the 
active species formed under any given set of experimental 
conditions. The data shown in figure 4:12 illustrates that the 
negative inotropic response is proportional to the [Aq]
generated which is suggestive of a causal relationship.
However, the [Aq] formed by [NPj's < 10 ^M cannot be
determined accurately by spectrophotometry and so the data
neccessarily covers a narrower range, heavily weighted towards 
the top end of the log[NP]-response curve. Even so, it is
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clear that the effective concentrations of active species 
produced are very much less (>100 fold) than the [NP] used. In 
order to explore this relationship further, a more complete 
dose response curve is required and a method for estimating 
the [Aq] generated at lower [NPl's is described in the 
following chapter.
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A procedure for estimating 
the extent of photolysis of nitroprusside.
Chapter 5
Introduction
The previous chapter established that the 
physiological potency of 'nitroprusside' depends upon the 
extent to which it undergoes photolysis. The inference is that 
an active photolytic product is responsible for the inotropic 
activity. The amount of this substance produced, and hence the 
size of the response, clearly depends on both the [NP] and the 
illumination conditions. In order to more fully understand the 
physiological efficacy of this substance, it is essential to 
relate the size of the response to the amount of photolysed NP 
over the entire range of [NP] and illumination conditions 
studied. This can be done in part by measuring the production 
of aquapentacyanoferrate (Aq) in the bath effluent. 
Unfortunately, measurements can only be made at [Ag]'s > luM 
and at these concentrations the effects on twitch tension are 
considerable. Data can therefore only be obtained for the top 
end of the dose response curve. In order to construct a 
complete dose response curve, [Aql's lower than luM must be 
estimated. This entails determining the efficiency of 
breakdown of NP at concentrations that produce measurable 
amounts of Aq, and then using it to calculate the amount 
produced at much lower [NPj's. This procedure must take into 
account all the factors that influence the photolytic 
reaction, such that the effective concentration of active 
agent generated in the exposure tube can be reliably 
estimated.
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I. Determination of the estimation procedure.
Theory
The [Aq] formed in the exposure tube is estimated from 
the absorbance change at 395nm:
[Aq] = A/e eqn,{1)
where A = measured change in absorbance
e = molar extinction coefficient for Aq at 395nm (=743
- 1  - 1  M cm )
Under 'ideal' conditions when the overall efficiency 
is 1.0, the maximum amount of Aq that can be formed is when 
all the NP is photolysed (ie. [Aq]=[NP] ). The overall
efficiency (E) of the photolytic process is therefore given by
E=[Aq]/[NP] eqn.(2)
or
[Aq]=E [NP]
Under the dynamic conditions pertaining in the present 
experiments, the maximum attainable [Aq] is related to the
[NP] by:-
[Aq]= p0(q/m)[NP] eqn.(3)
where
p = the probability that every photon will interact with 
a molecule of NP
0 = the quantal efficiency of the photolytic reaction
(moles.einstein ^)
q = photon flux (photons . sec ^)
m = number of molecules of NP flowing through the
-1exposure tube (sec )
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It is clear that p and (q/m) are inversely related.
Thus, p will tend towards unity when q<<m, and towards zero
when m<<q. Under ideal conditions of flow and illumination,
p=l and so
[Aq] = 0(q/m)[NP] eqn.(4)
from which we have that:
0 = [Aq]/(q/m)[NP] eqn.(5)
The photon flux (q) is given by:-
q = Al/hv eqn.(6)
where A ~ wavelength of light (m)
I = intensity of illumination (W) 
h = Planck's constant <6.63 xlO~^^J.sec'“^ )
V = velocity of light (2.99 x lO^m.sec"^)
and the number of molecules flowing through the tube per
second by;-
m = [NP].F.Av eqn.(7)
where F = flow rate (l.sec. ^)
OQAv= Avagadro's number (6.02 x 10 )
Eqn.(5) has the dimensions of molecules.photon~^which
is more usually expressed as moles,einstein”^(where 1 einstein 
23= 6.02 X 10 quanta). It is important to emphasise that
eqn.(5) is only valid for ideal conditions of flow and
illumination, when p=1.0. In practice, if q>>m, caused either 
by increasing the intensity of illumination or by reducing the 
[NP], or both, then the apparent value of 0, which we denote 
by 0' is given by:
0' = p .0 eqn.(8 )
Clearly, estimates of [Aq] generated in experiments 
using [NP] < 10 , where it is not possible to measure the
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change in absorbance directly, can only be made when the 
relationship between p and q/m is known. This can be found for 
any given wavelength providing 0 is first determined under
ideal conditions, since from eqn. (4) we see that;
p = [Aq]/(q/m)0[NP] = 1.0 eqn.(9)
Experimental results
1. Effect of varying flow rate on Aq production
Eqn.(3) shows that [Aq] formed is directly 
proportional to the intensity of illumination (q) and 
inversely proportional to the flow rate (m). The importance of 
flow rate is shown in figure 5:1. Here, lOmM NP was exposed to 
20mW light at 457nm, The flow rate was varied from 2.5 to 15 
mls.min ^. Curve A shows that [Aq] decreases with increasing
—Iflow rate, from arround 700uM at 2.5 mls.min to lOOuM at 15 
-1mls.min . Conversely curve B shows that the [Aq] is directly 
proportional to the transit time. The apparent value for the 
quantal efficiency (0' = p0) is shown by the open squares
(curve C) measured at each of the flow rates. The mean value
is found to be 0.074. The consistency of these estimates of
0' show that the method is able to compensate for large
variations in flow rate, much greater than those encountered 
in the actual experiments.
2. Relationship between lAq] formed and q/m
Eqn.(8) shows that [Aq] generated is linearly related
to the product q/m and [NP] with a gradient of p0:
p0 = [Aq]/(q/ra)[NP] eqn.(10)
Figure 5;2(A) shows the results of an experiment in 
which the production of Aq was measured over a wide range of
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Figure 5:1
This figure shows a composite plot of the effects of 
varying the flow rate through the exposure tube, upon the 
photolysis of a lOmM NP solution exposed to 20mW 457nm laser 
light.
A - Relationship between the concentration of 
aquapentacyanoferrate (Aq) produced under different flow rates 
(F) .
B - Relationship between the Aq concentration against 
the transit time (T) that each molecule spends in the exposure 
tube.
C - Plot of the apparent quantal efficiency 0' (= 
p0) as calculated from eqn.10, for each flow rate value. The 
consistency of this value suggests that the equation can 
compensate for large variations in flow rates. The line shows 
the mean p0 value, which is 0.074.
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Figure 5:2
A - Graph of the linear relation between Aq produced 
and (q/m).NP for a single experiment in which either the flow 
rate (open dots) or intensity of illumination (closed dots) 
was varied duing an exposure of lOmM NP perfusate by 457nm 
laser light. The single linear relation implies that the 
(q/m).NP factor compensates for both changes in flow rate or 
intensity.
B - The linear relation between Aq and (q/m).NP under 
conditions similar to A, are plotted for different wavelengths 
of incident light according to the key below. Although the 
linear relationship is constant for variations in intensity, 
the gradient is dependent on the wavelength of illumination.
a 454 nm
b 457 nm
c 488 nm
d 496 nm
e 514 nm
f 5 28 nm
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q/m values. This was acheived by altering q and m 
independently ie. either by varying flow rate while keeping 
the intensity constant (open circles), or by changing the 
intensity while keeping flew rate constant (closed circles). 
The data are almost superimposable and yield the same linear 
relationship between [Aq] and the product (q/m)[NP]. Thus, 
evaluating q/m is able to compensate for differences in the 
efficiency of photolysis which result from variations in the
flow rate and/or intensity of illumination.
Experiments using a different [NP] and different
wavelengths (see legend fig.5;2(B)) yield a similar linear 
relationship between [Aq] and (g/m)[NP]. Note, however, that 
the gradient of the lines are different and that they vary 
inversely with wavelength.
3. Effect of varying [NP] on p
The probability p that each photon will interact with 
a molecule of NP is determined by several factors. First, it 
depends upon the geometry of the exposure tube, in as much as 
this affects the dispersion of light within the lumen. This is 
an invariant property unique to the tube being used. Secondly, 
p will depend on [NP] flowing through the tube. The mean free 
distance between molecules will vary inversely as the cubed
root of the [NP]. Thus, for a IM solution the mean free path 
is estimated to be l.lSnm, increasing by a factor of 100 times 
to 118nm on diluting the solution to 10~^M. Clearly, this is 
an important determinant of p since photons which pass through 
the tube without encountering a molecule of NP are 
ineffective.
The real value for the quantal efficiency of the
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Figure 5:3
The value of p was calculated (via eqn. 9) for a 
range of NP concentrations under constant flow (lOmls/min.) 
and illumination conditions (20mW 457nm ). The value increases 
with increasing NP conc. until it reaches a maximum plateau 
value above 2.5 10 NP. Above this concentration, further 
increases in NP do not increase p such that the photolytic 
conditions are optimal for these experimental conditions. If 
we assume that p=1.0 under these conditions, then the plateau 
value of p is equivalent to the quantal efficiency for the 
wavelength involved. In this experiment this is estimated to 
be 0.1152 (+0.0021) mol/einstein for 457nm (n-8).
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photolytic process can be found from experiments such as that
illustrated in figure 5:3. Here, 0' (=p0) was measured over
a range of [NPl's under conditions of constant flow
(lOmls.min ^)and illumination (20mW, 457.9nm). These results
show that 0' increases with increasing [NP] until it reaches
— 3a limiting value above 2.5 x 10 M. Further increases in [NP] 
has no further effect on 0'. Thus, at [NP]>2.5 mM, p is 
maximal (=1) and 0' = 0, This data returned a value for 0 
at 457.9nm of 0.1151 ±  0.0021 moles.einstein ^(n=8). Similar 
experiments for 4B8nm and 514nm wavelengths gave values of 
0.053 and 0.023 mole.einstein  ^ respectively.
Figure 5:4 shows these estimates of 0 plotted as a 
function of wavelength together with two additional values at 
366 and 436nm taken from Wolfe and Swinehart's (1975) 
measurements. The absorption spectrum for exposed NP (5mM) is 
also illustrated and the data have been scaled at 366nm so 
that they superimpose. The estimates of 0 increase with 
decreasing wavelength by a factor of 15.9 over the entire 
range. The peak in the absorption spectrum (at 395nm) is the 
optimal wavelength for cleaving the nitrosyl ligand. The value 
of 0 should therfore be maximal at 395nm, but this wavelength 
was not available by the laser used in these experiments.
4. Relationship between p and q/m
In order to estimate the [Aq] formed at low [NPj's 
the relationship between p and q/m must be found. Since 0 was 
estimated under ideal conditions as described above, p can be 
obtained from eqn.(9) under any set of experimental 
conditions.
P = [Aq]/(q/m)0[NP]
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Figure 5;4
Quantal efficiency values, estimated for each of the 
wavelengths used in this study, are shown plotted on the 
scanning absorption spectra of photolysed NP along with other 
values from the literature. This illustrates the wavelength 
dependence of the photolytic reaction, and why the quantal 
efficiency values increase with shorter wavelengths. The 
quantal efficiency values are given below;
nm mole/einstein
366 0.37 (Wolfe & Swinehart, 1975)
43 6 0.18 ( " " " " )
457 0.1152
488 0.0530
514 0.0233
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Fig.5:5 shows the relationship between log p and log 
(q/m), for a range of flow rates, intensities of illumination, 
wavelengths and (NP]*s, The value of log p is seen to increase 
linearly from arround -1.5 at (q/ra)= 10 to reach a plateau 
value of arround 0 at q/m < 0.1. Linear regression analysis 
shows that:
log p = -0.695 + (-0.788(log (q/m))) eqn.(11)
(regression coefficient = 0.99)
This relationship can be used to estimate 0 from the 
data presented earlier, in fig.5:1, curve C. At a flow rate of
—  IlOmls.min , p is estimated to be 0.64, which since the value 
of 0' is 0.074, gives a corrected value of 0 = 0.1156 (0.074 
X 0.64). This closely compares with the 0 value for this 
wavelength (=0.1152) estimated under optimal experimental 
conditions (ie. the plateau values in fig.5:3).
The predictive value of the method can be tested by 
comparing theoretical values for [Aq] generated under a given 
set of conditions with those actually measured. This is
illustrated by the data in fig.5:6, The relationship is linear 
with a Isope of 1.02 and a least squares regression 
coefficient of 0.99. The data include measurements at all 
three wavelengths, for different flow rates, [NPl's and
illumination intensities.
In the analysis that follows, the assumption is made 
that the relationship between p and q/m also holds true at 
very low [NPl's, and that the [Aq] can therefore be reliably 
estimnated by extrapolation of the linear portion of fig.5:5. 
It is probable that this assumption is justified because the
fixed geometry of the tube on one hand and the physical
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Figure 5:5
The probability factor p was calculated for a range of
flow rates, intensities, wavelengths and [NP]s. Log p when
plotted against log (q/m) linearized the relationship 
2(R =0.99), up to a maximum plateau value when p=1.0. This
means that ideal photolytic conditions (ie. when p=1.0) exist
when q/n is small, and that at higher values of q/n ( >
0.128), the value of p decreases with the relationship;
P^^q (-0.695 +( -0.788(log q/m)))
-Fig. 5:5-
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Figure 5:6
The estimation procedure was tested against a wide
range of experimental conditions in which the Aq concentration
was directly measured. The estimated value was plotted against
the real measured value as shown. There is a very good linear 
2correlation (R = 0.99) between the two sets of results, with a 
slope of nearly 1.0 which suggests that the estimation 
procedure is accurate.
-Fig. 5:6-
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relationship between intermolecular distance and [NP] on the 
other are the major determinants of p. At the very least, this 
approach provides an order of magnitude estimate of the degree 
of photolysis which can then be related to the response shown 
by the muscle.
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II. Relationship between degree of photolysis and 
physiological responses
The several NP dose response curves shown in the 
previous chapter, obtained using different wavelengths and 
intensities of illumination, are all transformed into single 
curves by plotting the data as a function of the [Aq] formed 
in the exposure tube. Figure 5:7 shows the relationship 
between log[Aq] and peak twitch tension, using data previously 
included in the individual dose-response curves of figure 4:8. 
Figure 5:8 shows the relationship for dP/dt (A) and TTP (B) 
plotted against log[Aq], the data for which was previously 
shown in figs.4:10 & 4:11 respectively. The experimentally
measured [Aq], indicated by the open symbols, are shown 
together with those estimated using eqn,(3) (closed symbols). 
Each data point represents averaged responses and [Aqj's, as 
determined for a standardised set of experimental conditions 
(flow rate, wavelength, intensity of illumination and [NP]). 
The [Aq] generated in the exposure tube is here used as an
indicator of the photolytic reaction. Stoichiometrically, one 
molecule of NP generates a single molecule of Aq, so the 
abscissa for each curve can be directly related to NP 
breakdown.
There are three points to emphasise concerning these
results;
First, by taking account of all the experimental 
variables, and using these to estimate the quantity of NP
photolysed, makes it possible to translate the data points
onto single log dose response curves. Significantly, those 
points for which [Aq] was measured directly exactly
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Figure 5:7
The log dose response curves to photodegraded NP, as 
determined by the estimated Ag concentration, are shown. All 
three wavelengths and two intensities (closed circles) lie on 
the same dose response curve which is almost linearly related 
to twitch depression. Measured Aq values (open circles) are 
also lie on this curve, which lends further evidence that the 
estimation procedure is accurate.
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Figure 5:8
The percent reduction in both the maximum rate of rise 
of tension (dP/dt;D) and time to peak tension (TTP;0)r are 
plotted against l-ogEAq]. Both estimated (closed symbols) and 
measured (open symbols) Aq values are shown, incorporating a 
variety of wavelengths, intensities and [NP]s. The values
for dP/dt is 3.9x 10 ^whereas it is 4.2x 10  ^ for TTP.
-Fig. 5:8
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superimpose on the upper end of each curve.
Secondly, physiological effects are detectable when 
the experimental conditions are such that only 50-100nm NP is 
photolysed. The low threshold concentration is an indicator of 
the extreme sensitivity of the preparation to the active agent 
formed.
Third, the substance generated by photolysis, affects 
the three twitch parameters differently. The ED^^values 
increase in the order 0.4uM (dP/dt), luM (peak twitch) and 
4.2uM (TTP). The curve relating dP/dt to [Aq] is particularly 
steep rising to a maximum plateau over one decade from around
_710 to 10 M, In comparison, those which relate peak twitch 
and TTP to [Ag] both extend over approx. 2.5 decades and show 
no tendency to level off even when [Aq] reaches 40-50uM.
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Introduction
The results presented thus far have established that a 
photolytic product of NP, produced in nM-uM amounts, is 
responsible for its physiological effects. The experiments now 
to be described were undertaken in an attempt to identify the 
substance concerned. As noted earlier, the products of 
photolysis will depend upon the ambient conditions of 
exposure, solvent used, pH, etc, and for the conditions used 
throughout this study the reaction sequence would be expected 
to follow Wolfe and Swinehart's (1975) scheme (see fig.6:1). 
Here, the primary photochemical event splits NP into 
pentacyanoferrate and nitric oxide (NO).The pentacyanoferrate 
is then rapidly hydrated to form aquapentacyanoferrate (Aq). 
NO does not react directly with water, but it readily combines 
with dissolved oxygen to form dinitrogen tetroxide or nitrogen 
dioxide, which dissociates in water to produce nitrous acid 
and nitrate. Nitrous acid itself dissociates to produce 
nitrite, nitrate, NO and hydrogen ions (Wolfe & Swinehart, 
1975). There are thus a number of substances that must be 
considered potential candidates for the physiologically active 
agent.
Inspection of fig.6:1 shows that the fate of NO formed 
during photolysis is 0^ dependent whereas that of Aq is not. 
This means that the equilibrium between the several products 
can be perturbed in a predictable manner by changing the O^ 
tension: raising it will favour the production of NO^and NO^ 
at the expense of NO, while reducing it will suppress this
“Page 6.1-
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Figure 6:1
The photochemical decomposition of nitroprussi^e.
1/2 NO
\n 0. 1/2 NO.
hr
NO*
1/2 H _0
5HCN
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pathway such that more NO remains in solution. Notice that
neither of these interventions will alter the fate of Aq.
There is another related consequence of changing [Og]
which is relevant in the present context. The production of
superoxide anions (Og), which are highly reactive and combine
readily with NO to form NO^, will be favoured at high
tensions. Superoxide ions can be generated by the reduction of
2 +dissolved O^ using ferrous (Fe ) ions, conversely, cupric 
2+(Cu ) ions, which have a redox potential lower than that of 
Og, will inhibit its formation. The enzyme superoxide 
dismutase (SOD), which catalyses the conversion of O^ to 
hydrogen peroxide, can also be used as a means of assessing 
the importance of superoxide ions (and by inference that of 
NO) in determining the inotropic response.
Finally, the haem group of haemoglobin (Hb) has a 
strong affinity for NO and can therefore be used as a NO 
scavenger. The reaction is extremely rapid (Antonini & 
Brunori, 1971) and the product formed, nitrosyl haemoglobin
(Hb-NO), is relatively stable. Its formation can be detected 
by conventional spectrophotometry and because of the unpaired 
electron associated with NO, it also generates a 
characteristic electron paramagnetic resonance (EPR) signal.
These considerations form the basis for the series of 
experiments described in this section. It will be seen that 
the results support the hypothesis that the inotropic response 
is due to NO.
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Results
Effects of varying oxygen tension on responses to photolysed 
NP
NP solutions with three different oxygen tensions were 
prepared from Ringers' solution saturated with either air, 
pure oxygen or pure nitrogen. The solutions were continuously 
bubbled throughout the experiment to ensure that the [Og] 
remained constant. This was regularly checked using an oxygen 
electrode. The [O^l's obtained were 74 +0.020 uM (Ng
saturated), 260 +0.014 uM (air saturated) and 910 +0.080 uM
(0^ saturated).
The experimental protocol first established the 
'normal' response to photolysed NP (20mW, 457.9nm) in air
saturated solutions, when peak twitch tension had reached its 
new steady state level, the perfusate was switched to 
saturated solution containing the same En p ]. Again the twitch 
was allowed to stabilise before switching the perfusate over 
to N^ saturated NP solution. The preparation was allowed to 
recover in air saturated (normal) Ringers' solution before 
repeating this procedure with a different [NP]. Control
experiments showed that changing the oxygen tension alone, in 
either Ringers' solution or protected NP solution, had no 
effect on the twitch. Moreover, the efficiency of photolysis 
was found to be independent of oxygen tension as demonstrated 
by the [Aq] measurements listed in table 6:1.
Figure 6:2 (A,B) shows recordings of responses to two 
[NP] at each of the three oxygen tensions. In panel A ([NP]= 
SOuM) the twitch depression in air saturated solution is 
slightly reversed by switching to oxygen saturated solution.
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Table 6:1
[ AQÜAPENTAC YANOFERRATE ] 
(mM)
(NPJ AIR
10 2.83 ± 3.2 3.03 ± 0.19 3.10 ± 0,36
5 X lO'^M 6.53 ± 0.12 7,53 ± 0.77 7.00 ± 0.84
5 X lO'^M 12.10 ± 1.9 12.8 X 1.82 12.4 + 1.92
10“^M 20.6 ± 3.8 18.9 ± 4.46 21.2 ± 4.07
5 X -310 51,1 ± 14.2 56.3 ± iO.4 58,9 ± 14.2
[Ogi (mmole.1 0.074 ± 0.02 0.26 + 0.014 0.92 ± 0.08
STEADY-STATE CONCS.
FLOW RATE: 10 mis. min*^
ILLUMINATION: 20 mW AT 457.9 nm.
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Figure 6:2
The top bars in these panels depict the oxygen content 
of the perfusate, an upward deflection representing an 
increase, (Og- oxygen saturated) whereas a downward 
deflection represents a decrease (Ng- nitrogen saturated) from 
the normal air saturated solution. The middle bar indicates 
the changeover of the perfusate from normal ringer to ringer 
containing either 50uM [NP] (panel A) or ImM [NP] (panel B) 
which was constantly illuminated in the exposure tube by 20raW 
457nm laser light. The computerised traces show the peak 
tension of every twitch, according to the scale bars on the 
right (each bar represents O.OSmN).
-Fig. 6:2-
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On changing to the low oxygen ( saturated) solution the 
reduction in twitch tension is significantly greater than that 
produced by the air saturated solution. Qualitatively similar 
changes are seen at the higher [NP] (=lmM) shown in panel B, 
although the reversal in high oxygen containing solutions is 
much greater.
The effects of varying the oxygen tension on the shape 
of the twitch is shown in fig.6:3 for three different [NP]’s 
and in fig.6;4 at different times during a response 
([NP]=0.5mM). As found previously, the decrease in peak twitch 
tension is associated with reductions of both dp/dt and TTP 
tension. Once again, the extent to which these are affected is 
related to the overall reduction in peak twitch tension: small 
depressions are associated only with a decrease in dp/dt, 
whereas larger depressions are also associated with a 
shortening of the TTP. Significantly, the effects of varying 
the oxygen tension for a given [NP] closely mimic those 
produced by changing the [NP] at a fixed oxygen tension. Thus, 
enhanced responses in low oxygen tensions are associated with 
reductions in both dP/dt and TTP, whereas at high oxygen 
tensions the predominant effect is on dp/dt and TTP is barely 
affected. These results show that either altering the [NP] at 
a fixed oxygen tension, or varying the oxygen tension for a 
fixed [NP], affect the twitch in qualitatively similar ways. 
The inference to be drawn is that they serve the same purpose, 
in affecting the concentration of the physiologically active 
agent formed during photolysis. Figure 6:5 shows the 
accumulated data from a series of experiments in which 
responses were recorded for [NP]'s spanning the range 5x10 ^
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Figure 6:3
Individual steady state twitches of three different NP 
concentrations of at various oxygen tensions, are shown 
superimposed on the preceding control twitch. The 
differentiated form of these traces are drawn underneath on 
the same time scale, to more clearly show the changes in 
twitch parameters. The scale bars on the right are O.OSmN for 
the twitch tension traces and 0.5 mN/sec for the 
differentiated traces, the time bar common to both is 0.5sec.
-Fig. 6:3-
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Figure 6:4
Individual twitches are shown that were recorded at
various times throughout a response to 5.10 NP during which 
the oxygen content of the perfusate was varied. The twitches 
are grouped to show the effects in air, high oxygen, or low 
oxygen NP solutions with the position of each respective 
twitch being indicated by the corresponding letter in the
complete experimental trace above. As before, the change of 
perfusate and oxygen tension are indicated by the bars above 
the trace. The differentiated tension traces are shown below 
the corresponding twitches and clearly show the changes in
twitch shape produced by the change in oxygen levels.
The scale bars for the trace represent O.OSmN 
(vertical) and 2mins.(horizontal) whereas those below 
represent O.OSmN (twitches), O.SmN/sec. (differentiated 
twitches) and O.Ssec.(common to both).
-Fig. 6:4
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Figure 6:5
The log dose response curves to oxygen (Og), nitrogen 
(Ng) and air saturated NP solutions that were exposed to 20mVJ 
457nm laser light are shown. Each point is the mean value (+ 
S-E.) of 6-8 experiments. The size of each response is 
normalised to that produced by 5.10 M air saturated NP in 
order to compare the relative effects of altering the oxygen 
level.
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-2to 10 M at the three oxygen tensions. Each point is the 
averaged response (+ S.E.) for 6-8 experiments. The curves are 
normalised to the response recorded using 5mM NP in air
saturated solution for ease of comparison. The illumination 
conditions (20mW, 457,9nm) and flow rate (lOmls/min) were the 
same for each oxygen tension. The normal dose response curve 
(air saturated solutions) is shown by the filled circles and 
that obtained for Ng-saturated solutions by the open squares. 
The effect of reducing the oxygen tension is to produce an
upward and leftward shift in the dose response curve,
indicating that the efficacy of the perfusate is enhanced. 
This result is as expected if the physiologically active agent 
is nitric oxide. However, by the same reasoning, the high 
oxygen curve should be displaced to the right. Instead,
increasing the oxygen tension for iNPl's < 10~^M had little 
effect, as the dose response curve up to this point is
indistinguishable from the air saturated (normal) curve. As 
the [NP] is increased, the response in high oxygen becomes 
progressively smaller such that the twitch tension eventually 
recovers back to its control value at 10~^M. This results in
an unusual bell shaped leg dose response curve.
Evidence that Aq is not the physiologically active agent
The above results clearly argue against a
physiological role for Aq. This conclusion is based on the 
following lines of evidence.
First, where it was possible to measure [Aqj's 
directly (ie. at [NP]'s> 10 ^M), the results for a given [NP] 
were independent of the oxygen tension (see table 6:1), even 
though the inotropic responses obtained were very different.
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—  3Thus, for example at 10 M NP the peak twitch depressions for 
air, Ng-, and 0^~ saturated solutions were 63, 72 and 8 %
respectively. Although there was no significant difference in 
the measured [Aq] generated under these three conditions (see 
table 6:1).
These results also show that the efficiency of the
photolytic reaction is not oxygen dependent. In view of this, 
it is legitimate to estimate [Aq]'s for [NP]'s where it was 
not possible to measure them directly, as described in the 
previous chapter. These estimates can then be used to 
construct leg dose response curves for Aq, as shown in figure 
6:6(A). Superimposed upon this data are the [Aq] actually 
measured (filled tiangles fig.6:6(A)), which lie at the top 
end of each curve. Predictably however, the individual log
dose response curves do net superimpose but instead retain 
their separation. The most likely explanation for this is that 
while [Aq] is a useful indicator of the [NO] generated by the 
photolytic process, it does not provide a reliable estimate of 
the amount of free NO remaining in the solution. This instead, 
will vary directly with [Aq], but will also be inversely 
related to the oxygen tension ([O^l). 
ie. [NO]^ = K. [Aql/lOg]
If the physiological response is determined by the [NO] 
remaining in the solution, then re-plotting the size of the 
twitch depression as a function of [Aql/fOg] should bring the
data together into a single log dose response curve. Figure
6;6(B) shows the results of this analysis. There are two 
points to notice; First, the N^- and air-saturated curves 
(open squares & closed circles respectively) now exactly
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Figure 6:6
The amount of photodegredation of NP was estimated for 
the data in fig.6:5 using the Ag estimation procedure 
previously described. The resulting Aq log dose response 
curves are shown in panel A, along with measured Aq values. 
Note that the size of the twitch depression is not normalised 
in this graph and that the error bars are omitted for clarity. 
The shape and relative position of the curves are very similar 
to the NP dose response curves which suggest the differences 
are not due to varying amounts of Aq.
Panel B shows the same data as above divided by the 
relative oxygen concentration of each solution. This has the 
effect of bringing the nitrogen and air saturated curves onto 
a single curve, but the points for high oxygen at high Aq, all 
lie off this curve.
# -  air saturated 0.260 mM
O - oxygen saturated 0.920 mM
□  “ nitrogen saturated 0.074 mM
measured Aq values
—F ig. 6:6—
^ 100
80
cg(/)m 60 %_CLQ)TJ
1 40
O’
20
8 7 6
log Aqu a p .  conc. CM)
B
Cg
*cô(A0)i_Û.<D*D
%
100
80
60
40
20 Or
0
5 4 3 2 1 0
log Aqua/02
Chapter 6
superimpose. Secondly, for [NPj's < 10 the data obtained
using Og-saturated solutions lie along this same curve, 
whereas for [NPj's > 10 the response becomes almost
completely suppressed. This last point is especially 
significant, because it suggests that responses recorded under 
high Og conditions are not solely determined by the [NO]. 
Instead, it points to the production of another 
physiologically active product whose actions oppose those of 
NO and effectively protect the twitch. Presumably, this can 
only happen at relatively high [NPj’s and high 
oxygen tensions, but not in lower oxygen tensions (ie air or 
N^ saturated solutions)
This hypothesis can be understood by reference to 
figure 6:7. Here, the upper half of the diagram reproduces the 
dose response curves of fig.6:6(A), the lower half of the 
diagram shows the difference between the curves obtained using 
air and saturated solutions. This can be taken to
approximate to the leg dose response curve for the 
hypothetical antagonist, which increases in concentration from 
a threshold at 0.5 uM [Aq] to a maximum effect at arround 100 
uM [Aq]. These concentrations are equivalent to [Aq]/[02l 
molar ratios of 0.004 and 0.064 respectively.
More direct evidence showing that Aq is not the 
physiologically active substance formed during photolysis, 
comes from experiments in which preparations were perfused 
with synthetic Aq, kindly supplied by Dr A.R. Butler of the 
Chemistry Department. This was found to have no effect on the 
twitch, even when used at a concentration of 10~^ M. It will 
be recalled (see figs 5:7 & 5:8 ) that this concentration far
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Figure 6;7
The top half of this diagram is the same as that in
figure 6:6 (A) which shows the effects of different oxygen
levels on the Aq dose response curve. The bottom half shows
the difference curve between the air and oxgen saturated dose
response curves. The shape of this curve might suggest a dose
response curve for an agent which is produced in high oxygen,
is dependent on the Aq concentration and which antagonises the
nitric oxide reduction of the twitch. The concentration of
this agent is effective above Aq concentrations of 5 . 1 0 and
can totally antagonise the nitric oxide at concentrations
-4corresponding to 10 M Aq.
-Fig. 6:7-
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exceeds the values for the effect on peak tension (1000
x), on dP/dt (2500 x) and on TTP (240 x), so that we can 
safely assume that Ag is not involved in the inotropic 
response.
Evidence that neither nitrite nor nitrate ions are involved in
the inotropic response.
Nitrite (NO^ ,) and nitrate (NO^) are two important 
products of the secondary reactions which follow the primary 
photochemical process (see fig.6:1), Some consideration must 
therefore be given to the possibility that they contribute to 
the physiological response. The following evidence argues 
firmly against this;
First, the sense in which the responses are affected by 
changing the oxygen tension is contrary to what one would 
expect if either NO” or NO^ were involved. It will be recalled 
that lowering the oxygen tension inhibits, while raising it 
favours their formation. Thus if either of these ions were 
involved, the physiological responses should be enhanced in 
high oxygen and suppressed in low oxygen conditions, which.is 
the reverse of what is found experimentally. Secondly, 
experiments were performed in which preparations were directly 
exposed to different concentrations of NO” and N0“ . These 
showed that NO“is entirely ineffective, although NO^was found 
to have a negative inotropic effect at relatively high 
concentrations as illustrated by the log dose response curve 
of figure 6:8. The magnitude of the effect is small, producing 
a 25% depression at lOmM and with a threshold effect at lOOuM, 
It should be emphasised that these concentrations are greatly
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Figure 6:8
The depression of the twitch caused by various doses 
of nitrite is shown in the form of a log dose response curve. 
The concentration required to elicite a response ( 10"^M ) is 
too large to play a role in the negative inotropic action of 
photolysed NP.
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in excess of those which could be generated photolytically 
under the conditions of the experiments with NP.
Effect of agents which influence superoxide availability.
The results presented so far clearly favour nitric
oxide (NO) as being the product responsible for depressing the
twitch. This hypothesis was further tested by examining the
effect of agents which either stimulate or suppress superoxide
(Og) formation. Superoxide ions react rapidly with NO to form
nitrate. Thus the addition of agents which stimulate
superoxide production (eg. Fe^* ions) should inhibit
responses. The outcome is less predictable in the case of
substances which suppress superoxide levels (eg. superoxide
2+disrcutase or Cu ions). These will only enhance the effect of 
NP if significant basal superoxide levels are normally 
present, otherwise they should have no action. The following 
experiments were made using air saturated solutions of NP 
illuminated with 20mW light at 488nm,
24-Effect of Fe ions.Figure 6:9 (A,B) illustrate the effect cf
adding lOuM (A) and lOOuM (B) FeSO^ during responses elicited 
—3by 10 M NP. In both cases, the initial depression of the 
twitch is partially reversed by addition of Fe^^ ions. The 
'protective' effect of Fe^^was dose dependent in that the size 
of the reversal of the NP response was greater at lOOuM than 
at lOuM. Control experiments showed that Fe^^added to normal 
Ringer or unexposed NP had no effect on the twitch (see 
fig.6:9(B)) .
Effects of Cu^^ ions and SOD. The effects of adding Cu^^ or 
SOD tc the perfusate is illustrated in figures 6:9(C) and
-Page 6.9-
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Figure 6;9
Each panel shows a computer record of the depression 
in peak twitch tension produced by 10 NP perfusate exposed 
to 20mW 488nm laser light (NP). After the twitch tension had 
stabilised, the perfusate was changed to NP solution 
containing either lOuM (panel A) or lOOuM (panel B) ferrous 
sulphate (FeSO^), The ferrous ions increase the concentration 
of superoxide ions in solution which causes a partial reversal 
of the twitch depression. The effect of FeSO^ in normal ringer 
was also tested (panel B) which showed that it had no inherent 
inotropic action.
A decrease in the superoxide ion concentration was 
produced by adding copper sulphate (CuSC^) in a similar manner 
(panel C). This did not enhance the twitch depression as 
expected but had no effect or a small antagonistic effect on 
the twitch depression.
-Fig. 6:9-
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6:10(B). These agents would be expected to enhance the action 
of NP or else not affect it at all (see above). Paradoxically 
however, the responses were attenuated by. both. This is 
contrary to what was anticipated, although in both cases the 
effect was small. It may be significant that the protective 
action of Cu^^ appears to be dose related as lOOuM CuSO^ was 
more effective than lOuM. The reason for this unexpected 
effect is not known.
In summary, these results preclude a major role for 
superoxide ions in influencing the physiological responses to 
photolysed NP, at least when using air saturated solutions. 
However when the superoxide levels are increased by Ferrous 
ions, the responses are reduced. This result is consistent 
with the hypothesis that NO is responsible for depressing 
contractility. In retrospect,it would have been interesting to 
have investigated the significance of superoxide at low and 
high oxygen tensions, but this was not done.
Haemoglobin suppresses responses to photolysed NP.
The haem prosthetic group of haemoglobin ( and other 
haem containing proteins) reacts with NO to form 
nitrosyl-haemcglobin (Hb-NO). The reaction is extremely rapid 
and the product is stable under normal conditions (Antonini 
and Brunori, 1971). The absorption spectrum of haemoglobin is 
changed on binding NO, and this can be used as a means of 
identification. Furthermore, the unpaired electron associated 
with the bound NO renders Hb-NO paramagnetic, so that its 
formation can be confirmed by means of electron paramagnetic 
resonance(EPR) spectroscopy.
-Paqe 6.]0-
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Figure 6:10
Panel A shows the control depression of the twitch 
(50% reduction in the twitch) caused by 10”^M NP illuminated 
by 20mW 488nm laser light.
Panel B shows the same response in the presence of 30 
units of the enzyme superoxide dismutase (SOD). This enzyme 
catalyses the conversion of superoxide ions into hydrogen 
peroxide and so reduces the levels of O^ . SOD caused a slight 
reduction in the extent of the twitch depression (42% twitch 
reduction).
—Fig. 6:10—
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In the experiments described below, Hb is used as a 
direct means of 'scavenging' free NO generated by the 
photolytic process. The results will: show that the
physiological responses are attenuated by Hb in a dose 
dependent manner.
It was not practicable to identify Hb-NO formation 
under precisely the same conditions as were used for studying 
the physiological effects of Hb. EPR spectroscopy is 
relatively insensitive and greater concentrations cf both Hb 
and NP were required in order to generate adequate signals. 
However, Hb-NO production was detected in separate 
experiments, which in all other aspects exactly simulated the 
normal conditions.
ProtocolThe experiments neccessitated seme minor changes to 
the apparatus. There were two problems to overcome. First, Hb 
strongly absorbs light at wavelengths < 600nm; and secondly, 
Hb-NO can be made to phctodissociate, liberating free NO if 
exposed to strong light. Both problems were circumvented by 
keeping the NP and Hb solutions separate during photolysis, 
and only mixing them immediately prior to entering the muscle 
chamber. NP solutions flowed through the exposure tube (route 
A) and were exposed to 20mW of 488nm light in the usual way. 
Hb containing solutions were made to flow through a separate 
tube (route B) by-passing the exposure tube. The two routes 
were united through a T-junction, located close tc the exit of 
the exposure tube, which served as a mixing chamber for the 
two solutions. The flow rates through each route were 
carefully adjusted so that a 50:50 mixture was obtained. This
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was checked periodically by comparing the absorbances cf the 
chamber effluent and the initial (unmixed) solutions. 
Solutions of NP and Hb were made up at twice the required 
concentration to allow for dilution during mixing in the inlet 
tube to the muscle chamber.
Figure 6:11 (A,B&C) shows three responses to ImM NP
exposed to 20mW of light at 488nm. After allowing the twitch 
to stabilise, the perfusate in route B was switched from 
normal Ringer solution to Ringers solution containing Hb. 
Again the twitch was allowed to reach a new steady state 
before switching both perfusates to normal Ringers solution to 
allow the preparation to recover. These recordings show that 
the addition of Hb serves to diminish the NP response. The 
effect is clearly dose dependent, increasing with higher 
[Hb]'s until the effect of NP is completely suppressed in the 
presence of 2.5uM Hb (see fig.6:11(C)).
The results from a series of experiments similar to 
those illustrated in figure 6:11 are summarised in figure 
6:12. The filled circles show the peak twitch tension as a 
fraction of the control value in the presence of NP alone. The 
open circles show the steady state twitch tensions recorded in 
the presence of Hb and NP. Concentrations of Hb < O.luM have 
no effect on the response, but above this it becomes 
progressively reduced until complete recovery of the twitch is 
seen for [HbJ's > 2.5uM.
Spectroscopic identification of Hb-NO formation.
Hb avidly binds NO to form nitrosyl haemoglobin which
-Paqe 6.12-
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Figure 6;11
Each panel shows the depression of the peak twitch 
tension induced by 10 NP exposed to 20mW 488nm laser light.
After the response had stabilised, O.luM (panel A), l.OuM 
(panel B) or 2.5uM (panel C) haemoglobin (Hb) was added to the 
perfusate as described in the methods. Hb antagonises the 
negative inotropic effects of exposed NP in a dose dependent 
manner.
-Fig. 6:11-
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Figure 6;12
The size of the remaining twitch in 10 exposed NP
perfusate in the absence (closed dots) and presence (open 
dots) of varying concentrations of Hb, is expressed as a 
fraction of the control twitch and plotted against the Hb 
concentration. Increasing the Hb concentration above 10 
causes a dose dependent reversal of the twitch depression, 
until at concentrations higher than 2,5 uM it can totally 
reverse the effects of 10 NP.
-Fig. 6:12
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can be identified spectroscopically. The quantities of NP and 
Hb employed in the experiments described above were not 
sufficient to generate detectable EPR spectra and so the 
formation of Hb-NO was investigated in a separate series of 
experiments which were designed to simulate the conditions 
normally used.
Protocol All solutions were made up in Ng-flushed lOOmM 
phosphate buffer at pH 7,0. A solution of NP (SOmM) was made 
to flow through the exposure tube and illuminated with 2W 
laser light at 488nm, The high intensity of illumination was 
used to maximise NP photolysis. The exposed NP solution was 
then mixed with an equal volume of Hb (ImM) containing 
dithionite (DTN; 2mM). DTN was included to ensure that Hb was 
present in its deoxy form (see results). The resulting 
solution was allowed tc stand for 5min in a nitrogen 
atmosphere, and then diluted 10 fold with deoxygenated 
phosphate buffer. The final solution therefore contained Hb 
(50uM), exposed NP (2.5mM) and DTN (O.lmM), The absorption 
spectrum (350-750nm) was then recorded against 2,5mM NP 
without Hb as a blank, in a cecil dual-beam spectrophotometer 
interfaced to a BBC microcomputer. This procedure was repeated 
but this time NP was not exposed to light.
Standard samples of oxy- and nitrosyl-haemoglcbin were 
prepared for com.paritive purposes. Nitrosyl-Hb was synthesised 
in one of two ways; either by adding excess sodium nitrite to 
Hb containing DTN, or by bubbling Hb and DTN with NO gas. 
OxyEb was prepared by dissolving Hb in oxygen saturated 
phosphate buffer without the addition of DTN.
EPR spectroscopy was performed on a sample of the
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exposed NP and Hb, prepared as described above. Unphotolysed 
NP was first removed by putting the solution through a
Sephadex G-25 column under anaerobic conditions. The fraction 
containing Hb was collected and aliquots were frozen in thin 
quartz tubes. EPR spectra were then recorded at 17°K. 
Identification of nitrosylhaemoglobin by absorption
spectroscopy.Figure 6:13 (A,C&E) shows the form of the
absorption spectrum of deoxyHb. A and C are produced by Hb 
alone whereas E also contains unexpcsed NP, The dominant
feature is the single, broad maximum centred at 555nm. This
region of the spectrum changes in a characteristic manner on 
ligand binding: the single peak at 555nm splits into twc 
sharper peaks. This is illustrated in B and D, which shows the 
absorption spectrum of standard samples of oxyHb and Hb-NO 
respectively. The spectrum for exposed NP and Hb is shown in 
F. This bears a close resemblance to the standard Hb-NO 
spectrum (D) with the twin peaks occuring at the same 
wavelengths (545nm & 570nm). The separation between the peaks 
is less clear but this may be due to the presence of unbound 
Hb.
These changes are illustrated more clearly by 
computing the difference spectra for each of the ligands. 
These are shown in fig,6:14. The area of interest lies between 
500 and 600nm. The top two difference spectra are produced by 
subtracting the spectrum of Hb alone from oxyHb (B-A; top 
trace) and from Hb-NO (D-C; middle trace). The lower trace 
shows the difference between Hb and the product formed by 
mixing exposed NP and Hb (F-E).
The shapes of these difference spectra are similar, in
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Figure 6:13
Shown here are the absorption spectra from 430-750 nm 
wavelength (space between each dot is 20nm), for the solutions 
described below. All solutions made up in lOOmM phosphate 
buffer, pH 7.0.
A & C- 50uM deoxygenated Hb in 0.2mM dithionite (DTN) read 
against buffer.
B - SOuM oxygenated Hb read against buffer.
D - 50uM deoxygenated Hb, O.lmM DTN and ImM sodium nitrite
read against buffer.
E - 50uM deoxygenated Hb, O.lmM DTN and 2.5mM unexposed NP 
read against 2.5mM unexposed NP.
F - 50uN deoxygenated Hb, O.lmM DTN and 2.5mM NP that was
exposed to 200mW 488nm laser light in the exposure tube (flow
rate; 7mls/min) read against 2.5mM photoexposed NP.
Fig. 6:13-
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Figure 6;14
The difference in the preceding absorption spectra 
were calculated to show the change in the absorption spectra 
of Hb upon combining with oxygen (1), or nitric oxide (2 & 3).
Trace 1 - difference between oxygenated (HbO) and deoxygenated 
Hb ( B-A ; fig.6:13 )
Trace 2 - difference between standard NO-Hb and deoxygenated 
Hb ( D-C ; fig. 6:13)
Trace 3 - difference between NO-Hb produced by NP photolysis
and Hb ( F-E ; fig. 6:13). (N.b. this trace is at twice the 
gain of the other two)
-Fig. 6:14-
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that each comprises twc peaks on either side of a trough. 
However, there are subtle differences between them which are
of significance. The position of the first (left) maxima is 
located at 537nm for oxyHb, but at 533nm for Hb-NO and also 
for the mixture produced from exposed NP and Hb, The position 
of the minimum also differs, as it occurs at 557nro for oxyHb 
but at 555nm for the other two spectra. These minor 
differences between the maxima and minima for the two ligands 
agree with spectra published in the literature (Antonini and 
Brunori, 1971).
Further confirmation that Hb-NO is formed under the
experimental conditions used in this study comes from EPR 
spectroscopy. This method relies upon the single unpaired 
electron associated with NO which becomes bound to the haem 
group. Thus, both Hb and oxyHb which lack an unpaired electron 
are EPR 'silent'. Two EPR spectra are shown in figure 6:15; 
the lower one is taken from a paper by Trittelvitz, Sick and 
Gersonde (1972), which shows the EPR signal generated by Hb-NO 
at ph 5.1 at a temperature of 77 K, The upper spectrum is from 
the same sample of exposed NP and Hb that gave the absorption
spectrum F in fig,6:13. It closely resembles the lower
spectrum, showing very sharp 'hyperfine splitting', 
characteristic of the highly protonated (low pH) form of 
Hb-NO.
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Figure 6:15
Spectra A is the EPR spectra for the same solution 
that produced spectra F in figure 6:13. A sample of this 
solution was prepared for EPR spectroscopy as described in the 
methods and read at 17 K, scan lOOOG, midscan 3500G.
Spectra B shows the EPR spectra of NO-Hb as recorded 
by Trittelvitz, Sick & Gersonde (1972) at pH 5.1, 77 K, drawn 
on the same scale.
-Fig. 6:15-
100 G
chapter 6 
Discussion
Photolysis of NP results initially in the expulsion of
NO and the formation cf pentacyanoferrate, This event
initiates a complex reaction sequence that leads to the
formation of several ionic species, some of which have been
investigated as potential causative agents for the inotropic
effects of ’NP' on frog trabeculae. The results of these
experiments preclude a major role for NC~, N0~ and Aq, and
instead strongly implicate NO as being the physiologically
active agent formed during photolysis. The main evidence in
support of this claim is based on the observation that
substances which are known to react with NO, and therefore act
as NO scavengers, consistently depress responses to photolysed
NP. These include dissolved (molecular) oxygen (Og),
superoxide anions (o”) and haemoglobin. Under ’normal’ (air
saturated solutions) conditions, the most important endogenous
scavenger is O^. Thus, the use of nitrogen flushed solutions
to decrease the oxygen tension, greatly potentiates the
response. The value obtained using N^-saturated solutions
is approx. 10 fold smaller than that for air saturated
solutions (fig.6:5). In contrast, there is little evidence for
the involvement of superoxide in modulating the effects cf
'NP' at normal oxygen tensions, because neither Cu^^ions nor
SOD are able to potentiate responses. Indeed, both were found
to antagonise the effects of NP, if only to a small degree. On
2 4"the other hand, Fe ions which stimulate superoxide formation 
at normal oxygen tensions, significantly attenuate responses. 
This implies that superoxide could play a more significant
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role at very high oxygen tensions. This point is referred to 
again later.
The most important evidence in support cf an essential 
role for NO comes from experiments in which Hb was used as an 
exogenous scavenger for NO. The results from these are 
entirely consistent with the hypothesis that NO is directly 
responsible for the effects on the twitch, it will be recalled 
that different concentrations of Hb were added during the 
responses evoked by ImM NP exposed to 20mW laser light at 
488nm. This produced a dose related attenuation of the 
response, with a threshold effect at O.luM, which increased 
sigmoidally until it entirely reversed the effects of NP at 
concentrations greater than 2.5uM (fig,6:12). Since there are 
four haem groups per molecule of Hb (tetramer), and each haem 
group can react with a single molecule of NO, then these 
concentrations have the capacity to bind 0.4uM and lOuM NO 
respectively (Antonini and Brunori, 1971). Spectrophotometric 
measurements of Aq production under the conditions of these 
experiments (as an indication of NO production) returned a 
mean value of 12uM (n=5) which is in good agreement with the 
[Hb] required to completely suppress the response.
Spectroscopic measurements have shown that NO is 
liberated during photolysis and that it can bind to Hb under 
conditions which simulate as closely as possible the 
experiments referred to above. The product nitrosyl 
haemoglobin (Hb-NO) has a characteristic absorption spectrum 
which differs significantly from that of Hb. Deoxy-Hb has a 
single, broad absorbance peak with a maximum at 555nm, but on 
binding NO this splits into two,centred at 545nm and 575nm
-Page 6.17-
chapter 6
(Antonini and Brunori, 1971). The substance generated by 
mixing exposed NP with Hb has a spectrum which bears a close 
resemblance to this (cf, fig.6:13 (D & F)), although its
precise shape is not identical to standard Hb-NO. However, EPR 
spectroscopy of this same sample provided incontroversible 
evidence for the presence of Hb-NO. Neither Hb nor HbO contain 
an unpaired electron and are therefore EPR silent such that 
there can be no ambiguity resulting from contamination of the 
sample with either of these proteins. The EPR spectrum
actually obtained (fig.6:15, upper trace) is virtually 
identical to that obtained by Trittelviche, Sick and Gersonde 
(1972) (fig.6:15, lower trace). These authors studied the 
effect of pH on the EPR spectrum of HbNO at low temperatures. 
They found that lowering the pH exaggerates the hyperfine 
lines characteristic of HbNO. The spectrum obtained here was 
actually generated by a sample dissolved in lOOmM phosphate 
buffer at a nominal (room temperature) pH of 7.0. However,
Williams-Smith, Bray, Barber, Tsopanakis and Vincent (1977) 
have reported that rapid freezing of phosphate buffered
solutions for EPR spectroscopy causes a large decrease (2-3 pH 
units) of the apparent pH. There is little doubt that this 
situation is inadvertantly simulated here and that the EPR
spectrum obtained is the highly protonated form of Hb-NO.
There is other less direct evidence that lends support 
to the hypothesis that NO is responsible for the *NP* 
response. Under certain conditions, NO is a potent stimulator 
of guanylate cyclase (GC) the enzyme which catalyses the 
conversion of guanosine triphosphate (GTP) to cyclic guanosine 
monophosphate (cGMP) (Waldman and Murad, 1987) . Flitney,
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Moshiri and Singh (1980a,b) have demonstrated that the 
negative inotropic effect of NP on frog ventricular muscle is 
accompanied by substantial increases in intracellular cGMP 
levels. Until now, this was attributed to a direct effect of 
the NP anion, but the experiments in question were not 
conducted in complete darkness and the results of the present 
study make it virtually certain that some photolysis must have 
occured. Indeed, as has been emphasised throughout this study, 
when adequate care is taken to exclude light, NP has no 
physiological effect on frog ventricular muscle.
The situation is clearly very different for vascular 
smooth muscle cells. The smooth muscle relaxant action of NP 
and the other so-called *nitrovasodilators', such as glyceryl 
trinitate, amyl nitrate, hydroxylamine and azide, are not 
light dependent. Indeed with the exception of NP, all are 
photostable and it is common practice when using NP clinically 
to take care to ensure that it is not exposed to light, 
either before or during infusion. Nevertheless, all of those 
agents can cause smooth muscle relaxation; all can stimulate 
GC; and they all produce a rise in intracellular cGMP levels. 
There is clear evidence too that the production of free NO is 
a crucial step in their mechanism of action (Waldman and 
Murad, 1987). These considera-tions lead one to conclude that 
frog ventricular cells must lack the capacity to extract NO 
from NP, since they can only respond to NP if NO is first 
liberated photolytically. It is possible to be more specific 
about the difference between these two cell types, because the 
ability of smooth muscle to release NO appears to depend upon 
tissue thiol (SH) groups (Needleraan and Johnson, 1973) or
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direct interaction with the prosthetic haerc group of GC 
(Craven & DeRubertis, 1978). Part of the evidence for the 
latter agent is the observed reaction of Hb with NP to form 
NO-Hb, but this was not seen in these experiments, as intact 
NP did not react with Hb (craven & DeRubertis, 1978), 
Artefactual photolysis of NP may explain this observation, as 
then NO-Hb would be formed as shown here. These and some 
related questions, are considered in the following chapters.
Finally, some mention must be made of the paradoxical 
effects of high oxygen tensions on responses to [NP]*s > 10~^ 
M , referred to earlier. Most of the experimental data obtained 
by varying the oxygen tension could be made to fit on a single 
dose response curve by plotting the twitch depression as a 
function of the ratio [Aql/EO^], with the notable exception of 
that obtained at high [O^] (960uM) using [NP3*s >10~^M
(fig.6:6(B)). These concentrations led to a progressive 
diminution and eventually a complete suppression of the 
response to NP giving rise to an unusual bell-shaped dose 
response curve. Notice here that substantial twitch 
depressions were seen at corresponding (Aqj/lO^] ratios at 
oxygen tensions of 74 or 240uM. These observations suggest 
that the combination of high NO and O^ levels creates a 
fundamentally different environment which has a ’protective* 
effect on the twitch. One possibility to be considered is that 
high oxygen tensions generate greater superoxide levels. 
Qualitatively, the effect of this would be as seen, to
suppress the *NP* response. However, responses generated by 
[NP]<10 ^M should also be suppressed, but this was not so; 
these data lie on the same dose response curve as that
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obtained using air saturated solutions.
Another possibility is that one or more of the 
products generated by the reaction of NO with O^ (fig.6:1) 
acts via an independent cellular mechanism to produce a 
positive inotropic response. This would then serve to oppose 
the response normally evoked by NO. There is no direct 
evidence to support this view. No positive inotropic effect 
was recorded in any experiments with NO^ or NO^ nor incidently 
with synthetic Aq.
Experiments by Murad, Lewicki, Brandwein, Mittal &
Waldman (1981), concerned with the kinetics of GC activation
by NO, provide a clue as to what might be happening. These
authors showed that treatment of the isolated enzyme with NO
leads to activation at low concentrations but inhibition at
high concentrations. Their dose-response is therefore
bell-shaped. The activation of GC is known to depend
critically on its redox state and in particular, on conditions
which favour the retention of functionally important SH groups
and which also keep the haem iron in its ferrous state. A
highly oxidising environment will compromise these
requirements, by allowing the formation of disulphide bonds
between neighboring SH groups and the oxidation of Fe^^ to 
3*fFe , either or both of which would tend to suppress the 
enzyme. If the action of NO on frog trabeculae is mediated 
through GC, then such an environment could de-activate the 
enzyme and lead to a restoration of normal contractility. This 
is similar to the de-activation seen with isolated GC due to 
’overoxidation' (see Gen. Intro.).
CHAPTER 7
Preliminary investigations into the 
influence of thiols on the nitroprusside response.
and on the inotropic ability of synthetic 
nitrosothiols on frog ventricle.
Chapter 7
introduction
The previous chapters have shown that nitric oxide 
generated by photolysis of NP is responsible for its negative 
inotrcpic action on frog ventricle. The complete 
ineffectiveness of intact NP is surprising in view of its 
action on vascular smooth muscle. The liberation of NO is the 
neccessary intermediate step in the mechanism of action of NP. 
In smooth muscle this is thought to be mediated through 
intracellular thiols (primarily cysteine) which cleave the NO 
group off NP tc form short-lived S-nitroso-thiol 
intermediates. The nitrosothiol intermediates then yield the 
NO to the prosthetic haem group of guanylate cyclase, which
stimulates its activity (Ignarro et al, 1981; see gen. 
intro.). The inability of frog ventricle to 'denitrate' intact 
NP could be due to a lack of available thiol groups. The 
addition of cysteine to intact NP may therefore enable it to 
induce a negative inotropic response. It has been previously 
reported that NP + cysteine spontaneously form 
nitroso-cysteine which is known to be a potent activator of 
guanylate cyclase (Ignarrc et al, 1981), Thiols also have a 
potentiating effect on NO activation of GC, so that addition 
of cysteine to photolysed NP might also potentiate the
response. Preliminary experiments were conducted to 
investigate the role of cysteine in the inotropic efficacy of 
both intact and photolysed NP. The direct action of two
synthesised nitrosothiols was also investigated:
s-nitrosocysteine and s-nitoso-N-acetylpenicillamine,
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Methods
The procedures for recording tension from isolated 
frog ventricular trabeculae were as described previously. The 
perfusates were prepared as before, in complete darkness and 
illuminated by 20mW 488nm laser light during its passage 
through the exposure tube. The responses to three different 
solutions was tested; (i) cysteine alone, (ii) cysteine plus 
intact NP (unexposed) and (iii) cysteine plus photolysed NP.
The reponses tc two nitrosothiols were also tested;
nitrosocysteine or S-nitroso-N-acetyl-penicillamine.
Nitroso-cysteine was prepared according to Pryor, Church, 
Govindan & Crank (1982). Nitrogen dioxide (NO^) gas was added 
slowly to a solution of cysteine in ethanol or water, and the 
resulting green solution is separated off and air dried to 
give deep green crystals. Nitroso-N-acetylpenicillamine was 
similarly prepared by adding NaNC^, dissolved in water (IM), 
to N-acetyl-D-L-penicillamine (0.5M) dissolved in acidified 
methanol, the product being separated and crystalised as 
before (Field, Dilts, Ravichandran, Lenhert & Carnahan, 1978). 
The Nitroso-N-acetyl-penicillamine was used as it was more 
stable than nitrosocysteine. Each nitrosothiol was dissolved 
in ethanol, and diluted in Ringer just before application to 
the muscle (unless otherwise stated). In all cases an
appropriate ethanol 'blank' was tested to determine the
effects of the vehicle.
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Results
The results will show that cysteine,.NP + cysteine and 
the synthetic nitrosothiols (nitrosocysteine and
s-nitroso-acetylpenicillaraine) all affect twitch contractions. 
Nitrosocysteine and nitroso-acetylpenicillamine produced the 
most consistent effects; both were found to depress the 
twitch. The effects of cysteine whether tested alone or in 
combination with NP (intact or photolysed) were more variable 
and appeared to depend upon the previous history of the 
preparation.
Effects of cysteine alone
Cysteine (5mM) alone had a variable effect on the 
twitch, depending upon the time it was tested during the 
experiment. Some responses are shown in figure 7:1. Cysteine 
alone did not appreciably affect the twitch when it was 
applied at the start of the experiment (panel A). This was its 
most consistent action. However, later during the experiment, 
after the muscle had been allowed to recover from responses to 
either photolysed NP, or photolysed NP 4 cysteine or synthetic 
nitrosothiols, cysteine induced a large depression of the 
twitch (panel B). The effect was transient, showing 
spontaneous recovery, and its magnitude was found to depend 
upon the severity of the twitch depression elicited 
previously. This effect is illustrated by reference to panels 
B & C in figure 7:1. The response shown in panel B was larger 
(42% depression) than that in panel C (28% depression). The 
response in B was recorded after the preparation had recovered 
from a 70% depression induced by nitrosocysteine (see later)
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Figure 7:1
Panel A shows the effect of perfusing 5mM cysteine in 
normal Ringer at the start of an experiment. Cysteine has 
little effect on the size of the peak twitch tension (7% 
twitch reduction)
Panel B shows the same solution of cysteine (5mM) 
applied to the muscle at the end of the same experiment as in 
A. Here, cysteine causes a marked transient depression of the 
twitch (45% twitch reduction) that spontaneously recovers back 
to control levels. In between these applications, the muscle 
had been subjected to various negative inotropic agents (ie. 
photolysed NP, NO-thiols) but had fully recovered in normal 
Ringer before the second application of cysteine.
Panel C shows the effect of applying SmM cysteine to 
the muscle at the end of an experiment, which again caused a 
transient reduction in twitch tension (28%). After the twitch 
had spontaneously recovered, a second application of the same 
cysteine solution failed to elicite the same effect (only 7% 
twitch reduction).
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whereas c was after a 40% depression produced by 
nitroso-penicillaraine. Note that both cysteine responses show 
spontaneous recovery. The recovery rates are similar, with 
half times of 8mins (B) and 7mins (C). After recovery in 
normal Ringer, solution, a subsequent application of cysteine 
fails tc produce the same effect: in C, only a 7% reduction in 
peak tension, and again showing spontaneous recovery.
Responses to cysteine in the presence of intact NP
Intact (unexposed) NP does not affect the responses on 
fresh preparations. However, it was able to prevent or reverse 
the depression caused by cysteine applied at a later time in 
the experiment, after preparations had recovered from prior 
responses. Figure 7:2 shows the effect of applying NP (5roM) 
during a cysteine response. This was recorded after recovery 
in normal Ringers solution from prior exposure to photolysed 
NP. Cysteine produces a small reduction in twitch tension, as 
before. The addition of NP (prior to spontaneous recovery) 
accelerates the recovery process.
These observations would suggest that cysteine is not 
able to react with intact NP to release NO or to form 
nitrosocysteine, since either (or both together) would have 
produced a greater twitch depression (see later)
Effects of cysteine on responses to photolysed NP
Two kinds of experiment were performed. In the first, 
a response to photolysed NP was produced and sufficient time 
was allowed for the twitch tension to reach its new 
(depressed) steady state. The perfusate was then switched over 
to NP + 5mM cysteine. In the second, a control response to 
photolysed NP was recorded and the preparation allowed to
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Figure 7:2
The effect of intact nitroprusside in the presence of 
cysteine was tested on frog ventricular twitch tension. 
Cysteine (5mM) was added alone to the perfusate which caused a 
slight decrease in twitch tension (12%). The perfusate was 
then changed to a cysteine solution containing 5.10”^M intact 
NP, The twitch tension quickly recovered back to control 
levels in the presence of intact NP.
■Fig. 7:2-
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recover in normal Ringers solution before taking the effects
of cysteine + exposed NP into consideration. The results
obtained were essentially similar to the other protocol.
The effects of a standard (5mM) concentration were
found to depend upon the concentration of NP used. Figure 7:3
shows the responses produced at three different NP
— 5concentrations. At the lowest [NP] (10 M) the addition of
cysteine potentiated the response (A), increasing the extent
of the depression by a factor of approx. 2 fold (ie. from 12% 
-4to 24%). At 10 M NP (B) cysteine has the reverse effect: the
initial twitch depression was reduced from 45% to only 24%. 
-3With 10 NP (C), the recovery produced by cysteine was only 
transient: the depression was 53% initially, and temporarily 
recovered to 18%. However, continued perfusion caused a 
secondary depression to arround 45% of control. Figure 7:4
-3shows a response to 5. 10 M exposed NP, with and without
cysteine. In the presence of cysteine the depression was
reduced to 30%, as compared to 50% with NP alone.
The results of these experiments are summarised in
figure 7:5. The dose response curve to photolysed NP alone has
the expected sigmoidal shape, similar to that described
previously for NP solutions exposed to 20mW of 488nm laser
light ( Flitney & Kennovin, 1986). However, in th'e presence of
cysteine, the log dose response curve takes on a bell-shape:
at low [NPl's the responses are augmented, but they become
— 5progressively reduced at concentrations less than 2.5. 10 M
NP. The shape of this curve is reminiscent of that obtained 
using NP solutions at high oxygen tensions (see fig.6:5). The 
reason why cysteine has this dual effect is not clear and some
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Figure 7:3
This figure shows the effect of adding 5raM cysteine on 
the twitch depression produced by three different 
concentrations of NP exposed to 20mW 488nm laser light. The 
twitch depression induced by lower concentrations of 
photolysed NP are enhanced by the presence of cysteine (panel 
A) whereas it antagonises the response to higher NP 
concentrations (panel B & C). The reversal of the twitch
depression caused by the addition of cysteine to 10~^M 
photolysed NP is transient. This is not seen at lower NP 
concentrations.
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Figure 7:4
This figure shows the reduction in twitch tension 
— 3produced by 5.10 M NP exposed to 20mw 488nm laser light in 
the absence (A) and presence (B) of 5 mM cysteine. It is clear 
that the presence of cysteine markedly reduces the size of the 
twitch depression ( from 57% to 30% ).
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Figure 7:5
The log dose response curve to photolysed NP in the 
absence (closed circles) and presence (open circles) of 5mM 
cysteine are shown in this diagram. Each point represents the 
mean (+ SE.) of 3-5 experiments. The presence of cysteine 
markedly alters both the shape and position of the dose 
response curve.
-Fig. 7:5-
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possibilities are considered later.
Effects of synthetic nitrosothiols on twitch tension
Nitrosothiols have been implicated in the stimulation
of guanylate cyclase by NO and NP (Ignarro et al, 1981;
Waldman & Murad, 1987). The effects of two nitrosothiols,
nitrosocysteine and nitroso-N-acetyl-penicillamine, have
therefore been tested. Nitrosocysteine was prepared and
isolated in the crystalline form. It was then dissolved in
>ethanol before being diluted with Ringers solution to give a
— 3 —4final conentration of 10 or 10 M. The purity of the sample
used was not determined rigorously and so the concentrations
quoted are only nominal values. Figure 7:6 shows the effects
of 10 ^M (panel A) and 10 (panel B) of freshly prepared
nitrosocysteine. Panel Ç shows the effect of the same solution 
-3of 10 M nitrosocysteine, approximately Ihour after the 
response shown in figure panel B.
Freshly prepared nitrosocysteine has a profound 
negative inotropic response, reducing the twitch to 50% (A) or 
10% (B) of its control value. The effect is rapid in onset, 
being essentially complete in Sminutes. The same solution of 
nitrosocysteine as was used for the response illustrated in 
panel B, was applied again 1 hour later, when it was still 
effective, producing a 70% reduction of the twitch in approx. 
2,5 mins. The last response (panel C) had to be curtailed as 
the volume of perfusate available was limited. The ethanol 
vehicle, tested without nitrosocysteine at the appropriate 
concentration has a negligible effect on the twitch (second 
response in panel B). The effects of nitrosocysteine were 
readily reversible on re-perfusing preparations with normal
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Figure 7:6
This figure shows the effect of 10 (panel A) and
-310 M (panel B) preprepared nitroso-cysteine on the peak 
twitch tension of a frog trabeculum. This nitrosothiol has a 
strong negative inotrcpic action on frog ventricle, reducing 
the twitch to 44% (panel A) and 86% (panel B) respectively. 
Panel C shows that a subsequent application, 1 hour later of 
the same solution as in panel B, still produces a large twitch 
depression (70%). The effects of ethanol which is used as a 
solvent for the NO-cysteine, has a small but negligible effect 
on the twitch tension (panel B).
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Ringers solution.
The apparent stability of nitrosocysteine in solution, 
as judged by its ability tc significantly depress the twitch 
even after Ihr is puzzling. Nitrosocysteine is relatively 
unstable in solution with a half life of under lOmins (craven 
& DeRubertis, 1983). Retention of the ability to suppress the 
twitch may therefore mean that NO liberation could be 
responsible for its effects. This last possibility has not 
been tested. The question might be answered by studying the 
reponses in the presence and absence of oxygen or haemoglobin.
Responses elicited by nitrosopenicillamine are 
illustrated in figure 7:7. This compound is relatively stable 
in solution. The parent compound, acetylpenicillamine, was 
also tested. This was found to have a significant depressent
effect, but like that produced by cysteine, it was more
effective on preparations that had already been subjected to 
earlier treatments and did not significantly affect fresh
preparations. However, the nitroso derivative had a powerful 
negative inotropic effect. Figure 7:7 (B) shows that 50uM
nitroso-acetylpenicillamine produced a 41% depression of the 
twitch. The effect like that of nitrosocysteine, was fully
reversible on perfusing the preparation with normal Ringers 
solution. There was insufficient material available to allow 
an adequate study of the relative efficacies of 
nitrosocysteine and nitroso-acetylpenicillamine.
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Figure 7:7
Panel A shows the effect of O.lmM acetylpenicillamine 
alone, which was applied at the end of an experiment and has a 
similar action to cysteine in reducing twitch tension. The 
depression of the twitch does not however spontaneously 
recover in acetylpenicillamine solution.
Panel B shows the effect of 5.10
nitroso-acetyl-penicillamine (NOaP) on the frog ventricular 
peak twitch tension. Even at this low concentration, NOaP 
markedly reduces the twitch tension (41% twitch reduction).
Fig. 7:7-
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Discussion
The results described here show that cysteine alone 
does not affect the twitch contraction of trabeculae that have 
not previously been subjected to drug treatment. After 
procedures which depress the twitch, cysteine can then evoke a 
transient reduction in peak twitch tension, the size of which 
appears to be related to the extent of the depression caused 
by prior drug treatment. This suggests that the inotropic 
ability of cysteine is more dependent upon the legacy from 
previous responses than upon any inherent capacity to alter 
the twitch. There can be little doubt that the ultimate site 
of action of NP, and presumably the other synthetic 
nitrosothiols too, is on the enzyme guanylate cyclase and this 
raises the possibility that prior exposure to agents which 
depress the twitch may leave the enzyme in a refractory 
condition. It has been suggested that the nitrovasodilators 
mediate their effects on vascular smooth muscle by oxidising 
thiol groups to disulphides (Needleraan, Jaschik & Johnson, 
1973). The activity of purified GC in vitro has also been 
shown to be markedly affected by the availability of SH groups 
(Waldman, Rapoport & Murad, 1987). This may also be true of 
the GC in frog ventricular cells, since the evidence of the 
present study suggests that NP acts through NO activation of 
GC. If we assume that this is so, then treatment with 
photolysed NP could result in the conversion of some SH groups 
to disulphides, causing activation of the enzyme and 
consequent depression of the twitch. There would then be fewer 
SH groups free to respond to another NP challenge. This is
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thought to be the basis of the tolerance shown by vascular 
smooth muscle to repeated exposure to the nitrovasodilators 
(Needleman & Johnson, 1973). This has recently been shown to 
occur at the level of the purified GC enzyme (Waldman, 
Rapoport & Murad, 1987). Cysteine is a potent sulphydryl 
reducing agent, able to re-convert disulphide bridges back to 
free thiols- This could lead to stimulation of basal enzyme 
activity, similar to that seen following treatment of crude 
arterial supernatants with dithiothreitol(DTT). In fact DTT 
has been reported to activate, to have no effect on, or else 
to inhibit crudely purified GC, depending upon whether the GC 
is initially in the oxidised, in a 'ground state* or is 
reduced, respectively {Waldman & Murad, 1987). If the 
guanylate cyclase in 'fresh' trabeculae were in a 'ground' 
oxidation state then cysteine would not affect the basal rate, 
and so would not alter twitch tension. Following oxidation 
(and activation) of the enzyme (eg. by photolysed NP or by 
nitrosothiols), the enzyme would remain in the oxidised state, 
such that subsequent reduction by cysteine could then cause 
re-activation. It may seem strange that oxidised enzyme does 
not remain activated but this has been shown to be the case 
with purified guanylate cyclase (Braughler, Mittal & Murad, 
1979). Brandwien & Murad (1983) showed that the activity of GC 
following stimulation with nitric oxide decayed with time, 
despite the continued presence of nitric oxide throughout. The 
rate of decrease was found to be temperature dependent and 
could be prevented by addition of DTT to the incubation 
medium. Once the activity had spontaneously decreased to basal 
rate, the addition of DTT increased the activity back to its
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maximal level (Brandwien & Murad, 1983).
These considerations suggest that the variable 
inotropic actions of cysteine may be a consequence of the 
oxidisation state of guanylate cyclase. This could account for 
the spontaneous recovery of the twitch in the presence of 
cysteine, because the enzyme would become progressively more 
reduced back to its neutral 'ground' state. Further 
applications of cysteine would then be ineffective which is in 
agreement with the observed results.
The lack of an effect of unphotolysed nitroprusside in 
the presence of cysteine suggests that cysteine is unable to 
cleave the nitrosyl moiety, contrary to previous reports 
(Ignarro et al, 1981). The reported formation of 
nitrosocysteine under similar conditions may be an artefact, 
caused by the release of NO through photolysis, which then 
combines with cysteine (Ignarro et al, 1981). Other authors 
agree that mixtures of NP and cysteine at pH 7.6 do not form 
nitrosocysteine (Craven & DeRubertis, 1983). Cysteine and/or 
other thiols may normally be present in frog ventricle but 
they do not seem to be involved in nitroprusside cleavage. 
Whether this is true for other nitrovasodilators is not known. 
The more permeant GTN, for instance may elicit an effect on 
frog ventricle due to degradation by intracellular thiols, but 
further investigation is required.
The effects of photolysed NP are markedly modified by 
the addition of cysteine. The free nitric oxide produced by 
photolysis of NP would be expected to react with cysteine in 
solution to form nitrosocysteine. This is in agreement with 
the reported ability of cysteine to react with either free
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nitric oxide or photolysed NP to form nitrosocysteine (Pryor, 
Church, Govindan & Crank, 1982; Ignarro et al, 1981). since 
nitrosocysteine is reported to be more potent at stimulating 
guanylate cyclase than free nitric oxide, it was anticipated 
that cysteine would potentiate responses to photolysed 
nitroprusside (Ignarro & Greutter, 1980). The direct reducing 
action of cysteine should assist in this action, as reducing 
agents have been shown to potentiate the activation of crude 
and purified soluble guanylate cyclase by nitrovasodilators 
and by nitric oxide (Kimura, Mittal & Murad, 1975). A 
potentiating effect was seen for lower concentrations of 
nitroprusside. Concentrations of NP which were too weak to 
elicit a response alone, markedly reduced the twitch in the 
presence of cysteine. Above concentrations of 2.5 10~^M NP 
however, cysteine antagonised the response, and the extent of 
this effect increased with increasing NP concentrations. 
Instead of shifting the NP dose response curve leftward and 
upward, cysteine changed the shape of the curve, from its 
normal sigmoidal to a bell shape. The reason for this is not 
clear, as any effect of cysteine on free nitric oxide (i.e. 
scavenging NO to form NO-cysteine and so impeding its 
diffusion into the cell) could occur throughout the range of 
nitroprusside concentrations and so would not explain the 
change in shape of the dose response curve. The similarity of 
this curve to that obtained at high oxygen tensions might 
suggest a similar mechanism of action. It was postulated that 
the latter could be due to the combined effects of a high 
oxidising environment, created by using oxygen saturated 
Ringer, together with high nitric oxide concentrations, to
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’overoxidise' guanylate cyclase and result in decreased
activity. The reducing environment produced by cysteine could 
have similar effects in moving the redox state of the enzyme 
away from its optimal value. It has been shown that cysteine 
and DTT reduce the activity of guanylate cyclase (activated by 
the oxidant dehydroascorbic acid) in both intact cells and 
broken cell homogenates by a factor of 2 (Haddox, Stephenson, 
Moser, Goldberg, 1978). The reason why increasing the oxidant 
(ie. nitric oxide) concentration while keeping that of the
reductant (ie. cysteine) constant, decreases the activity of 
the enzyme is unclear." The postulated role of different
critical sulphydryl groups being responsible for different 
aspects of the enzyme activation (ie. basal activity, nitric 
oxide activation, oxygen inactivation etc) and the suggestion 
that each is separately susceptible to various oxidising and 
reducing agents, gives some idea of the complexity of the 
regulation of guanylate cyclase by redox agents (Waldman & 
Murad, 1987). Another complication is that most of these
studies are performed on the isolated enzyme which could be in 
different redox states depending on the isolation procedures 
used, the previous oxidation state in the tissue, and the 
particular environment of the enzyme incubation. For these 
reasons it is hard to draw any conclusions about the in vivo 
situation from in vitro studies.
Preprepared nitrosocysteine was shown to be a potent 
negative inotropic agent that quickly depresses the twitch 
(90% in under 5min). This may be due to the relatively high 
concentration of nitrosothiol used ( ImM ) which is 
approximately 20 times greater than that which could be
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produced by reacting cysteine with the highest concentration 
cf photolysed NP used in these experiments. Nitrosocysteine is 
a very unstable compound which decomposes even in the 
crystalline state and has been shown to rapidly decompose in
solution of pH 7.6 with a half life of 10 minutes (Craven &
DeRubertis, 1973). It was thought therefore that 
nitrosocysteine would lose some of its potency with time, but 
this was not the case, as even after an hour the same solution 
of nitosocysteine could elicit an equivalent depression of the 
twitch. Indeed, the later application appeared to depress the 
twitch at a faster rate than the initial one. This raises the 
question whether the intact nitrosocysteine molecule is
responsible for these effects or whether they are due instead 
to one of its decomposition products. Since decomposition of 
NO-cysteine would liberate nitric oxide then this could
directly reduce the twitch. Previous studies have reported 
that a solution of fully decomposed nitrosocysteine is equally 
as effective as a freshly prepared one at stimulating 
guanylate cyclase activity (Craven & DeRubertis, 1983). 
Evidence that nitroso-acetyl-penicillamine which is more 
stable than NO-cysteine, still elicits a negative inotropic 
response suggests that intact nitrosothiols are effective at 
stimulating GC. Whether nitroso-acetyl-penicillamine is as 
effective as NO-cysteine cannot be ascertained at the present 
time, but it would seem that both intact or decomposed 
nitrosothiols may be potent negative inotropic agents.
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The effects of photolysed and intact nitroprusside on 
mammalian vascular smooth muscle.
Chapter 8
Introduction
The preceding chapters have shown that the action of 
NP on frog ventricle is dependent on prior photolysis of the 
molecule to release nitric oxide. As NP is used clinically 
as a vasodilator,it seemed appropriate to investigate whether 
this mechanism played a role in its effects on vascular 
smooth muscle. Numerous studies have shown that NP elicits 
a strong relaxant effect on precontrated isolated smooth 
muscle preparations, but little if any have appreciated the 
photosensitivity of the drug. If NP was not protected from 
light in these studies then little is known about whether 
photolysis has a role in eliciting the drug action in smooth 
muscle. When intravenously infused into whole animals, 
including man, photolysis of NP in the infusion bottle could 
affect the drug action. Indeed prior photolysis has been 
suggested to be responsible for the release of cyanide upon 
infusion into whole animals (Bisset, Butler, & Glidewell, 
1981). As has already been said, NP along with the other 
nitrovasodilators are postulated to act through release of 
nitric oxide to form nitric oxide containing intermediates. 
This is thought to involve thiols, especially cysteine, 
associated with the smooth muscle, which cleave the NO off 
the parent molecule. Some groups have erroneously postulated 
that NP spontaneously forms nitrosocysteine in the presence 
of cystiene, but this can be attributed to photolytic 
release of nitric oxide which then reacts with the thiol 
(Ignarro et al, 1981; Craven & DeRubertis, 1978). Another
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group aware of the photosensitivity of NP, have shown that 
the nitrosyl group is cleaved off NP in the dark by arterial 
soluble fraction (Leewenkamp et al, 1981). Since it is the 
liberation of NO that is responsible for the drug action, 
then this would suggest that intact NP can elicit an effect 
on smooth muscle, although photolytic liberation of NO may 
potentiate this effect.
The experiments about to be described investigated 
whether prior photolysis of NP affects the relaxant response 
in vascular smooth muscle. As was expected, the results show 
that photolysis augments the relaxant effect which lends 
further evidence to the hypothesis that release of the 
nitric oxide is involved in mediating smooth muscle 
relaxation.
Page 8.2-
chapter 8
Methods
Dissection; Experiments were made using small strips of 
isolated rabbit ear artery. A length of artery (2-3 cm) was 
dissected from the dorsal surface of a rabbit's ear and 
placed in a dissection dish filled with Kreb's solution 
(composition (raM): NaCl, 118; KCl, 4.7; NaHCO^, 25; NaH^PO^, 
1.15 ;CaCl^ .5;NgCl2, 1.13; glucose, 5.6; bubbled with 95% 
02:5% CO2 ; pH 7.4). A segment of artery was cut out, rolled 
and snared with tungsten wire loops, such that the smooth 
muscle fibres were orientated in the direction of motion of 
the force transducer (fig. 8:1). This arrangement ensured 
that the luminal surface of the artery was exposed directly 
to the bathing solution. In some experiments a more 
sensitive force transducer was employed which allowed small 
strips of unrolled artery to be used.
Arterial strips were mounted in the apparatus and 
left to equilibrate for 1-2 hrs in Kreb's solution. The 
optimum length for contractures was then established as 
follows. Isometric contractures were elicited by exposing 
preparations to 5uM phenylephrine (PE), a relatively stable 
asagonist. This was repeated several times, increasing the 
length of the preparation (0.1 mm increments) between 
successive contractures, until the maximum contracture 
tension was obtained (fig. 8:2). Preparations set up in this 
way performed consistently throughout the experiments, as 
can be judged from the last two contractures (see fig 8:2, 
4&5), taken at the begining and at the end of an experiment.
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Figure 8:1
This diagram shows the dissection of the rabbit ear 
arterial preparation. A small segment of isolated rabbit ear 
artery is cut away as shown (A). A longitudinal incision is 
made along one side (B) and the artery opened out to form a 
flat sheet of tissue <C). This is then rolled in a direction 
90“ to the original curvature (D) and snared in the 
tungsten wire loops of the muscle holders (E). This 
procedure ensures that the long axis of the smooth muscle 
fibres (indicated by the arrowed lines) is parallel to the 
direction of motion of the force transducer.
■Fig. 8:1-
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Figure 8:2
This diagram shows a tracing from an original chart 
recording illustrating the procedure used to standardise the 
length of the muscle. The preparation was stretched by 0.1mm 
(large arrows) between successive contractures elicited by a 
standard dose ( 5 uM) of phenylephrine (downward arrows), 
until the size of the contracture was maximal. The 
contracture then remained constant throughout the duration 
of the experiment, as demonstrated by the last two 
contractures on the right, as the far right one was recorded 
at the end of the experiment.
-Fig. 8:2-
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Apparatus: Contractions were elicited by exposing
preparations to PE, instead of using electrical stimulation 
as in the experiments with forg trabeculae. This required a 
minimum of two inlet routes to the muscle chamber: route A, 
the normal one incorporating the exposure tube; and a second 
route B, in which solutions were made to flow through a 
parallel tube, optically isolated from, but close to, the 
exposure tube (fig. 8:3). Solutions passing through the 
exposure tube (route A) were selected in the usual way by
means of the six-way tap. Kreb's solution flowed
continuously through route B. Each tube was connected to one 
inlet of a two-way constant flow tap (T). This permitted 
only one of the two solutions to reach the muscle chamber, 
while the other flowed to waste. The flow rate through each 
route was adjusted to be the same (lOmls/min.), The combined 
volume of the muscle chamber and its inlet pipe was kept 
small (0.1ml) to allow rapid solution changes and to
minimise 'dead space' effects. Standard contractures were
elicited by switching from normal Kreb's solution (route B) 
to Kreb's solution containing PE (route A; through exposure 
tube). The duration of each contracture was determined 
either manually, or by using a microcomputer which operated 
a mechanical drive to the two-way tap.
All solutions were prepared and kept in the dark 
prior to use, unless stated otherwise.
It was necessary to maintain the preparation at 35“c 
throughout the experiment. This was acheived by means of a 
heat exchanger system (fig.8:3). A peristaltic pump (P) was
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Figure 8:3
Apparatus used to maintain the temperature of the solution 
at 35°C
C - heat exchange coil (in cross section to show pipes 
within)
Ex - exposure tube (route A)
PT - perfusate tube (route B)
T “ motorised two-way constant flow tap
WJ - water jacket arround muscle chamber
P - peristaltic pump to circulate warm water
-Fig. 8:3-
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made to circulate warm water through a coil (C), wrapped 
tightly arround the inlet tubes, and then on through a water 
jacket (WJ) surrounding the muscle chamber. The preparation 
was maintained at the required temperature (+ 1°C) by
careful adjustment of the temperature of the fluid entering 
the coil; the rate of circulation of water through the coil; 
and the flow rate of experimental solutions through the 
muscle chamber.
Experimental Protocol; Two types of experiments were 
performed.
Type 1 experiments: ability of NP to attenuate PE
contractures.
Two procedures were used;
A. Responses to different concentrations of PE were recorded 
and the results obtained used to construct a 'standard* dose 
response curve. The experiment was then repeated but with PE 
solutions containing 5uM NP that had been either kept in the 
dark, or else subjected to photolysis by; (i). pre-exposing 
solutions to ’white* light, as described in chapter 3, or 
(ii). illuminating solutions in the exposure tube, * en 
route* to the muscle chamber, with 20mW laser light at a 
wavelength of 457.9nm.
B. Groups of three contractures were elicited as follows: 
the first, to luM PE alone; the second, to luM PE + 
protected NP; and the third, to luM PE + laser exposed 
(20mw;457.9nm) NP. The concentration of NP used (range: 
25nM-500uM) was changed between each set of three
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contractures.
Type II experiments; The ability of NP to relax 
pre-contracted arterial strips.
The abiltiy of protected NP and of laser photolysed 
NP (20mW, 457.9nm) to cause relaxation of pre-contracted
arterial strips was studied. Again, two procedures were 
used;
A. PE contractures were evoked in the usual way. When the 
steady plateau of tension had been reached (generally, 
l~2min.) the perfusate was switched from PE alone to PE + 
5uM unexposed NP (route A). After l-2min. the laser was 
switched on for a period of l-2min. It was then switched 
off so that the preparation was once again perfused with PE 
+ unexposed NP. Then, generally 4-5min. later, the perfusate 
was switched to normal Kreb's solution (route B) and the 
preparation allowed to relax.
B. Here, the relaxant effect of different concentrations of 
NP (range; lnm-25uM) was tested on preparations 
precontracted with a standard dose (luM) of PE. The 
efficiency of unexposed and laser photolysed NP was then 
compared.
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Results
The results of these experiments show that NP is 
able to attenuate contractures to PE and that it can also 
cause relaxation of pre-contracted preparations. In both 
cases, its efficacy is potentiated by photolysis.
The ability of NP to attenuate PE contractures
Type  lA experiments; Effects of a fixed dose (5uM) of NP on
PE contractures.Figure 8;4 shows a series of superimposed 
contractures produced by PE alone (top traces), PE+5uM 
protected NP (middle traces) and PE+5uM pre-exposed ('white* 
light) NP (bottom traces). The concentrations of PE used are 
given beneath each set of contractures.
These recordings show that both intact and 
photolysed NP can depress PE contractures. The results of 5 
similar experiments are summarised in the dose response 
curves of figure 8;5. The peak tension generated is here 
expressed as a percentage of the maximum produced by PE 
alone (open squares). There are two points to note. First,
intact NP causes the dose response curve to be displaced to 
the right (filled circles) shifting the ED^^ value for PE 
from 0.73uM to 2.0uM. Secondly, pre-exposing NP solution to 
white light significantly enhances its depressant effect, 
causing the dose response curve to be shifted even further 
to the right (open circles) such that the ED^^ value is now 
increased from 0.73uM to 3.3uM, Quantitatively, photolysis 
of NP under the experimental conditions used here increased 
its potency by (3.3/2.0 =) 1.65 fold.
The potentiating effect of photolysis is |
significantly greater when NP solutions are exposed to laser j
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Figure 8:4
Contractures produced by phenylephrine in the 
presence of 5 uM unexposed NP (middle traces), or 5uM 
photolysed NP by pre-exposure to white light (bottom 
traces), are shown superimposed on the control contracture 
to PE alone (top traces). The concentration of PE used is 
shown below each set of contractures.
-Fig. 8:4-
2min
0.5mN
2.5 10 -6
PÊ conc.
chapter 8
Figure 8:5
Plotted here are the log dose response curves to PE
alone (white squares) in the presence of 5uMand
nitroprusside that was either protected from (black dots) or 
photolysed by (white dots) exposure 
point is the mean value from experiments (+ standard
error)
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light en route to the muscle chamber. Figure 8:6 shows a 
series of contractures to PE alone (upper traces), PE 
containing 5uM protected NP (middle traces) and to PE 
containing 5uM laser exposed NP (bottom traces). Except for 
the illumination conditions, these recordings can be 
compared directly to those shown in figure 8:4. Again, it is 
clear that protected NP depresses PE contractures. The 
effect is more pronounced at the lower PE concentrations. 
However; notice that the depression caused by laser 
photolysis is significantly greater than that seen with 
solutions pre-exposed to white light. This is illustrated by 
comparing the contractures produced by 0.25uM PE as 
preparations were able to generate an appreciable force in 
the presence of solutions pre-exposed to white light, but 
laser photolysis abolished the contracture completely. This 
point is taken up again later.
Type IB experiments: Effect of different concentrations of 
NP on contractures evoked by a constant dose (luM) of 
PE.Figure 8:7 shows two sets of paired contractures, 
elicited by luM PE alone and luM PE in the presence of 
differing concentrations of NP (range: 5, 10~^- 10 ^N). The 
upper row demonstrate the effect of intact NP and the lower . 
row the effect of NP pre-exposed to white light.
There are two points to emphasise concerning these 
data. First, the attenuation of the PE contracture increases 
with increasing NP concentrations. This is true for both 
intact and photolysed NP. Secondly, the degree of the 
depression of the contracture is invariably greater after
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Figure 8:6
Contractures to various conentrations of 
phenylephrine in the presence of nitroprusside that was 
either unexposed (middle traces) or photolysed by 20mW 457nm 
laser light (bottom traces) are shown superimposed on the 
preceding control contracture to PE alone (top traces).
■Fig. 8:6-
2min
0.5mN
2.5 1 0 - 6
PE conc.
Chapter 8
Figure 8;7
This diagram shows the antagonism produced by 
various doses of nitroprusside on contractures produced by 
10 phenylephrine. The PE contractures produced in the
presence of intact (upper panel) and photolysed (by white 
light;lower panel) NP are shown superimposed on the 
preceding control contracture to PE alone (top traces). The 
nitroprusside concentration used is shown above each group 
of contractures.
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Figure 8:8
The antagonistic log dose response curves for 
nitroprusside, that was either completely protected from 
light (closed circles) or prexposed to white light (open 
circles), on the contracture produced by luM phenylephrine 
are shown.
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photolysis,
The accumulated results from 9 experiments of this 
type are plotted in figure 8:8. Here, the maximum
contracture tensions recorded in the presence of protected 
(filled circles) and pre-exposed (open circles) NP are 
expressed as a percentage of those obtained with PE alone. 
There is little difference between the two sets of data for 
[NP]'s < luM. However, above luM the curves diverge and the 
contracture tension falls steeply following exposure of NP
to white light. The concentrations required to produce a 50% 
reduction in contracture tension are 5.4uM for pre-exposed 
NP, as compared with 20.3uM for intact NP.
Relaxant effects of NP on pre-contracted arterial strips 
Type 2A experiments: Effects of a fixed dose of NP (SuM) on 
strips precontracted with PE. The ability of protected and 
laser exposed NP to relax pre-contracted preparations was 
studied. Figure 8:9 shows three recordings which illustrate 
the experimental procedure. The upper line shows the pattern 
of solution changes. Arterial strips were first contracted
by perfusing them with Kreb's solution containing PE alone.
The perfusing solution was then changed during the plateau 
phase of the contracture, to one containing the same
concentration of PE plus 5uM protected NP. This caused
preparations to slowly relax to a new steady level of
tension. The laser was then switched on for approximately 
Iminute (horizontal bars). The effect was immediate; 
photolysis of NP resulted in a dramatic, fast relaxation, 
causing the tension to fall to a much lower steady state
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Figure 8:9
Preparations were precontracted by various 
concentrations of phenylephrine and then perfused with 
protected nitroprusside. This causes the preparation to 
relax. After the force had reached its new steady level, the 
perfusate was illuminated by 20mw 457nm laser light. This 
causes an increase in the extent of relaxation. The 
changeover of solutions is shown by deflections of the line 
in the top panel and the duration of illumination depicted 
by the thicker horizontal bar. The superimposed individual
contractures(on the right) are similar to those in figure 
~58:8 for 10 M PE, plotted on the same timescale, to show the 
similar effects of NP using the two different methods.
-Fig. 8:9-
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level. The magnitude of the 'extra' relaxation upon 
photolysis varied inversely with the PE concentration; thus, 
at 0.5uM PE, the contracture is virtually abolished during 
the period of illumination, while at lOuM PE, the force 
stabilises at about 75% of its initial (PE alone) control 
value. The recovery of tension, when illumination ceases, is 
equally dramatic. When the laser is switched off, the 
contrature tension increases rapidly, rising to the value 
seen on perfusing the preparation with protected NP.
It was found that results obtained using this 
procedure were identical to those obtained earlier, in the
type lA experiments when NP solutions were exposed to laser 
(but not white) light. This is illustrated by comparing the 
third contracture of figure 8:9 with the fifth group of 
three superimposed contractures shown earlier in figure 8:6. 
The latter group is reproduced to the right of figure 8:9, 
after making allowance for the different sizes of the two 
preparations by scaling the peak contracture tensions in PE 
alone to the same value. Notice also that the same 
concentrations of NP (SuM) and of PE (lOuM) were used and
that the illumination conditions were identical 
(20raW;457.9nm). The horizontal dotted lines in figure 8:9
clearly show that the relaxation of pre-contracted strips 
causes the contracture tension to fall to the same level as 
that developed by evoking separate contractures in the
presence of intact and laser photolysed NP.
The accumulated data from both kinds of experiment 
are plotted together in figure 8:10. The 'developed' and 
'relaxed' contracture tensions are all normalised to the
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Figure 8;10
The log dose response curve to phenylephrine (white 
squares), is shown in the presence of 5.10~^M nitroprusside 
that was either completely protected from, (closed circles), 
or exposed to, (open circles), 20mW 457nm laser 
illumination. Each point shows the mean and standard error 
of 5-8 experiments.
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peak values seen with PE alone. The dose response curve to 
PE (open squares) is slightly shifted to the right with 5uM 
protected NP (filled circles). The ED^^value is increased 
from 0.36uM to 0.55uM, a factor of 1.5 fold. This is 
qualitatively similar to the displacement seen in a 
different series of experiments depicted in figure 8:5, 
although it is somewhat smaller. The most significant 
features of figure 8:10 are the large rightward shift of the 
dose response curve and the marked reduction in maximum 
contracture tensions caused by laser photolysis of NP (open 
circles). The value for PE increases from 0.36uM to
1.7uM, a factor of 4.7 fold, and the maximum contracture 
tension is reduced to 78% of that obtained with PE alone.
Response of arterial strips to combined type 1 & 2
procedures
Figure 8:11 shows representative recordings from an 
experiment in which contractures to luM PE were allowed to 
develop in the presence of different concentrations of NP, 
initially protected from light and later, at the peak of the 
contracture, exposed to laser light (20mW; 457.9nm). Control 
contractures to luM PE alone were performed in between each
'test' contracture to PE + NP. The size of these
contractures remained constant and are equivalent to that 
produced by PE plus 2.5nM protected NP (far left, fig.8:11). 
The developed tension in the presence of protected NP 
decreases with increasing NP concentrations, as seen 
previously (cf. fig,8:7; upper row). The relaxant effect
induced by laser photolysis of NP also increases with
increasing NP concentrations.
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Figure 8:11
The effect of laser exposure during a contracture 
antagonised by intact nitroprusside is illustrated in this 
diagram. The perfusate was illuminated by 20mW 457nm laser 
light (depicted by black bar) during contractures elicited 
by 10 phenylephrine in the presence of various
concentrations of unexposed nitroprusside.
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The results for this and similar experiments are 
shown in figure 8:12. The filled circles show peak
contracture tension in the presence of intact NP, expressed 
as a percentage of that produced by luM PE alone. The open 
circles show the contracture produced by luM PE after the NP 
is photolysed. The concentration of intact NP producing a 
50% reduction in the contracture tension is estimated to be 
5.14UM. The comparable figure for the ability of laser
photolysed NP to relax the muscle to the same extent is
45nM. Notice here that InM photolysed NP caused a detectable 
(10%) relaxation of pre-contracted preparations, whereas the 
threshold concentration for intact NP is 100 times higher 
(10“^M).
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Figure 8:12
The antagonistic dose response curves for the 
effects of unexposed (closed circles), or laser photolysed 
(open circles), nitroprusside on contractures elicited by 
10 phenylephrine are shown. Each response is normalised
to the size of the preceding control contracture to PE 
alone.
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Discussion
The ability of NP to cause relaxation of vascular
smooth muscle is the physiological basis for its
avtihypertensive action in vivo. There is strong evidence to
show that this action is linked to its ability to stimulate
guanylate cyclase activity to raise intracellular cGMP
levels, a property which it shares with the other so-called
'nitrovasodilators* (Rapoport & Murad, 1983; Waldman &
Murad, 1987). The nitrovasodilators are aptly named as they
are all capable, under appropriate conditions, of forming or
releasing nitric oxide which appears to be essential for
their activation of guanylate cyclase (Ignarro et al, 1981;
see gen. intro-). The enzyme contains a labile haem
prosthetic group, and stimulation of its activity by NO is
thought to depend on the formation of a nitrosyl-haem.
The experiments presented here show that both
protected and photolysed NP can antagonise contracture
development to PE and also cause relaxation of
pre-contracted arterial strips. The ability of intact NP to
effect these changes is especially significant. It is clear
that in this respect, vascular smooth muscle is strikingly
different to frog ventricular muscle. The latter is
completely insensitive to intact NP, even when used at
—2concentrations of 10 M. In contrast, the threshold effect 
for protected NP on the development of PE contractures is 
seen at around lOOnm (fig.8;6, 8;12). There are two
possible explanations for this difference; vascular smooth 
muscle may have a mechanism for 'stripping' NO from NP which
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is lacking in frog ventricular cells, or alternatively, the 
responses of vascular smooth muscle are not mediated by NO, 
but by some other mechanism. The second explanation is not 
considered likely for two reasons, first, the photolysis of 
NP, which is known to cause NO release (Wolfe & Swinehart, 
1975), greatly enhances its efficacy, both in inhibiting 
contractures and inducing relaxation. Secondly, evidence in 
the literature strongly supports the idea that NO mediates 
the effects of NP ( and other nitrovasodilators) on vascular 
smooth muscle (see Chapter 1), It therefore seems probable 
that smooth muscle cells possess reactive groups which are 
able to interact with NP, extract NO and transfer it to 
guanylate cyclase. There is evidence that thiols present in 
the cytosol of smooth muscle are involved in this sequence of 
events (Ignarro et al, 1981). It is postulated that they 
react with nitrovasodilators to form an nitrosothiol 
intermediate which then stimulates GC.
The extreme sensitivity of vascular smooth muscle to
NO, implied by the experiments presented here, deserves
special mention. Consider the data shown in figure 8:10,
Calculations of the amount of NO formed under the conditions
used here, using the procedure described in chapter 5, show
that this could not have been more than 30nM, yet this is
sufficient to cause an almost 5 fold increase in the EDr^5 0
value for PE. Consider also the antagonistic dose response 
curve of figure 8:12. Similar calculations show that a NO 
concentration of only 37pM is sufficient to produce a 
threshold relaxant effect, 805pM induces half relaxation, 
whereas 5nM completely relaxed an arterial strip
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pre-contracted by luM PE. These concentrations are lower 
than the 0.2uM reported in the literature to fully relax a 
bovine coronary arterial strip precontracted by 30mM K 
(Gruetter, Barry, McNamara, Kadowitz & ignarro, 1981). It 
is important to emphasise that these values must represent 
upper estimates, because there is no reliable method of 
estimating the amount of NO lost through secondary reactions 
with dissolved oxygen (Wolfe & Swinehart, 1975). The less 
favourable (ie. highly oxygenated) conditions in this report 
may explain the discrepancy, as nitric oxide generated by 
photolysis in these experiments would not be so readily 
lost.
In connection with this last point, mention should 
be made of the much greater efficacy of laser photolysed NP 
as compared to NP pre-exposed to white light. Estimates of
the half life of NO in solution range from 6-30 seconds
depending on oxygenation and temperature of the solution. 
Therefore, although the duration of exposure to white light 
was much greater, and hence the total amount of NP 
photolysed was greater, it is probable that very little NO 
survives before being applied to the preparation. Exposure 
to laser light on the other hand, yields smaller quantities 
of NO, but it is generated immediately before the solution 
reaches the muscle and so there is little time for it to 
react with dissolved oxygen. Spectrophotometric measurements 
of [Aq] formed during a 1.5hr exposure to white light show 
that 0.67UM NO is generated from 5uM NP, which greatly 
exceeds (by 22 times) that produced by laser photolysis of
the same solution en route to the chamber (30nM). A
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comparison of the relative efficacies of the two procedures 
sugest that >95% of the NO formed by pre-exposing NP to 
white light is consumed prior to use.
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Summary and general discussion
chapter 9 
Summary
(1), A study has been made of the mechanism of action of 
nitroprusside on isolated frog ventricular trabeculae and 
rabbit ear arterial strips.
(2). The nitroprusside anion per se has no physiological 
action on frog ventricle (see chapters 3&4>, However, 
photolysis of nitroprusside results in the formation of a 
labile photolytic product which has a potent negative 
inotropic effect. The follow evidence is presented in support 
of this hypothesis (see chapter 4):-
i. The extent of photolysis of nitroprusside, as 
determined by the aquapentacyanoferrate concentration, 
correlates with the degree of depression of the twitch,
ii. Photolysis of nitroprusside has been shown to be 
dependent on both the intensity and wavelength of the incident 
light. Higher intensities of illumination, which are more 
potent in inducing photolysis, produce a greater reduction in 
twitch tension.
iii. Shorter wavelengths of illumination have a more 
potent effect than longer wavelengths at the same intensity.
(3). The photolytic product responsible is shown to be labile, 
as the time between exposure of nitroprusside and application 
to the muscle is critical in determining the extent of the 
negative inotropic response (see chapter 3)
(4). The following evidence shows that the physiologically
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active photolytic product is nitric oxide (see chapter 6):-
i. Agents which are known to combine with nitric oxide 
(ie. haemoglobin, superoxide anions or oxygen) are shown to 
inhibit the response. Nitrogen-flushed solutions augmented the 
response, whereas oxygen-flushed solutions attenuated it.
ii. The other products of photolysis, namely 
aquapentacyanoferrate, nitrate and nitrite, have all been
shown to be physiologically inactive.
iii. The production of nitric oxide was confirmed by 
reacting the products of photolysis with haemoglobin. 
Haemoglobin avidly binds nitric oxide to form 
nitrosyl-haemoglobin, which was identified by both visible and 
electron paramagnetic resonance spectroscopy.
(5). The reduction in peak twitch tension is associated 
primarily with a reduction in the maximum rate of rise of 
tension, but at more severe depressions, the time to peak 
tension is also shortened. A reduction in the rate of 
relaxation is sometimes observed although this is not 
consistently seen (see chapter 4).
(6). A procedure is described for estimating the concentration 
of nitric oxide formed from low concentrations of 
nitroprusside (< 10 ^M), insufficient to generate detectable 
quantities of aquapentacyanoferrate, Estimations of the 
quantal efficiency of photolysis at different wavelengths were 
obtained during the course of this study (see chapter 5).
(7). Cysteine did not enable nitroprusside to induce a
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response without prior exposure to light. However, it
potentiated the response to low concentrations of photolysed
—5nitroprusside (<10 ), but attenuated the action at higher 
concentrations (see chapter 7).
(8). The results suggest that cysteine cannot react directly 
with intact nitroprusside to form nitrosocysteine, It was 
shown that haemoglobin does not react with intact 
nitroprusside to produce nitrosyl-haemoglobin (see chapter 
6&7) .
(9). Synthetic nitrosothiols (nitrosocysteine and 
s-nitroso-N-acetylpenicillamine) are potent negative inotropic 
agents (see chapter 7).
(10). The nitroprusside anion per se induces relaxation of 
precontracted mammalian vascular smooth muscle. However, this 
effect is markedly potentiated by photolysis (see chapter 8).
(11). It is concluded that the mechanism of action of 
nitroprusside in both frog ventricle and mammalian arterial 
smooth muscle involves activation of guanylate cyclase by 
nitric oxide.
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General Discussion
Many of the points raised by this study have already 
been discussed in the relevant chapters and so will not be 
repeated here. Instead, the major findings will be discussed 
in the context of previous reports and in relation to possible 
future studies.
The major conclusion is that photolysis of 
nitroprusside (NP) increases its efficacy to decrease tension 
in both frog ventricle and mammalian vascular smooth muscle. 
The active photolytic product has been identified as nitric 
oxide which supports the hypothesis that NP, along with the 
other 'nitrovasodilators* , mediates its action through a 
nitric oxide intermediate. A wealth of evidence now exists 
that nitric oxide directly stimulates guanylate cyclase in 
vascular smooth muscle, which raises cGMP levels and induces 
relaxation. However, it is difficult to relate the results 
described here with those previously reported, because the 
photosensitivity of NP has not been fully appreciated. Over 
90% of the reports using NP fail to mention the precautions 
taken (or otherwise) to protect NP from light. Others (<10%) 
briefly mention that NP was protected from light, but do not 
say to what extent. In practice this normally entails 
preparing the solution in light then wrapping the container in 
aluminium foil. Unless the experiment is conducted in complete 
darkness throughout, which is not very practicable, then 
exposure to light will occur. This has led to the suggestion 
that nitroprusside spontaneously releases NO in aqueous 
solution, a phenomenon that can only occur through photolysis.
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It is possible that protection from light is not normally 
adequate to prevent this.
The extreme photosensitivity of NP is not widely 
appreciated, as only small intensities of light for brief 
periods are sufficient to degrade physiologically significant 
amounts. For example, the brief exposure (<0.5sec) to low 
intensity (<1.5W) white light described in chapter 3, 
generates enough NO to elicite a large depression in frog 
ventricular contractility. As the sensitivity of smooth muscle 
to NO is very much greater (see chapter 8), then arguably, 
even less photolysis might be sufficient to influence the 
physiological response. Previously reported pharmacological 
and chemical actions of NP may not be due to NP per se, but 
nitric oxide released through its photochemical destruction.
The lower efficacy of pre-exposed NP as compared to 
that photolysed in situ, emphasises that the site and timing 
of illumination is also important. if photolysis occurred 
before application (eg. during preparation or storage), then a 
reduction in efficacy may ensue, as the concentration of both 
intact NP and liberated NO will decrease. This will depend on 
the time interval between illumination and application, as 
well as on the level of oxygenation of the solution. On the 
other hand, photolysis in situ (eg. in the organ bath or 
enzyme assay) or just before application, might potentiate the 
response, as the released NO would interact directly at the
site of action. The usual assumption that photolysis leads to
a decrease in efficacy is therefore not true.
In view of the above, the results of previous reports
using NP must be interpreted with caution. Very rarely are
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adequate precautions taken to prevent photolysis, and this has 
led to difficulty in interpreting results, in future studies, 
experiments should be made with both protected and photolysed 
NP.
Inadvertent photolysis of NP may have led to incorrect 
conclusions about its pharmacological reactions. A recent 
example is in a study comparing the antagonistic effects of 
cyanide and methylene blue on arterial relaxation induced by 
EDRF and some nitrovasodi lators (NP, GTN &
S-nitroso-N-acetylpenicillamine) (Ignarro, Harbison, Wood & 
Kadowitz, 1985). It was found that methylene blue antagonised 
relaxation by all these relaxants, but cyanide only inhibited 
responses to NP. It was proposed that cyanide was ’chemically 
inactivating’ NP as preincubation of cyanide with NP inhibited 
its ability to relax smooth muscle. However, this only occurs 
if cyanide and NP are incubated at 37°C for 12-15 minutes in a 
highly oxygenated Krebs solution. A similar incubation in low 
oxygenated solution was ineffective. Photolysis of NP could 
explain these results. There was no mention of any precautions 
to protect NP from light, and it was claimed that NP releases 
nitric oxide gas . The decrease in efficacy may be due to a 
decrease in NP concentration through degradation. In high 
oxygen the NO released would be rapidly scavenged, whereas 
more NO would remain in solution in low oxygen, which could 
explain why the effect was not seen in low oxygen conditions. 
Also, the reported change in the spectral properties of 
preincubated NP would be consistent with the production of 
aquapentacyanoferrate. It appears therefore that cyanide must 
antagonise the relaxant action of NP by some other mechanism
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(possibly by binding to intracellular haem) than by chemically 
inactivating NP. This is substantiated by Leeuwenkamp et al 
(1986), who showed that cyanide did not affect NP breakdown by 
crude aortic soluble fraction in the dark.
Although this study has been highlighted, it is by no 
means unique. In general, the extent of photolysis and its 
influence on experimental results cannot be assessed.
An important conclusion to be drawn from the present 
study is that frog ventricle is insensitive to intact NP, but 
mammalian smooth muscle is not. Evidence in the literature 
suggests that thiol or haem groups in smooth muscle are 
responsible for cleaving NO from NP (see gen.intro.). Most of 
the evidence for this is plagued with doubts concerning the 
influence of photolysis. For example, the reported 
•spontaneous' formation of nitrosocysteine or
nitrosohaemoglobin when NP is added to either cysteine or 
haemoglobin (Hb), has been used as evidence for this 
hypothesis. However, results presented here (chapters 6&7) 
show that Hb can form nitrosyl-haemoglobin only with 
photolysed NP. Indirect evidence is also presented that intact 
NP and cysteine do not interact, as this mixture fails to have 
any effect on a preparation shown to be sensitive to 
preprepared nitrosocysteine (chapter 7). These results suggest 
that prior photolysis may be responsible for the in vitro 
formation of these nitrosocompounds. This does not of course, 
preclude their possible formation in vivo, as there may be a 
tissue co-factor/s (ie, a reducing agent) which mediates 
nitrosyl cleavage from NP. Direct evidence for this is the 
reported cleavage of NP by crude aortic soluble fraction in
“Page 9.7-
chapter 9
the dark {Leeuwenkamp et al, 1986).
Since frog ventricle is unresponsive to intact NP, it 
is postulated that this tissue lacks the ability to degrade 
NP. Photolysis however, releases nitric oxide which then 
induces a potent negative inotropic effect. It was previously 
shown that this correlates with an elevation of cGMP levels in 
hypodynamie frog heart. This led to the suggestion that cGMP 
is involved directly in regulating the inotropic status of the 
frog heart. If this hypothesis is correct, then it follows 
that intact NP should not alter intracellular cGMP. However, 
preliminary experiments carried out during the course of this 
study showed that both intact and pre-exposed NP (see chapter 
3) raised [cGMP] 2-4 fold, although only photolysed NP 
depressed the twitch. This is the first indication to date 
that cGMP may not be as directly involved in regulating 
contractility as previously thought. These experiments were 
conducted on normal (non-hypodynamic) ventricles using 
pre-exposed NP. For reasons given earlier (see chapter 3), 
these conditions are not ideal and further studies are 
therefore required. Levels of cGMP in normal and hypodynamie 
ventricles in response to treatment with intact or photolysed 
(in situ) NP should be measured before any definitive 
conclusions can be drawn. It may be that" frog ventricle has 
physiologically distinct pools of cGMP which mediate different 
functions, as has been suggested for mammalian heart. 
Interestingly, preliminary experiments have shown that atrial 
natriuretic peptide (ANP), an agent known to stimulate 
particulate guanylate cyclase, has no effect on frog 
ventricle. Thus, either the ANP receptor or particulate GC is
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absent in frog, or else if present then it is coupled to an 
intracellular pool of cGMP which is not associated with the 
regulation of contraction. Measurements of [cGMP] in the 
presence of ANP are required before any conclusions can be 
drawn.
The effects of photolysis were also briefly
investigated in mammalian cardiac preparations. Neither 
photolysed nor intact NP had any effect on the contractility 
of mouse papillary muscle or rat ventricular trabeculae, which 
is in agreement with previous studies. Preliminary
measurements on isolated rabbit ventricular myocytes, showed 
that both intact and photolysed NP elevated cGMP levels 11-13 
fold (in the presence of IBMX), It would appear, then, that 
photolysis is not necessary to stimulate GC activity in 
mammalian heart. The function of cGMP in this tissue remains 
enigmatic and further studies, possibly using specific 
phosphodiesterase inhibitors, are required in order to 
recognise these discrete cGMP pools and identify their 
physiological function.
The recent identification of EDRF as nitric oxide and 
the discovery of ANP has led to renewed interest in the role
of guanylate cyclase and cGMP in regulating both cardiac and 
vascular smooth muscle contractility. The discovery of an 
endocardial-derived contractile factor in mammalian heart is 
also of considerable interest. It is likely that these 
developments will prove to be of great significance in 
understanding the pathogenesis of various cardiovascular 
disorders, especially hypertension, and that they will result 
in new strategies in the design of improved methods of 
treatment.
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Triiiuoperazine suppresses the * phasic* com ponent o f the K+ contracture  
in  frog atrial trabeculae
By F. W. F iiiT N E Y  and G. K e n n o v i n .  Department of Physiology and Pharmacology, 
University of St Andrews, St Andrews, Fife K Y 16  9TS
Trifluoperazine (TFP; Smith, Kline & French Ltd, Welwyn Garden City, Herts) 
is an inhibitor of Ca*‘*'-activated calmodulin (Levin & Weiss, 1977). An earlier report 
(Flitney, Moshiri, Robertson & Singh, 1981) showed that T FP depresses twitch 
contractions of frog ventricular muscle. In this communication we demonstrate that 
it also depresses contractures of frog atrial trabeculae, and that it inhibits the 
phasic component preferentially. Trabeculae were mounted in a perfusion chamber
10s
A B C D  jsOmN
I.
10-* m -TFP 
5 min
2 X10"* m-TFP 
5 min
L
 ^ 10-* m-TFP
\  5 min
10-* m-TFP 
20 min
Fig. 1. A-D, pairs of contractures (test and controls; upper records), together with traces 
highlighting the differences between the two (control minus test ; lower records). The effect 
of TFP increases with time (C, D) and is fully reversible. It is dose-dependent (A-C) and 
preferentially depresses the phasic component (C). The latter effect is half-maximal at 
1-2 /tM (measured after 5 min exposure), under which conditions the effect on the tonic 
component is negligible.
and attached to a strain gauge using tungsten-wire snares. They were stimulated 
electrically (0*2 Hz; 3-12 V  ; 1-5 ms) and the rest length adjusted to give a maximal 
twitch. Contractures were elicited (30 s duration, 15 min intervals) using Ringer’s 
solution containing 2(X) mM-KCl. The effects of T F P  were tested by pre-treating 
preparations with concentrations ranging from 10"’ to 10"* m for 5-65 min.
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Photochem ical degradation o f nitroprusside in  relation to its negative  
inotropic action on frog heart
B y F . W, F l i t n e y  and G. K en n o v in . Department of Physiology and Pharmacology 
{Westbum Annexe), University of St Andrews, Fife K Y 16 9TS
The nitroprusside anion ([Fe(CN)gNOp" ) is stable in the dark but readily 
undergoes photolysis when exposed to light (Wolf &  Swinehart, 1975). The experi­
ments in Fig. 1 show that its negative inotropic effect on frog heart (Flitney, Moshiri 
&  Singh, 1980o, b) is probably caused by a photodegradation product- The experiments 
were conducted in a darkened room with a red safe-light as the only means of 
illumination. Isolated ventricular trabeculae were used from specimens of Rarva 
temporaria.
R + NPp + NP' NPA
100 mN
5 min R + NP .NP
Light on
3-
Fig. i. A, a preparation was exposed to 10~* m-NP, freshly prepared and protected from 
light, with little effect on the twitch. The perfusion fluid was then changed for one 
containing NP which had been pre-exposed to light (60 W tungsten bulb at 20 cm for 16 h) 
to ensure its photolysis (denoted NP*). Peak twitch tension declined (to 42 % of control) 
and recovered on re-perfusing with 10“* m  protected NP. B, a preparation was first 
perfused with protected NP, which again had little effect on the twitch. Light generated 
by a tungsten halogen source (160 W) was then directed onto the preparation for 5 min 
using a fibre-optics guide. Twitch tension declined dunng the period of illumination.
The experiments show that exposure of N P  to light is essential to elicit a negative 
inotropic response. N P  is known to be a potent activator of the enzyme guanylate 
cyclase (Murad, Arnold. Mittall & Braughler, 1979) and our previous experiments 
showed that it increased cyclic"GMP levels in frog heart. The present observations 
therefore raise an interesting question : is the stimulation of guanylate cyclase also 
dependent upon a photodegradation product ? If so, photoactivation of guanylate 
cyclase (by illuminating preparations previously loaded with protected NP) could 
permit intracellular cyclic G M P  levels to be increased abruptly.
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L aser-induced photolysis o f nitroprusside: response o f isolated frog ventri­
cu lar trabeculae to photodegradation products
B y  F , W. F l i t n e y  and G. K e n n o v in .  Department of Physiology, University o f  St 
Andrews, St Andrews, Fife K Y 16  9TS
Twitch contractions of frog ventricular trabeculae are unaffected by nitroprusside 
(NP; [Fe(CN)gNO]^) but are depressed by products which are generated during its 
photolysis (Flitney &  Kennovin, 1985). Here we demonstrate that the response is 
quantitatively related to the spectral efficacy of the photolytic process. Preparations 
were superfused with N P  and with N P  which had been illuminated (en route to the 
muscle chamber) with monochromatic light from an Argon ion laser (A (nm) — 514 5, 
488,457-9).
B
Wib)
(0
NR r NP
488 nm 457*9 nmA = 514*5 nm
8 0-4 X -468
10- *  10- 'M —  {npkm)
Fig. I d , Effects of varying intensity o f illumination and A on responses to photolysed
NP: (a) pattern of Illumination (numbers =  light intensity (mW)); (b) solution changes;
NR =  normal Ringer; (c) twitch tension; (d) sample twitches (C =  control; 3 ,20 = mW).
B, Log dose-response curves for NP exposed to 3 mW laser light at As indicated.
The results (Pig. I A , B) show that the effect on the twitch (a) increases with 
increasing light intensity and (6) varies inversely with A. The EDgq values estimated 
from Fig. IB (and from similar dose—response curves, not shown) are reciprocally 
related to both the intensity of illumination (I) and the quantal efficiency (<P) of 
photolysis.
These observations reinforce our earlier conclusion that responses of the frog 
ventricle previously attributed to * nitroprusside’ (e.g. Flitney, Moshiri &  Singh, 
1980) are in reality caused by one (or more) of its photodegradation products.
We thank the Wellcome Trust wid British Heart Foundation for support, and Mr W. Burke 
(Burke Electronics Ltd, Gla^ow) for lending us the laser used in this study.
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Is the stim ulation o f guanylate c y c la se  by nitrogen(II) oxide responsible for 
the negative inotropic effect o f * nitroprusside* on frog ventricular trabe­
cu lae  ?
B y  F . W. F l i t n e y  and G. K e n n o v in . Departmeni o f Physiology, University of St 
Andrews, St Andrews, K  Y 16 9TS
Twitch contractions of frog ventricular trabeculae are unaffected by the nitro­
prusside anion (pentacyanonitrosylferrate(II) or [Fe“ (CNljNO]®") but are depressed 
by products formed during its photolysis (Flitney &  Kennovin, 1986). The absorption 
of a photon (by Fe“ ligand) results in pentacyanoferrate(III) and nitrogen(II) oxide 
(*N0) formation (Wolf &  Swinehart, 1975). The subsequent fate of *N0 is oxygen- 
dependent whereas that of pentacyanoferrate(III) is not. The (‘NO] can therefore be 
altered by varying [Oj] in the perfusate. Log dose-response curves to laser- 
photolysed nitroprusside (NP) are shown in Fig. 1 for nitrogen-, air- and oxygen- 
flushed solutions. 120
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Fig. 1. Dose-response curves to NP in solutions flushed with N,. air and 0$. NP solutions 
exposed to laser light (A = 457*9 nm. 20 mW) en route to the chamber. Flow rate — 9-5 ml 
min“^ . Means±s.E.s, n — 0-8 preparations.
The Ng curve ((Oj] =  O il mmol 1~') is displaced to the left relative to the air curve 
([O2] =  0 35 mmol 1”*). The high 0% curve ([0%] =  1*25 mmol M )  is similar to that 
for air at [NPJ’s <  100 jkm but responses are markedly depressed at higher [NP]’s. 
These results provide evidence that ‘N O  is the active species and that it exerts its 
effects via the enzyme guanylate cyclase (GC). This interpretation is consistent with 
the known effects of ‘N O  on purified GC. which displays a bell-shaped dose-activity 
relationship (Murad, Arnold, Mittall & Braughler, 1979).
We thank the Wellcome Trust and British Heart Foundation for supporting this study.
R EFER EN C ES
F u t n e y ,  F .  W. & K e n n o v i n ,  G. (1986). J . Physiol. 380, 37P.
M u r a d ,  F., A r n o l d ,  W. P., M i t t a l l ,  C. K. & B r a u g h l e r ,  J. M. (1979). Adv. Cyclic Nud. Res. 11, 
175-204.
W o l f ,  S . K . &  S w i n e h a r t ,  J. H . (1975). Inorg. Chem. 14, 1049-1053.
[From the Proceedings o f the Physiological Society, 19-20 June 1987
Jovm al o f Physiology, 392, 43P, 1987]
Photolysis o f nitroprusside enhances its relaxant effect on rabbit arterial 
sm ooth  m uscle
Bv F. VV. F litney and O, K e n n o v i n . Department of Physiology, University of St 
Andrews. St Andrews K  Y 16 9TS
Nitroprusside (NP) must first be photolyst'd before it can exert a depressant effect 
on twitch contractions of frog ventricular trabeculae (Flitney & Kennovin, 1986). 
The experiments to be described will show that the situation is different for 
mammalian smooth muscle. Strips of rabbit ear artery were made to contract with 
phenylephrine (PE) and then perfust*d with solutions which also contained NP. The 
latter were kept in the dark initially but then exposed for 1-2 min to laser light 
(A =  457'9 nm. 20 m W )  en route to the muscle chamber.
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Fig. I. A. Individual responses to PE and to protected or laser-photolysed (horizontal 
bar) NP. B, Log dose-response curves for PE alone (□), PE + protected NP (# )  and 
PE + exposed NP (O) Traces in d, consecutive contractions (superimposed) showing 
similar responses to those induced during single contractions (a-c). Means+s.E., n — 5 
preparations.
Fig. 1A shows that protected N P  causes a small relaxation. This effect is greatly 
enhanced during exposure to light (horizontal bars). Dose-response curves to PE in 
the presence of 5 /(M-NP (Fig. 1B) show that the efficacy of N P  is increased ca. 3-5 x 
following its photolysis.
W e thank the Wellcome Trust and British Heart Foundation for supporting this work.
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H aem oglobin  suppresses the negative inotropic effect o f  photolysed  
nitroprusside on  isolated  frog ventricular trabeculae: identification o f  
nitrosyl-haem  form ation by electron param agnetic reson ance and absorp­
tion spectroscopy
B y  F . W. F l i t n e y  and G. K e n n o v in . DepartmeTU o f Biology and PrecUnical 
Medicine, UniversUy of S t Andrews, Si Andrews K Y  16 9TS, Fife, Scotland
Photolysis of nitroprusside (NP) generates a reaction product which depresses 
twitch contractions of frog ventricular trabeculae. Evidence was presented earlier 
(Flitney &  Kennovin, 1987) implicating nitric oxide (NO*) as the physiologically 
active species formed. The experiments now reported show that the inotropic effect 
can be attenuated and may be suppressed entirely by haemoglobin (Hb) in /<m 
concentrations (Fig. I A ). The haem prosthetic group reacts with NO* under the 
conditions of our experiments to form nitrosyl-haem. This has been identified (a) by 
splitting of the 655 n m  absorption band of deoxyhaemoglobin (Fig. 1B) and (6) by 
the appearance of an electron paramagnetic resonance (EPR) signal (Fig. 1C) 
showing the hyperhne structure characteristic of highly protonated nitrosyl-haem 
(Trittelvitz et al. 1977).
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Fig. l .A ,  responses to 1 mm-NPexposed to laser light (A =  467*9 nm, 20 mW) without (# )  
and with Hb (O)- B, splitting of 555 nm absorption maximum of deoxy-Hb on binding 
of NO* ligand. C, EPR spectrum (17 K. scan 1000 G, mid-scan 3500 G ; in 100 mw 
phosphate buffer, pH 7 at 20 *C) showing hj*perfine structure typical of nitrosyl-haem.
These results support our earlier contention that NO* is the cardioactive species 
formed during photolysis of NP.
We thank the Wellcome Trust and British Heart Foundation for grant support and Dr J. Ingledew and Mr R. Rotherby for EPR facilities.
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